Scolaris Content Display Scolaris Content Display

طراحی‌ قطر (gauge) و سر سوزن برای پیشگیری از سردرد متعاقب بی‌حسی نخاعی (PDPH)

Collapse all Expand all

References

Amuzu 1995 {published data only}

Amuzu J, Patel S, Maitra‐D'Cruze A. Incidence of postdural puncture headache after Cesarean section: comparison of 26g Atraucan and 25g Whitacre spinal needles. Regional Anesthesia 1995;20(2S):150. CENTRAL

Brattebo 1995 {published data only}

Brattebo G, Wisborg T, Rodt S A, Roste I. Is the pencil point spinal needle a better choice in younger patients? A comparison of 24G Sprotte with 27G Quincke needles in an unselected group of general surgical patients below 46 years of age. Acta Anaesthesiologica Scandinavica 1995;39(4):535‐8. [PUBMED: 7676793]CENTRAL

Buettner 1993 {published data only}

Buettner J, Wresch K P, Klose R. Postdural puncture headache: comparison of 25‐gauge Whitacre and Quincke needles. Regional Anesthesia 1993;18(3):166‐9. [PUBMED: 8323889 ]CENTRAL

Campbell 1993 {published data only}

Campbell DC, Douglas MJ, Pavy TJ, Merrick P, Flanagan ML, McMorland GH. Comparison of the 25‐gauge Whitacre with the 24‐gauge Sprotte spinal needle for elective caesarean section: cost implications. Canadian Journal of Anaesthesia 1993;40(12):1131‐5. [PUBMED: 8281588 ]CENTRAL

Chaudhry 2011 {published data only}

Chaudhry MA, Ahmad RZ, Qureshi ZA. Postdural puncture headache comparative study between 25 guage pencil point needle and 25 gauge quincky needle. Pakistan Journal of Medical and Health Sciences 2011;5(1):50‐4. [EMBASE: 2012548141]CENTRAL

Corbey 1997 {published data only}

Corbey MP, Bach AB, Lech K, Frorup AM. Grading of severity of postdural puncture headache after 27‐gauge Quincke and Whitacre needles. Acta Anaesthesiologica Scandinavica 1997;41:779‐84. [PUBMED: 9241342]CENTRAL

Crock 2014 {published data only}

Crock C, Orsini F, Lee KJ, Phillips RJ. Headache after lumbar puncture: randomised crossover trial of 22‐gauge versus 25‐gauge needles. Archives of Disease in Childhood 2014;99(3):203‐7. [PUBMED: 24233069]CENTRAL

De Andres 1999 {published data only}

De Andres J, Valia JC, Errando C, Rico G, Lopez‐Alarcon MD. Subarachnoid anesthesia in young patients: a comparative analysis of two needle bevels. Regional Anesthesia and Pain Medicine 1999;24:547‐52. [PUBMED: 10588560]CENTRAL

Despond 1998 {published data only}

Despond O, Meuret P, Hemmings G. Postdural puncture headache after spinal anaesthesia in young orthopaedic outpatients using 27‐g needles. Canadian Journal of Anaesthesia 1998;45:1106‐9. [PUBMED: 10021962]CENTRAL

Devcic 1993 {published data only}

Devcic A, Maitra‐D'Cruze A, Sprung J, Patel S, Kettler R. PDPH in obstetric anesthesia: comparison of 24‐gauge Sprotte and 25‐gauge Quincke needles and effect of subarachnoid administration of fentanyl. Regional Anesthesia 1993;18:222‐5. [PUBMED: 8398955 ]CENTRAL

Fernandez 1993 {published data only}

Fernandez Lasalde FD. Post dural punction migrane: a comparative study of its effects using needles of the Quincke and Whitacre type [Cefalea post punción dural: estudio comparativo de su incidencia utilzando agujas tipo Quincke y Whitacre]. Revista Argentina de Anestesiologia 1993;51(4):241‐4. [172411]CENTRAL

Fernandez 2003 {published data only}

de Diego‐Fernandez R, Tisner Madrid ML, Cabrerizo Torrente P, Sanjoaquin Mur T. Comparison of two 27‐G‐caliber needles for spinal anesthesia. Study of 1,555 patients [Comparación de dos agujas de calibre 27G para anestesia raquídea.Estudio sobre 1.555 pacientes]. Revista Española de Anestesiología y Reanimación 2003;50(4):182‐7. [ibc‐28291]CENTRAL

Flaatten 2000 {published data only}

Flaatten H, Felthaus J, Kuwelker M, Wisborg T. Postural post‐dural puncture headache. A prospective randomised study and a meta‐analysis comparing two different 0.40 mm O.D. (27 g) spinal needles. Acta Anaesthesiologica Scandinavica 2000;44(6):643‐7. [PUBMED: 10903010]CENTRAL

Fox 1996 {published data only}

Fox RGT, Reiche W, Kiefer M, Hagen T, Huber G. The influence of an atraumatic needle with a Sprotte bevel and a needle with a Quincke bevel on the incidence of complaints following myelography after lumbar puncture [Inzidenz des Postmyelographiesyndroms (PMS) und postmyelographischer Beschwerden nach lumbaler Punktion mit der bleistiftformigen Nadel nach Sprotte im Vergleich zur Nadel nac Quincke]. Radiologe 1996;36(11):921‐7. [PUBMED: 9036434]CENTRAL

Geurts 1990 {published data only}

Geurts JW, Haanschoten MC, Wijk RM, Kraak H, Besse T C. Post‐dural puncture headache in young patients. A comparative study between the use of 0.52 mm (25‐gauge) and 0.33 mm (29‐gauge) spinal needles. Acta Anaesthesiologica Scandinavica 1990;34(5):350‐3. [PUBMED: 2143882]CENTRAL

Gonzalez 2000 {published data only}

González Santillán JM, Cedillo Maguey A, Cárdenas Jurado J, Gómez Ortiz I, Cortés Rosas NE. Post puncture headache in young ambulatory patients, comparing two different kinds of spinal anesthesia needles for lower limb surgery [Cefalea postpunción en pacientes jóvenes y "ambulatorios", comparando dos tipos de agujas para anestesia espinal en cirugía de extremidad inferior]. Revista Mexicana de Anestesiología 2000;23(4):161‐6. [304288]CENTRAL

Grover 2002 {published data only}

Grover VK, Bala I, Mahajan R, Sharma S. Post‐dural puncture headache following spinal anaesthesia: comparison of 25g vs 29g spinal needles. Bahrain Medical Bulletin 2002;24(4):131‐4. [EMBASE: 2003022034]CENTRAL

Hafer 1997 {published data only}

Hafer J, Rupp D, Wollbrück M, Engel J, Hempelmann G. The effect of needle type and immobilization on postspinal headache [Die Bedeutung von Nadeltypund Immobilisation für denpostspinalen Kopfschmerz]. Der Anaesthesist 1997;46(10):860‐6. [PUBMED: 9424969 ]CENTRAL

Harrison 1993 {published data only}

Harrison PB. The contribution of needle size and other factors to headache following myelography. Neuroradiology 1993;35(7):487‐9. [PUBMED: 8232869]CENTRAL

Hopkinson 1997 {published data only}

Hopkinson JM, Samaan AK, Russell IF, Birks RJS, Patrick MR. A comparative multicentre trial of spinal needles for Caesarean section. Anaesthesia 1997;52(10):1005‐11. [PUBMED: 9370847]CENTRAL

Imarengiaye 2002 {published data only}

Imarengiaye CO, Edomwonyi NP. Evaluation of 25‐gauge Quincke and 24‐gauge Gertie Marx needles for spinal anaesthesia for caesarean section. East African Medical Journal 2002;79(7):379‐81. [PUBMED: 12638834]CENTRAL

Imbelloni 1997 {published data only}

Imbelloni LE. Whitacre and 26G Atraucan needles in patients under 50 years [Comparaçäo entre agulha 27G Whitacre com 26G Atraucan para cirurgias eletivas em pacientes abaixo de 50 anos]. Revista Brasileira de Anestesiologia 1997;47(4):288‐96. [198071]CENTRAL
Imbelloni LE, Carneiro AN. Is the Huber point needle a better choice for young patients? a comparison of 26G Atraucan with 27G Quincke needles in general surgical patients under 50 years [É a agulha ponta de huber a melhor escolha em pacientes jovens? comparaçäo entre agulha 26G atraucan com 27G quincke para cirurgias em pacientes abaixo de 50 anos]. Revista Brasileira de Anestesiologia 1997;47(5):408‐16. [238812]CENTRAL

Kang 1992 {published data only}

Kang SB, Goodnough DE, Lee YK, Olson RA, Borshoff JA, Furlano MM, et al. Comparison of 26‐ and 27‐G needles for spinal anesthesia for ambulatory surgery patients. Anesthesiology 1992;76(5):734‐8. [PUBMED: 1575341]CENTRAL

Kim 2011 {published data only}

Kim M, Yoon H. Comparison of post‐dural puncture headache and low back pain between 23 and 25 gauge Quincke spinal needles in patients over 60 years: randomized, double‐blind controlled trial. International Journal of Nursing Studies 2011;48(11):1315‐22. [PUBMED: 21561619]CENTRAL

Kleyweg 1995 {published data only}

Kleyweg RP, Hertzberger LI, Carbaat PA. Less headache following lumbar puncture with the use of an atraumatic needle; double‐blind randomized study. Nederlands Tijdschrift voor Geneeskunde 1995;139(5):232‐4. [PUBMED: 7854485 ]CENTRAL
Kleyweg RP, Hertzberger LI, Carbaat PAT. Significant reduction in post lumbar puncture headache using an atraumatic needle: a double‐blind controlled clinical trial. Journal of the Neurological Sciences 1997;18(9):S304. CENTRAL
Kleyweg RP, Hertzberger LI, Carbaat PAT. Significant reduction in post‐lumbar puncture headache using an atraumatic needle. A double‐blind, controlled clinical trial. Cephalalgia 1998;18(9):635‐7. [PUBMED: 9876888]CENTRAL

Kokki 1996 {published data only}

Kokki H, Hendolin H. Comparison of 25 G and 29 G Quincke spinal needles in paediatric day case surgery. A prospective randomized study of the puncture characteristics, success rate and postoperative complaints. Paediatric Anaesthesia 1996;6(2):115‐9. [PUBMED: 8846276]CENTRAL

Kokki 1998 {published data only}

Kokki H, Hendolin H, Turunen M. Postdural puncture headache and transient neurologic symptoms in children after spinal anaesthesia using cutting and pencil point paediatric spinal needles. Acta Anaesthesiologica Scandinavica 1998;42(9):1076‐82. [PUBMED: 9809091]CENTRAL

Kokki 1999 {published data only}

Kokki H, Salonvaara M, Herrgard E, Riikonen P. Postdural puncture headache is not an age‐related symptom in children: a prospective, open‐randomized, parallel group study comparing a 22‐gauge Quincke with a 22‐gauge Whitacre needle. Paediatric Anaesthesia 1999;9(5):429‐34. [PUBMED: 10447907 ]CENTRAL

Kokki 2000 {published data only}

Kokki H, Heikkinen M, Turunen M, Vanamo K, Hendolin H. Needle design does not affect the success rate of spinal anaesthesia or the incidence of postpuncture complications in children. Acta Anaesthesiologica Scandinavica 2000;44(2):210‐3. [PUBMED: 10695916]CENTRAL

Kuusniemi 2013 {published data only}

Kuusniemi K, Leino K, Lertola K, Pihlajamäki K, Pitkänen M. Comparison of two spinal needle types to achieve a unilateral spinal block. Journal of Anesthesia2013; Vol. 27, issue 2:224‐30. [CN‐00878559; PUBMED: 23065050]CENTRAL

Lavi 2006 {published data only}

Lavi R, Yernitzky D, Rowe JM, Weissman A, Segal D, Avivi I. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology 2006;67(8):1492‐4. [PUBMED: 17060584]CENTRAL

Lynch 1992a {published data only}

Lynch J, Arhelger S, Krings‐Ernst I. Post‐dural puncture headache in young orthopaedic in‐patients: comparison of a 0.33 mm (29‐gauge) Quincke‐type with a 0.7 mm (22‐gauge) Whitacre spinal needle in 200 patients. Acta Anaesthesiologica Scandinavica 1992;36(1):58‐61. [PUBMED: 1539481 ]CENTRAL

Mayer 1992 {published data only}

Mayer DC, Quance D, Weeks SK. Headache after spinal anesthesia for cesarean section: a comparison of the 27‐gauge Quincke and 24‐gauge Sprotte needles. Anesthesia and Analgesia 1992;75(3):377‐80. [PUBMED: 1510258]CENTRAL

McGann 1992 {published data only}

McGann GM, Gleeson FV, Kelly I, Valentine AR, Platts A, Butler P, et al. The influence of needle size on post‐myelography headache: a controlled trial. British Journal of Radiology 1992;65(780):1102‐4. [PUBMED: 1286418]CENTRAL

Morros‐Vinoles 2002 {published data only}

Morros‐Vinoles C, Perez‐Cuenca MD, Cedo‐Lluis E, Colls C, Bueno J, Cedo‐Valloba F. Comparison of efficacy and complications of 27G and 29G Sprotte needles for subarachnoid anesthesia. Revista Española de Anestesiologia y Reanimacion 2002;49(9):448‐54. [PUBMED: 12516488 ]CENTRAL

Muller 1994 {published data only}

Muller B, Adelt K, Reichmann H, Toyka K. Atraumatic needle reduces the incidence of post‐lumbar puncture syndrome. Journal of Neurology 1994;241(6):376‐80. [PUBMED: 7931432 ]CENTRAL

Oberoi 2009 {published data only}

Oberoi R, Kaul TK, Singh MR, Grewal A, Dhir R. Incidence of post dural puncture headache: 25 gauge Quincke vs 25 gauge Whitacre needles. Journal of Anaesthesiology Clinical Pharmacology 2009;25(4):420‐2. [EMBASE: 2009564360]CENTRAL

Pan 2004 {published data only}

Pan PH, Fragneto R, Moore C, Ross V. Incidence of postdural puncture headache and backache, and success rate of dural puncture: comparison of two spinal needle designs. Southern Medical Journal 2004;97(4):359‐63. [PUBMED: 15108829 ]CENTRAL
Pan PH, Fragneto R, Moore C, Ross V, Justis G. The incidence of failed spinal anesthesia, postdural puncture headache and backache is similar with Atraucan and Whitacre spinal needles. Canadian Journal of Anesthesia 2002;49(6):636‐7. [PUBMED: 12067883 ]CENTRAL

Pedersen 1996 {published data only}

Pedersen ON. Use of a 22‐gauge Whitacre needle to reduce the incidence of side effects after lumbar myelography: a prospective randomised study comparing Whitacre and Quincke spinal needles. European Radiology 1996;6(2):184‐7. [PUBMED: 8797976 ]CENTRAL

Peterman 1996 {published data only}

Peterman SB. Postmyelography headache rates with Whitacre versus Quincke 22‐gauge spinal needles. Radiology 1996;200(3):771‐8. [PUBMED: 8756930]CENTRAL

Pippa 1995 {published data only}

Pippa P, Barbagli R, Rabassini M, Doni L, Rucci FS. Postspinal headache in Taylor's approach: a comparison between 21‐ and 25‐gauge needles in orthopaedic patients. Anaesthesia and Intensive Care 1995;23(5):560‐3. [PUBMED: 8787254 ]CENTRAL

Pittoni 1995 {published data only}

Pittoni G, Toffoletto F, Calcarella G, Zanette G, Giron G P. Spinal anesthesia in outpatient knee surgery: 22‐gauge versus 25‐gauge Sprotte needle. Anesthesia and Analgesia 1995;81(1):73‐9. [PUBMED: 7598286 ]CENTRAL

Prager 1996 {published data only}

Prager JM, Roychowdhury S, Gorey MT, Lowe GM, Diamond CW, Ragin A. Spinal headaches after myelograms: comparison of needle types. American Journal of Roentgenology 1996;167(5):1289‐92. [PUBMED: 8911197]CENTRAL

Rafique 2014 {published data only}

Rafique K, Saeed M, Chaudhry IA, Mahmood S, Tamur M, Sadiq T, et al. Post spinal headache (PDPH), spinal headache, spinal needle. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:774‐7. [EMBASE: 2014808829]CENTRAL

Rasmussen 1989a {published data only}

Rasmussen BS, Blom L, Hansen P, Mikkelsen SS. Postspinal headache in young and elderly patients. Two randomised, double‐blind studies that compare 20‐ and 25‐gauge needles. Anaesthesia 1989;44:571‐3. CENTRAL

Rasmussen 1989b {published data only}

Rasmussen BS, Blom L, Hansen P, Mikkelsen SS. Postspinal headache in young and elderly patients. Two randomised, double‐blind studies that compare 20‐ and 25‐gauge needles. Anaesthesia 1989;44:571‐3. CENTRAL

Riley 2002 {published data only}

Riley ET, Hamilton CL, Ratner EF, Cohen SE. A comparison of the 24‐gauge Sprotte and Gertie Marx spinal needles for combined spinal‐epidural analgesia during labor. Anesthesiology 2002;97(3):574‐7. [PUBMED: 12218522]CENTRAL

Saenghirunvattana 2008 {published data only}

Saenghirunvattana R, Tantivitayatan K, Chumnanvech W, Tangsukkasemsun S, Siritongtaworn P. A comparison study between newly‐designed pencil‐point and cutting needles in spinal anesthesia. Journal of the Medical Association of Thailand 2008;91(Suppl 1):S156‐61. [PUBMED: 18672608 ]CENTRAL

Santanen 2004 {published data only}

Santanen U, Rautoma P, Luurila H, Erkola O, Pere P. Comparison of 27‐gauge (0.41‐mm) Whitacre and Quincke spinal needles with respect to post‐dural puncture headache and non‐dural puncture headache. Acta Anaesthesiologica Scandinavica 2004;48(4):474‐9. [PUBMED: 15025611]CENTRAL

Schmittner 2010 {published data only}

Schmittner MD, Terboven T, Dluzak M, Janke A, Limmer ME, Weiss C, et al. High incidence of post‐dural puncture headache in patients with spinal saddle block induced with Quincke needles for anorectal surgery: a randomised clinical trial. International Journal of Colorectal Disease 2010;25(6):775‐81. [PUBMED: 20148254 ]CENTRAL

Schmittner 2011 {published data only}

Schmittner M, Dluzak M, Janke A, Bussen D, Beck G. Comparison of 29‐ and 25‐gauge Quincke spinal needles for patients undergoing anorectal surgery in saddle block technique. European Journal of Anaesthesiology 2009;26(Suppl 45):21. CENTRAL
Schmittner MD, Urban N, Janke A, Weiss C, Bussen DG, Burmeister MA, et al. Influence of the pre‐operative time in upright sitting position and the needle type on the incidence of post‐dural puncture headache (PDPH) in patients receiving a spinal saddle block for anorectal surgery. International Journal of Colorectal Disease 2011;26(1):97‐102. [PUBMED: 20652572 ]CENTRAL

Schultz 1996 {published data only}

Schultz AM, Ulbing S, Kaider A, Lehofer F. Postdural puncture headache and back pain after spinal anesthesia with 27‐gauge Quincke and 26‐gauge Atraucan needles. Regional Anesthesia 1996;21(5):461‐4. [PUBMED: 8896009 ]CENTRAL

Sears 1994 {published data only}

Sears DH, Leeman MI, Jassy LJ, O'Donnell LA, Allen SG, Reisner LS. The frequency of postdural puncture headache in obstetric patients: a prospective study comparing the 24‐gauge versus the 22‐gauge Sprotte needle. Journal of Clinical Anesthesia 1994;6(1):42‐6. [PUBMED: 8142098 ]CENTRAL

Shah 2010 {published data only}

Shah VR, Bhosale GP. Spinal anaesthesia in young patients: evaluation of needle gauge and design on technical problems and postdural puncture headache. Southern African Journal of Anaesthesia and Analgesia 2010;16(3):24‐8. [EMBASE: 2010571960]CENTRAL

Shaikh 2008 {published data only}

Shaikh JM, Memon A, Memon MA, Khan M. Post dural puncture headache after spinal anaesthesia for caesarean section: a comparison of 25 g Quincke, 27 g Quincke and 27 g Whitacre spinal needles. Journal of Ayub Medical College 2008;20(3):10‐3. [PUBMED: 19610505]CENTRAL

Sharma 1995 {published data only}

Sharma SK, Gambling DR, Joshi GP, Sidawi JE, Herrera ER. Comparison of 26‐gauge Atraucan and 25‐gauge Whitacre needles: insertion characteristics and complications. Canadian Journal of Anaesthesia 1995;42(8):706‐10. [PUBMED: 7586110 ]CENTRAL

Shutt 1992 {published data only}

Shutt LE, Valentine SJ, Wee MYK, Page RJ, Prosser A, Thomas TA. Spinal anaesthesia for Caesarean section: comparison of 22‐gauge and 25‐gauge Whitacre needles with 26‐gauge Quincke needles. British Journal of Anaesthesia 1992;69(6):589‐94. [PUBMED: 1467102]CENTRAL

Smith 1994 {published data only}

Smith EA, Thorburn J, Duckworth RA, Reid JA. A comparison of 25 g and 27 g Whitacre needles for Caesarean section. Anaesthesia 1994;49(10):859‐62. [PUBMED: 7802179 ]CENTRAL

Srivastava 2010a {published data only}

Srivastava V, Jindal P, Sharma J P. Study of post dural puncture headache with 27g Quincke & Whitacre needles in obstetrics/non obstetrics patients. Middle East Journal of Anesthesiology 2010;20(5):709‐18. [PUBMED: 20803861]CENTRAL

Srivastava 2010b {published data only}

Srivastava V, Jindal P, Sharma J P. Study of post dural puncture headache with 27g Quincke & Whitacre needles in obstetrics/non obstetrics patients. Middle East Journal of Anesthesiology 2010;20(5):709‐18. [PUBMED: 20803861]CENTRAL

Standl 2004 {published data only}

Standl T, Stanek A, Burmeister MA, Gruschow S, Wahlen B, Muller K, et al. Spinal anesthesia performance conditions and side effects are comparable between the newly designed Ballpen and the Sprotte needle: results of a prospective comparative randomized multicenter study. Anesthesia and Analgesia 2004;98(2):512‐7. [PUBMED: 14742396]CENTRAL

Strupp 2001 {published data only}

Strupp M, Schueler O, Straube A, Von Stuckrad‐Barre S, Brandt T. "Atraumatic" Sprotte needle reduces the incidence of post‐lumbar puncture headaches. Neurology 2001;57(12):2310‐2. [PUBMED: 11756618 ]CENTRAL

Tabedar 2003 {published data only}

Tabedar S, Maharjan SK, Shrestha BR, Shrestha BM. A comparison of 25 gauge Quincke spinal needle with 26 gauge Eldor spinal needle for the elective Caesarian sections: insertion characteristics and complications. Kathmandu University Medical Journal 2003;1(4):263‐6. [PUBMED: 16388267 ]CENTRAL

Tarkkila 1992 {published data only}

Tarkkila PJ, Heine H, Tervo RR. Comparison of Sprotte and Quincke needles with respect to post dural puncture headache and backache. Regional Anesthesia 1992;17(5):283‐7. [PUBMED: 1419942 ]CENTRAL

Tarkkila 1994 {published data only}

Tarkkila P, Huhtala J, Salminen U. Difficulties in spinal needle use. Insertion characteristics and failure rates associated with 25‐, 27‐ and 29‐gauge Quincke‐type spinal needles. Anaesthesia 1994;49(8):723‐5. [PUBMED: 7943709 ]CENTRAL

Thomas 2000 {published data only}

Thomas SR, Jamieson DRS, Muir KW. Randomised controlled trial of atraumatic versus standard needles for diagnostic lumbar puncture. BMJ 2000;321(7267):986‐90. [PUBMED: 11039963]CENTRAL

Tourtellotte 1972 {published data only}

Tourtellotte WW, Henderson WG, Tucker RP, Gilland O, Walker JE, Kokman E. A randomized, double‐blind clinical trial comparing the 22 versus 26 gauge needle in the production of the post‐lumbar puncture syndrome in normal individuals. Headache 1972;12(2):73‐8. [PUBMED: 4262477 ]CENTRAL

Wiesel 1993 {published data only}

Wiesel S, Tessler MJ, Easdown LJ. Postdural puncture headache: a randomized prospective comparison of the 24 gauge Sprotte and the 27 gauge Quincke needles in young patients. Canadian Journal of Anaesthesia 1993;40(7):607‐11. [PUBMED: 8403134]CENTRAL

Wilkinson 1991 {published data only}

Wilkinson AG, Sellar RJ. The influence of needle size and other factors on the incidence of adverse effects caused by myelography. Clinical Radiology 1991;44(5):338‐41. [PUBMED: 1836989 ]CENTRAL

Zela 1994 {published data only}

Zela JR, Espinoza R, Ulibarri A, Hernandez DM. Post dural headache: the use of Whitacre BD No. 25 vs. Quincke No. 25 needle [Cefalea post bloqueo subaracnoideo con aguja Whitacre B‐D No. 25 vs Quincke No. 25]. Revista Mexicana de Anestesiologia 1994;17(2):66‐9. [138928]CENTRAL

Ansaloni 2000 {published data only}

Ansaloni L, Balzani C, Falaschi F, Pazè E. Post‐spinal headache after dural puncture with perpendicular or horizontal needle bevel direction: a randomized controlled trial in an African rural hospital. Tropical Doctor 2000;30(3):167‐9. [PUBMED: 10902480 ]CENTRAL

Benedetti 1992 {published data only}

Benedetti A, Calliari G, Leli G, Welber D. Sub‐arachnoid anesthesia with Sprotte and Whitacre types atraumatic needles in cesarean section. Minerva Anestesiologica 1992;58(7‐8):437‐9. [PUBMED: 1508356 ]CENTRAL

Braune 1992 {published data only}

Braune HJ, Huffmann G. A prospective double‐blind clinical trial, comparing the sharp Quincke needle (22G) with an 'atraumatic' needle (22G) in the induction of post‐lumbar puncture headache. Acta Neurologica Scandinavica 1992;86(1):50‐4. [PUBMED: 1519474 ]CENTRAL

Browne 2005 {published data only}

Browne IM, Birnbach DJ, Stein DJ, O'Gorman DA, Kuroda M. A comparison of Espocan and Tuohy needles for the combined spinal‐epidural technique for labor analgesia. Anesthesia and Analgesia 2005;101(2):535‐40, table of contents. [PUBMED: 16037172 ]CENTRAL
Browne IM, Birnbach DJ, Stein DJ, O'Gorman DA, Santos AC, Kelly‐Francis SB, et al. Comparison of Espocan and Tuohy needles for combined spinal‐epidural (CSE) analgesia [abstract]. Anesthesiology2001; Vol. 94, issue 1A:Abstract no: A18. [CN‐00363793]CENTRAL

Carrada 1997 {published data only}

Carrada S, Whizar V, Pérez A, Cabrera N. Postdural puncture headache incidence in young patients. A double blind comparative study with Atraucan 26, Quincke 26 and Whitacre 27 [Incidencia de cefalea postraquia en pacientes jóvenes. Estudio doble ciego, comparativo con Atraucan 26, Quincke 26 y Whitacre 2]. Revista Mexicana de Anestesiologia 1997;20(1):3‐10. [225059]CENTRAL

Charuluxananan 2005 {published data only}

Charuluxananan S, Kyokong O, Premsamran P. Comparison of 25 and 27 gauge needle in spinal anesthesia learning curve for anesthesia residency training. Journal of the Medical Association of Thailand 2005;88(11):1569‐73. [PUBMED: 16471104 ]CENTRAL

Das‐Neves 2001 {published data only}

Das‐Neves JFNP, Monteiro GA, De‐Almeida JR, Brun A, Sant'Anna RS, Soldate‐Duarte E. Spinal anesthesia with 27G and 29G Quincke and 27G Whitacre needles. Technical difficulties, failures and headache [Raquianestesia com agulha de Quincke 27G, 29G eWhitacre 27G. Análise da dificuldade técnica, incidência defalhas e cefaléia]. Revista Brasileira de Anestesiología 2001;51(3):196‐201. [DOI: S0034‐70942001000300002]CENTRAL

Eldor 2003 {published data only}

Eldor J. Whitacre spinal needle vs. Eldor spinal needle regarding the incidence of transient neurologic symptoms. Acta Anaesthesiologica Scandinavica 2003;47(5):635‐6. [PUBMED: 12699529 ]CENTRAL

Eshuis 1995 {published data only}

Eshuis JH. Fewer headaches following lumbar puncture when using an atraumatic needle; double‐blind randomized study. Nederlands Tijdschrift voor Geneeskunde 1995;139(13):693‐4. [PUBMED: 7723873 ]CENTRAL

Flaatten 1998 {published data only}

Flaatten H, Krakenes J, Vedeler C. Post‐dural puncture related complications after diagnostic lumbar puncture, myelography and spinal anaesthesia. Acta Neurologica Scandinavica 1998;98(6):445‐51. [PUBMED: 9875625 ]CENTRAL

Ginosar 2012 {published data only}

Ginosar Y, Smith Y, Ben‐Hur T, Lovett JM, Clements T, Ginosar YD, et al. Novel pulsatile cerebrospinal fluid model to assess pressure manometry and fluid sampling through spinal needles of different gauge: support for the use of a 22 G spinal needle with a tapered 27 G pencil‐point tip. British Journal of Anaesthesia 2012;108(2):308‐15. [PUBMED: 22157954 ]CENTRAL

Guclu 2006 {published data only}

Guclu E, Demiraran Y, Sezen G. Hearing loss after spinal anaesthesia: comparison of 22 and 25 G Quincke needles in a non‐elderly population. Clinical Otolaryngology 2006;31(4):344‐6. [PUBMED: 16911667]CENTRAL

Herbstman 1998 {published data only}

Herbstman CH, Jaffee JB, Tuman KJ, Newman LM. An in vivo evaluation of four spinal needles used for the combined spinal‐epidural technique. Anesthesia and Analgesia 1998;86(3):520‐2. [PUBMED: 9495405]CENTRAL

Huffnagle 1998 {published data only}

Huffnagle SL, Norris MC, Arkoosh VA, Huffnagle HJ, Ferouz F, Boxer L, et al. The influence of epidural needle bevel orientation on spread of sensory blockade in the laboring parturient. Anesthesia and Analgesia 1998;87(2):326‐30. [PUBMED: 9706925 ]CENTRAL

Jones 1994 {published data only}

Jones MJ, Selby IR, Gwinnutt CL, Hughes DG. Technical note: the influence of using an atraumatic needle on the incidence of post‐myelography headache. British Journal of Radiology 1994;67(796):396‐8. [PUBMED: 8173883 ]CENTRAL

Landau 2001 {published data only}

Landau R, Ciliberto CF, Goodman SR, Kim‐Lo SH, Smiley RM. Complications with 25‐gauge and 27‐gauge Whitacre needles during combined spinal‐epidural analgesia in labor. International Journal of Obstetric Anesthesia 2001;10(3):168‐71. [PUBMED: 15321605 ]CENTRAL

Lynch 1992 {published data only}

Lynch J, Arhelger S, Krings‐Ernst I, Grond S, Zech D. Whitacre 22‐gauge pencil‐point needle for spinal anaesthesia. A controlled trial in 300 young orthopaedic patients. Anaesthesia and Intensive Care 1992;20(3):322‐5. [PUBMED: 1524172 ]CENTRAL

Malhotra 2007 {published data only}

Malhotra SK, Iyer BA, Gupta AK, Raghunathan M, Nakra D. Spinal analgesia and auditory functions: a comparison of two sizes of Quincke needle. Minerva Anestesiologica 2007;73(7‐8):395‐9. [PUBMED: 17159767 ]CENTRAL

Mardirosoff 2001 {published data only}

Mardirosoff C, Dumont L, Deyaert M, Leconte M. Posture‐related distribution of hyperbaric bupivacaine in cerebro‐spinal fluid is influenced by spinal needle characteristics. Acta Anaesthesiologica Scandinavica 2001;45(6):772‐5. [PUBMED: 11421839 ]CENTRAL

Mazze 1993 {published data only}

Mazze RI, Fujinaga M. Postdural puncture headache after continuous spinal anesthesia with 18‐gauge and 20‐gauge needles. Regional Anesthesia 1993;18(1):47‐51. [PUBMED: 8448099 ]CENTRAL

Merlo 1989 {published data only}

Merlo A, Morant R, Ketz E, Gerig HJ, Senn HJ. Does post‐puncture syndrome following lumbar puncture depend on needle diameter?. Schweizerische Medizinische Wochenschrift 1989;119(49):1781‐6. [PUBMED: 2694368 ]CENTRAL

Nunes 1999 {published data only}

Nunes JF, Alves G, De Almeida JR, Silva R, Pedrosa G, Baptista A. Spinal anesthesia for cesarean section: headache evaluation with 25 G and 27 G Quincke and Whitacre needles [Raquianestesia para cesariana: avaliaçäo da cefaléia com agulhas de Quincke e Whitacre 25G e 27G]. Revista Brasileira de Anestesiologia 1999;49(3):173‐5. [277484]CENTRAL

Pjevic 1993 {published data only}

Pjevic M, Gvozdenovic L. Postspinal headache‐‐incidence and prognosis. Medicinski Pregled 1993;46(5‐6):201‐4. [PUBMED: 7869977 ]CENTRAL

Quinn 2013 {published data only}

Quinn C, MacKlin EA, Atassi N, Bowser R, Boylan K, Cudkowicz M, et al. Post‐lumbar puncture headache is reduced with use of atraumatic needles in ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 2013;14(7‐8):632‐4. [PUBMED: 23834161 ]CENTRAL

Russell 2002 {published data only}

Russell R, Popat M, Richards E, Burry J. Combined spinal epidural anaesthesia for caesarean section: a randomised comparison of Oxford, lateral and sitting positions. International Journal of Obstetric Anesthesia 2002;11(3):190‐5. [PUBMED: 15321547 ]CENTRAL

Samayoa 2004 {published data only}

Samayoa F, Ramos N, Sánchez A. Cefalea post punción dural al utilizar agujas de Quincke vrs. agujas de Whitacre en pacientes obstétricas. Revista Colombiana de Anestesiología 2004;32(4):253‐60. [195118230003]CENTRAL

Shah 2002 {published data only}

Shah A, Bhatia PK, Tulsiani KL. Post dural puncture headache in caesarean section ‐ a comparative study using 25 G Quincke, 27 G Quincke and 27 G Whitacre needle. Indian Journal of Anaesthesia 2002;46(5):373‐7. CENTRAL

Sinikoglu 2013a {published data only}

Sinikoglu NS, Yeter H, Gumus F, Belli E, Alagol A, Turan N. Reinsertion of the stylet does not affect incidence of post dural puncture headaches (PDPH) after spinal anesthesia [A reinserção do estilete não afeta a incidência de cefaleia pós‐punção dural (CPPD) após raquianestesia]. Revista Brasileira de Anestesiologia 2013;63(2):188‐92. [DOI: 10.1590/S0034‐70942013000200005]CENTRAL

Strupp 1998 {published data only}

Strupp M, Brandt T, Müller A. Incidence of post‐lumbar puncture syndrome reduced by reinserting the stylet: a randomized prospective study of 600 patients. Journal of Neurology 1998;245(9):589‐92. [PUBMED: 9758296 ]CENTRAL

Strupp 2009 {published data only}

Strupp M, Katsarava Z. Post‐lumbar puncture syndrome and spontaneous low CSF pressure syndrome. Der Nervenarzt 2009;80(12):1509‐19. [PUBMED: 19921503 ]CENTRAL

Thoren 1994 {published data only}

Thoren T, Holmstrom B, Rawal N, Schollin J, Lindeberg S, Skeppner G. Sequential combined spinal epidural block versus spinal block for cesarean section: effects on maternal hypotension and neurobehavioral function of the newborn. Anesthesia and Analgesia 1994;78(6):1087‐92. [PUBMED: 8198262 ]CENTRAL

Vallejo 2000 {published data only}

Vallejo MC, Mandell GL, Sabo DP, Ramanathan S. Postdural puncture headache: a randomized comparison of five spinal needles in obstetric patients. Anesthesia and Analgesia 2000;91(4):916‐20. [PUBMED: 11004048]CENTRAL

Van Den Berg 2011 {published data only}

Van Den Berg AA, Ghatge S, Armendariz G, Cornelius D, Wang S. Responses to dural puncture during institution of combined spinal‐epidural analgesia: a comparison of 27 gauge pencilpoint and 27 gauge cutting‐edge needles. Anaesthesia and Intensive Care 2011;39(2):247‐51. [PUBMED: 21485674 ]CENTRAL

Vilming 2001 {published data only}

Vilming ST, Kloster R, Sandvik L. The importance of sex, age, needle size, height and body mass index in post‐lumbar puncture headache. Cephalalgia 2001;21(7):738‐43. [PUBMED: 11595002 ]CENTRAL

Wilhelm 1997 {published data only}

Wilhelm S, Standl T. Continuous spinal anesthesia vs. combined spinal‐epidural anesthesia in emergency surgery. The combined spinal‐epidural anesthesia technique does not offer an advantage of spinal anesthesia with a microcatheter. Der Anaesthesist 1997;46(11):938‐42. [PUBMED: 9490580 ]CENTRAL

Bano 2004 {published data only}

Bano Farooq F, Haider S, Aftab S, Sultan ST. Comparison of 25‐gauge, Quincke and Whitacre needles for postdural puncture headache in obstetric patients. Journal of the College of Physicians and Surgeons Pakistan 2004;14(11):647‐50. [PUBMED: 15530271 ]CENTRAL

Buttner 1990 {published data only}

Buttner J, Wresch KP, Klose R. Does a cone‐shaped cannula needle offer an advantage in spinal anesthesia?. Regional‐Anaesthesie 1990;13(5):124‐8. [PUBMED: 2202024 ]CENTRAL

Castrillo 2015 {published data only}

Castrillo A, Tabernero C, Garcia‐Olmos LM, Gil C, Gutierrez R, Zamora MI, et al. Postdural puncture headache: impact of needle type, a randomized trial. Spine 2015;15:1571‐6. CENTRAL

De Andres 1994 {published data only}

De Andres J, Valia JC, Errando C, Rico G, Lopez‐Alarcon MD. Subarachnoid anesthesia in young patients: a comparative analysis of two needle bevels. Regional Anesthesia and Pain Medicine 1999;24(6):547‐52. [PUBMED: 10588560 ]CENTRAL

Fama 2015 {published data only}

Fama F, Linard C, Bierlaire D, Gioffre'‐Florio M, Fusciardi J, Laffon M. Influence of needle diameter on spinal anaesthesia puncture failures for caesarean section: a prospective, randomised, experimental study. Anaesthesia, Critical Care and Pain Medicine 2015;34:277‐80. CENTRAL

Fyneface‐Ogan 2006 {published data only}

Fyneface‐Ogan S, Mato CN, Odagme MT. Post‐dural puncture headache following caesarean section in Nigerian parturients: a comparison of two spinal needles. Nigerian Postgraduate Medical Journal 2006;13(3):200‐2. [MEDLINE: 17066105]CENTRAL

Harrison 1994 {published data only}

Harrison DA, Langham BT. Post‐dural puncture headache: a comparison of the Sprotte and Yale needles in urological surgery. European Journal of Anaesthesiology 1994;11(4):325‐7. [PUBMED: 7925339 ]CENTRAL

Hong 2015 {published data only}

Hong J, Jung S, Chang H. Whitacre needle reduces the incidence of intravascular uptake in lumbar transforaminal epidural steroid injections. Pain Physician 2015;18:325‐31. CENTRAL

Jager 1995 {published data only}

Jager H, Fenzl G, Schleifer J, Galli C. The postmyelography syndrome‐‐very rare in use of an "atraumatic needle". A controlled double‐blind study. Röntgenpraxis; Zeitschrift für radiologische Technik 1995;48(8):226‐8. [PUBMED: 7482038 ]CENTRAL

Jensen 1999 {published data only}

Jensen KM, Jensen LB, Felding M, Golbaekdal K I, Nielsen JA. Complications after spinal analgesia using three different spinal needles: Sprotee, Spinocan and Atraucan. Ugeskrift for Laeger 1999;161(49):6775‐8. [PUBMED: 10643362 ]CENTRAL

Kaul 1996 {published data only}

Kaul TK, Chopra H, Gautam PL, Anjali H. Hearing loss after spinal anaesthesia: relation to needle size. Journal of Anaesthesiology Clinical Pharmacology 1996;12(2):113‐6. [NI000672]CENTRAL

Knudsen 1998 {published data only}

Knudsen L, Dich‐Nielsen JO, Molgaard O, Staach LJ, Rasmussen A, Rajan RM. Atraucan, a new needle for spinal analgesia. Ugeskrift for Laeger 1998;160(32):4636‐9. [PUBMED: 9719744 ]CENTRAL

Lim 1992 {published data only}

Lim M, Cross GD, Sold M. Postdural puncture headache: a comparison between the 29 G Vygon and 24 G Sprotte needles. Der Anaesthesist 1992;41(9):539‐43. [PUBMED: 1416009 ]CENTRAL

Maclean 1994 {published data only}

Maclean AR, Lyons G, Dresner M. Post dural puncture headache; a comparison of the 27 gauge Quincke, 25 gauge Whitacre and the 24 gauge Sprotte needles. International Journal of Obstetric Anesthesia 1994;3(3):175‐6. [EMBASE: 1994224228]CENTRAL

Mignonsin 1991 {published data only}

Mignonsin D, Adande P, Bouabre E, Bondurand A. Isobar 0.5% bupivacaine spinal anesthesia: effects of 18 and 26 G spinal needles. Urgences Medicales 1991;10(2):58‐61. [EMBASE: 1991168386]CENTRAL

Palmieri 1993 {published data only}

Palmieri JT, Muniz M, Silva MC, Menezes P do T, Vianna A. Post dural puncture headache. A comparison between disposable and reusable Quincke needles. Regional Anesthesia 1993;18S1(15):17. CENTRAL

Puolakka 1997 {published data only}

Puolakka R, Jokinen M, Pitkänen MT, Rosenberg P. Comparison of postanaesthetic sequelae of clinical use of 27‐gauge cutting and noncutting spinal needles. Acta Anaesthesiologica Scandinavica 1997;41(6):164. [PUBMED: 9425967 ]CENTRAL

Vandana 2004 {published data only}

Vandana, Katyal S, Kaul Tej K, Sood D, Narula N, Singh A. Post dural puncture headache in spinal anaesthesia using 25 gauge versus 29 gauge Quincke needles. Journal of Anaesthesiology Clinical Pharmacology 2004;20(4):407‐9. [EMBASE: 2005134893]CENTRAL

Ahmed 2012 {published data only}

Ahmed J, Siddiqui SZ, Haider S, Siddiqui AS. Incidence and severity of post dural puncture headache after spinal anaesthesia for cesarean section; a comparison between 25G Quincke cutting and 25G Pencan pencil point spinal needles. Anaesthesia, Pain and Intensive Care 2012;16(1):106‐7. CENTRAL

Akdemir 2011 {published data only}

Akdemir MS, Karaman H, Olmez Kavak G, Tufek A, Celik F, Tokgoz O, et al. The association between needle types and headache. Regional Anesthesia and Pain Medicine 2011;36(5 Suppl 2):E223. CENTRAL

Bertolotto 2014 {published data only}

Bertolotto A, Motuzova Y, Sperli F, Capobianco M, Malentacchi M, Pulizzi A, et al. Post‐dural puncture headache is markedly reduced when 25 Sprotte needles are used. Multiple Sclerosis 2014;20(Suppl 1):160‐1. CENTRAL

Bertolotto 2014a {published data only}

Bertolotto A, Sperli F, Capobianco M, Malentacchi M, Pulizzi A, Malucchi S. 25G Sprotte needle strongly reduces the risk of post‐lumbare puncture headache in clinical practice. Neurology. 2014; Vol. 82 (10 Suppl 1). CENTRAL

Bham 2010 {published data only}

Bham E, Ung LK, Chan L. Comparison of 22/27g microtip vs 25g Pencan spinal needle; insertion characteristic and complications. Regional Anesthesia and Pain Medicine 2010;35(5):E68‐9. CENTRAL

IRCT201009292080N4 {unpublished data only}

IRCT201009292080N4. Comparison of Sprotte and Quincke needles with respect to post dural puncture headache. http://apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201009292080N4. Iranian Registry of Clinical Trials, (accessed 15 April 2015). CENTRAL

Lorthe 2014 {published data only}

Lorthe J, Shah S, Cohen S, Ramos D, Rah K, Kapadia A, et al. CSE for cesarean section: Gertie Marx versus Pencan spinal needles. Anesthesia and Analgesia 2014;118(5 Suppl 1):S188. CENTRAL

NCT00370604 {unpublished data only}

NCT00370604. Effect of small versus large epidural needles on postdural puncture headache study. https://clinicaltrials.gov/show/NCT00370604 (accessed 15 April 2015). [NCT00370604]CENTRAL

NCT01821807 {unpublished data only}

NCT01821807. Comparison of two spinal needles regarding postdural puncture headache. https://clinicaltrials.gov/show/NCT01821807 (Accessed 15 April 2015). CENTRAL

NCT02384031 {unpublished data only}

NCT02384031. Post‐dural puncture headache ‐ needles and biomarkers in CSF. https://clinicaltrials.gov/ct2/show/NCT02384031 (accessed 15 April 2015). CENTRAL

Shah 2011 {published data only}

Shah S, Cohen S, Negron‐Gonzalez M, Kiss G, Hunter CW. Combined spinal epidural (CSE) for cesarean section: Gertie Marx versus Pencan spinal needles. Anesthesia and Analgesia. 2011; Vol. 112 (5 Suppl 1). CENTRAL

Shaikh 2013 {published data only}

Shaikh H, Cohen S, Shah S, Shkolnikova T, Mohiuddin A, Shapiro P, et al. A comparison of gravity flow epidural block with combined spinal epidural (CSE) for cesarean section. Anesthesia and Analgesia. 2013; Vol. 116 Suppl 1. CENTRAL

Ahmed 2006

Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgraduate Medicine 2006;82(973):713‐6. [PUBMED: 7099089]

Alstadhaug 2012

Alstadhaug KB, Odeg F, Baloch FK, Berg DH, Salvesen R. Post‐lumbar puncture headache. Tidsskrift for Den Norske Laegeforening 2012;132(7):818‐21. [PUBMED: 22511093]

American Society of Anesthesiologists 2007

American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology 2007;106(4):843‐63. [PUBMED: 17413923]

Angle 2003

Angle PJ, Kronberg JE, Thompson DE, Ackerley C, Szalai JP, Duffin J, et al. Dural tissue trauma and cerebrospinal fluid leak after epidural needle puncture: effect of needle design, angle, and bevel orientation. Anesthesiology 2003;99(6):1376‐82. [PUBMED: 14639152]

Angle 2005

Angle P, Tang SL, Thompson D, Szalai JP. Expectant management of postdural puncture headache increases hospital length of stay and emergency room visits. Canadian Journal of Anaesthesia 2005;52(4):397‐402. [PUBMED: 15814755]

Arendt 2009

Arendt K, Demaerschalk BM, Wingerchuk DM, Camann W. Atraumatic lumbar puncture needles: after all these years, are we still missing the point?. Neurologist 2009;15(1):17‐20. [PUBMED: 9131853]

Arevalo‐Rodriguez 2013

Arevalo‐Rodriguez I, Ciapponi A, Munoz L, Roqué I Figuls M, Bonfill Cosp X. Posture and fluids for preventing post‐dural puncture headache. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD009199.pub2]

Armon 2005

Armon C, Evans RW. Addendum to assessment. Prevention of post‐lumbar puncture headaches: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005;65(4):510‐2. [PUBMED: 16116106]

Balshem 2011

Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401‐6. [PUBMED: 21208779]

Basurto 2013

Basurto OX, Uriona TSM, Martínez GL, Solà I, Bonfill CX. Drug therapy for preventing post‐dural puncture headache. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD001792.pub3]

Baumgarten 1987

Baumgarten RK. Should caffeine become the first‐line treatment for postdural puncture headache?. Anesthesia and Analgesia 1987;66(9):913‐4. [PUBMED: 3619102]

Berger 1998

Berger CW, Crosby ET, Grodecki W. North American survey of the management of dural puncture occurring during labour epidural analgesia. Canadian Journal of Anaesthesia 1998;45(2):110‐4. [PUBMED: 9512843]

Bezov 2010

Bezov D, Lipton RB, Ashina S. Post‐dural puncture headache: part I diagnosis, epidemiology, etiology, and pathophysiology. Headache 2010;50(7):1144‐52. [PUBMED: 20533959]

Boonmak 2010

Boonmak P, Boonmak S. Epidural blood patching for preventing and treating post‐dural puncture headache. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD001791.pub2]

Bradbury 2013

Bradbury CL, Singh SI, Badder SR, Wakely LJ, Jones PM. Prevention of post‐dural puncture headache in parturients: a systematic review and meta‐analysis. Acta Anaesthesiologica Scandinavica 2013;57(4):417‐30. [PUBMED: 23278515]

Calthorpe 2004

Calthorpe N. The history of spinal needles: getting to the point. Anaesthesia 2004;59(12):1231‐41. [PUBMED: 15549987]

Choi 2003

Choi PT, Galinski SE, Takeuchi L, Lucas S, Tamayo C, Jadad AR. PDPH is a common complication of neuraxial blockade in parturients: a meta‐analysis of obstetrical studies. Canadian Journal of Anaesthesia 2003;50(5):460‐9. [PUBMED: 12734154]

Ciapponi 2011

Ciapponi A, Glujovsky D, Bardach A, García Martí S, Comande D. EROS: a new software for early stage of systematic reviews. HTAi 2011 Conference. Rio de Janeiro, Brazil, 2011.

Ciapponi 2011a

Ciapponi A, Glujovsky D, Bardach A, García Martí S, Comande D. EROS: a new software for early stage of systematic reviews. ISPOR 3rd Latin America Conference. Hilton Mexico City Reforma in Mexico City, Mexico, 2011.

Clark 1996

Clark JW, Solomon GD, Senanayake PD, Gallagher C. Substance P concentration and history of headache in relation to postlumbar puncture headache: towards prevention. Journal of Neurology, Neurosurgery, and Psychiatry 1996;60(6):681‐3. [PUBMED: 8648338 ]

Davignon 2002

Davignon KR, Dennehy KC. Update on postdural puncture headache. International Anesthesiology Clinics 2002;40(4):89‐102. [PUBMED: 12409935]

Denny 1987

Denny N, Masters R, Pearson D, Read J, Sihota M, Selander D. Postdural puncture headache after continuous spinal anesthesia. Anesthesia and Analgesia 1987;66(8):791‐4. [PUBMED: 3605700]

Evans 2009

Evans RW. Diagnostic testing for migraine and other primary headaches. Clinical Neurology 2009;27(2):393‐415. [PUBMED: 19289222]

Glujovsky 2010

Glujovsky D, Bardach A, García Martí S, Comande D, Ciapponi A. New software for early stage of systematic reviews. XVIII Cochrane Colloquium. The Joint Colloquium of the Cochrane & Campbell Collaborations. Keystone Resort, Colorado, USA, 2010.

González‐Martínez 2005

González‐Martínez F, de León‐Belmar J, Navarro‐Gutierrez S, Herráiz‐de Castro C, Montero‐López L, Liaño‐Martínez H, et al. Lowered incidence of post‐lumbar puncture headache following the application of the second edition of the International Headache Society classification [Disminución en la incidencia de la cefalea pospunción lumbar tras la aplicación de la segunda edición de la Sociedad Internacional de Cefaleas]. Revista de Neurologia 2005;41(10):582‐6. [PUBMED: 16288419]

Grande 2005

Grande PO. Mechanisms behind postspinal headache and brain stem compression following lumbar dural puncture—a physiological approach. Acta Anaesthesiologica Scandinavica 2005;49(5):619‐26. [PUBMED: 15836674]

Guyatt 2008

Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck‐Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336(7651):995‐8. [PUBMED: 18456631]

Guyatt 2011

Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383‐94. [PUBMED: 21195583]

Guyatt 2011a

Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology 2011;64(4):395‐400. [PUBMED: 21194891]

Guyatt 2011b

Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso‐Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence—imprecision. Journal of Clinical Epidemiology 2011;64(12):1283‐93. [PUBMED: 21839614]

Guyatt 2011c

Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence—indirectness. Journal of Clinical Epidemiology 2011;64(12):1303‐10. [PUBMED: 21802903]

Guyatt 2011d

Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence—inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294‐302. [PUBMED: 21803546]

Guyatt 2011e

Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. Rating the quality of evidence—publication bias. Journal of Clinical Epidemiology 2011;64(12):1277‐82. [PUBMED: 21802904]

Guyatt 2011f

Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso‐Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology 2011;64(12):1311‐6. [PUBMED: 21802902]

Guyatt 2011g

Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso‐Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias). Journal of Clinical Epidemiology 2011;64(4):407‐15. [PUBMED: 21247734]

Halpern 1994

Halpern S, Preston R. Postdural puncture headache and spinal needle design. Metaanalyses. Anesthesiology 1994;81:1376‐83.

Harrington 2004

Harrington BE. Postdural puncture headache and the development of the epidural blood patch. Regional Anesthesia and Pain Medicine 2004;29(2):136‐63; discussion 135. [PUBMED: 15029551]

Headache Classification Subcommittee IHS 2004

Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004;24(Suppl 1):9‐160. [PUBMED: 14979299]

Higgins 2003

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60. [PUBMED: 12958120]

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

ICTRP

WHO. International Clinical Trials Registry Platform Search Portal. http://apps.who.int/trialsearch/Default.aspx.

Janssens 2003

Janssens E, Aerssens P, Alliet P, Gillis P, Raes M. Post‐dural puncture headaches in children. A literature review. European Journal of Pediatrics 2003;162(3):117‐21. [PUBMED: 12655411]

Kuczkowski 2006

Kuczkowski KM. The treatment and prevention of post‐dural puncture headache. Acta Anaesthesiologica Belgica 2006;57(1):55‐6. [PUBMED: 16617759]

McQuay 1998

McQuay HJ, Moore RA. An Evidence‐Based Resource for Pain Relief. Oxford: Oxford University Press, 1998.

Parker 1997

Parker RK, White PF. A microscopic analysis of cut‐bevel versus pencil‐point spinal needles. Anesthesia and Analgesia 1997;85(5):1101‐4. [PUBMED: 9356107 ]

Raskin 1990

Raskin NH. Lumbar puncture headache: a review. Headache 1990;30(4):197‐200. [PUBMED: 2186014]

RevMan 5.3 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Richman 2006

Richman JM, Joe EM, Cohen SR, Rowlingson AJ, Michaels RK, Jeffries MA, et al. Bevel direction and postdural puncture headache: a meta‐analysis. The Neurologist 2006;12(4):224‐8. [PUBMED: 16832241]

Sadashivaiah 2009

Sadashivaiah J, McLure H. 18‐G Tuohy needle can reduce the incidence of severe post dural puncture headache. Anaesthesia 2009;64(12):1379‐80. [MEDLINE: 20092525]

Thew 2008

Thew M, Paech MJ. Management of postdural puncture headache in the obstetric patient. Current Opinion in Anaesthesiology 2008;21(3):288‐92. [PUBMED: 18458543]

Tung 2012

Tung CE, So YT, Lansberg MG. Cost comparison between the atraumatic and cutting lumbar puncture needles. Neurology 2012;78(2):109‐13. [PUBMED: 22205758]

Turnbull 2003

Turnbull DK, Shepherd DB. Post‐dural puncture headache: pathogenesis, prevention and treatment. British Journal of Anaesthesia 2003;91(5):718‐29. [PUBMED: 14570796]

van Kooten 2008

van Kooten F, Oedit R, Bakker SL, Dippel DW. Epidural blood patch in post dural puncture headache: a randomised, observer‐blind, controlled clinical trial. Journal of Neurology, Neurosurgery and Psychiatry 2008;79(5):553‐8. [PUBMED: 17635971]

Wu 1991

Wu YW, Hui YL, Tan PP. Incidence of post‐dural puncture headache with 25‐gauge Quincke spinal needle. Anaesthesiologica Sinica 1991;29(1):538‐41. [PUBMED: 1758245]

Arevalo‐Rodriguez 2013a

Arevalo‐Rodriguez I, Muñoz L, Arevalo Jimmy J, Ciapponi A, Roqué iFM. Needle gauge and tip designs for preventing post‐dural puncture headache (PDPH). Cochrane Database of Systematic Reviews 2013, Issue 10. [DOI: 10.1002/14651858.CD010807; CD010807]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Amuzu 1995

Methods

  • Design: parallel‐group, 2 arms

  • Country: USA

  • Multisite: no

  • Needle tip used: atraumatic point

  • Needle diameter used: 26 vs 25

  • Number of attempts: 1.81 ± 0.13 vs 1.55 ± 0.08

  • Procedure: anaesthesia

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: unknown

  • Type of anaesthetic: hyperbaric bupivacaine + fentanyl

Participants

1. 208 patients enrolled (obstetric patients undergoing elective caesarean section)

Patients randomized to:

  • Atraucan spinal needle‐ASN (102, 49.03%)

  • Whitacre spinal needle‐WSN (106, 50.96%)

2. No randomized patients were excluded

3. No patients lost to follow‐up

4. Main characteristics of patients: unclear. "There were no significant differences between the patients in the two groups in terms of age, weight, height, previous history of c‐section and past history of headache"

Interventions

  1. ASN group (intervention): 26 G. "the spinal needle was advanced through a 1% lidocaine skin wheal at the L2‐3 or L3‐4 interspace until CSF return occurred". "patient (was) placed in the sitting position".

  2. WSN group (control): 25 G. "the spinal needle was advanced through a 1% lidocaine skin wheal at the L2‐3 or L3‐4 interspace until CSF return occurred". "Patient (was) placed in the sitting position"

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Number of attempts to achieve successful dural puncture

  3. Surgical anaesthesia

  4. Level of sensory blockade

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: no

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "were randomly assigned to…" (page 150)

Allocation concealment (selection bias)

Unclear risk

Quote: "were randomly assigned to…" (page 150)

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Brattebo 1995

Methods

  • Design: parallel‐group, 2 arms

  • Country: Norway

  • Multisite: no

  • Needle tip used: atraumatic vs traumatic

  • Needle diameter used: 24 vs 27

  • Number of attempts (> 2) = 7% (95% CI 4 to 11)

  • Procedure: anaesthesia

  • Site of the puncture: L2 to L5

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: unknown

  • Type of anaesthetic: lidocaine or bupivacaine

  • Patient position: sitting or lateral supine position

Participants

1. 200 patients enrolled (patients scheduled for surgery in the lower part of the body)

  • Patients randomized to:

    • Quincke 27 G (100, 50%)

    • Sprotte 24 G (100, 50%)

2. 2 patients randomized to Quincke group were excluded due to failures in identification of subarachnoidal space

3. No patients lost to follow‐up

4. Main characteristics of patients:

  • Gender ‐ male (number): Quincke group: 52; Sprotte group: 49

  • Age (mean, SD): Quincke group: 29.6, 7.5; Sprotte group: 29, 7.8

  • Position‐ lateral supine (number): Quincke group: 93; Sprotte group: 94

  • Site of the puncture L3‐4 (number): Quincke group: 75; Sprotte group: 75

  • Number of attempts at dural puncture > 2: Quincke group: 9; Sprotte group: 4

Interventions

  1. Quincke 27 G = disposable 27 G Quincke bevelled needle (Becton Dickinson Yale). The bevel was kept parallel to the spine.

  2. Sprotte 24 G = 24 G needle (Pajunk)

  3. Co‐interventions: most patients received midazolam 1 mg to 5 mg as premedication

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH: defined as a position dependent headache limiting daily activities

  2. Severe PDPH: need for an epidural blood patch

  3. Technical ease of the needle insertion: described on an arbitrary 3‐point scale, from easy to difficult

  4. Back pain

  5. Non‐specific headache

  6. Number of puncture attempts

  7. Spread of anaesthesia: adequate or insufficient

Notes

  1. Trial registration: not stated

  2. Funder: Medisinsk forskning I Finnmark

  3. Role of funder: financial support

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "… were randomised into two groups after written informed consent was obtained" (page 535)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "The patients did not know which needle was used"

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "After 72 hours all patient were contacted personally or by telephone, and questioned in a structured interview about problems or symptoms which could have been a result of the spinal anaesthetic. This interview was done by a nurse anaesthetist who was unaware of which needle that had been used, and whether any problems had occurred during the anaesthetic." (page 536)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Unclear risk

The role of the funder during the study was unclear (Medisinsk forskning I Finnmark)

Buettner 1993

Methods

  • Design: parallel‐group, 2 arms

  • Country: Germany

  • Multisite: no

  • Needle tip used: atraumatic vs traumatic

  • Needle diameter used: 25

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: unknown

  • Type of anaesthetic: 2 ml to 3.5 ml 0.5% bupivacaine (isobaric or hyperbaric solution with 8% glucose) or 1.5 ml to 2 ml 4% mepivacaine (hyperbaric solution with 9.5% glucose)

Participants

1. 400 women enrolled (consecutive patients receiving spinal anaesthesia for orthopaedic operations of the lower extremities)

Patients randomized to:

  • Whitacre (200, 50%)

  • Quincke (200, 50%)

2. No randomized patients lost to follow‐up

4. Main characteristics of patients:

  • Age (mean, SD): Whitacre group: 41.2, 16.2; Quincke group: 40.4, 17.7

  • Weight (mean, SD): Whitacre group: 76.1, 14.9; Quincke group: 76.1, 13.2

  • Height (mean, SD): Whitacre group: 173.5, 8.2; Quincke group: 173.2, 2

  • Gender ‐ male (number): Whitacre group: 150; Quincke group: 142

Interventions

  1. 25 G Whitacre needle

  2. 25 G Quincke needle. The bevel was held parallel to the dural fibres.

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH: postural headache, aggravated by standing, or sitting up, and relieving by lying down

  2. Non‐postural headache

  3. Severity of headache: scored on a 10 cm visual analogue scale

  4. Duration of headache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were randomly assigned to (…)" (page 166)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "Neither the interviewer nor the patient were aware of the kind of needle that had been used". (page 167)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Neither the interviewer nor the patient were aware of the kind of needle that had been used" (page 167)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Campbell 1993

Methods

  • Design: parallel‐group, 2 arms

  • Country: Canada

  • Multisite: no

  • Needle tip used: atraumatic needles

  • Needle diameter used: 24 vs 25

  • Number of attempts (1st or 2nd attempt): 90% vs 91%

  • Procedure: anaesthesia

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: unknown

  • Type of anaesthetic: hyperbaric 0.75% bupivacaine (Sterling‐Winthrop) and preservative‐free morphine (AH Robins Canada Inc) and Fentanyl (Janssen Pharmaceutica Inc)

Participants

1. 354 women enrolled (ASA 1 and 2 undergoing spinal anaesthesia for elective caesarean section)

Patients randomized to:

  • Sprotte (152, 50%)

  • Whitacre (152, 50%)

2. 4 patients (2 for each group) with failure to identify the subarachnoid space were excluded

Patients analysed:

  • Sprotte (150, 98.6%)

  • Whitacre (150, 98.6%)

3. Main characteristics of patients:

  • Age (mean, SD): Sprotte group: 32, 4.7; Whitacre group: 32, 5.3

  • Weight (mean, SD): Sprotte group: 73.9, 12.7; Whitacre group: 73.5, 11.4

  • Height (mean, SD): Sprotte group: 158.8, 7.5; Whitacre group: 158.7, 6.9

  • ASA I (number, %): Sprotte group: 137, 91%; Whitacre group: 135, 90%

Interventions

  1. 24 G Sprotte (Pajunk GmbH Medecin Technik, West Germany)

  2. 25 G Whitacre (Becton Dickinson, Rutherford, New Jersey)

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH: postural headache, aggravated by standing, or sitting up, and relieving by lying down

  2. Number of attempts at spinal needle insertion

  3. Dose of bupivacaine

  4. Block level

  5. Incidence of hypotension

  6. Severity of headache: mild, moderate, severe

  7. Non‐spinal headache

Notes

  1. Trial registration: not stated

  2. Funder: Becton Dickinson and Company, Rutherford, New Jersey

  3. Role of funder: supplementation of 25 G Whitacre spinal needles

  4. A priori sample size estimation: yes

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "They were randomized, using a randomization table, into two groups (…)". (page 1132)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "All patients were blinded to the needle utilized". (page 1132)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Patients were assessed after operation by an investigator blinded to the needle and not involved in their perioperative care". (page 1132)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

1.31% patients enrolled were not analysed

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Chaudhry 2011

Methods

  • Design: parallel‐group, 2 arms

  • Country: Pakistan

  • Multisite: no

  • Needle tip used: atraumatic vs traumatic

  • Needle diameter used: 25 G

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: L2‐3 or L4‐5

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: median approach

  • Type of anaesthetic: hyperbaric 0.5% bupivacaine 2 ml to 4 ml

Participants

1. 200 patients enrolled (patients from different surgical departments of Nawaz Sharif Social Security Hospital Lahore having different surgical procedures on the lower abdomen and lower limbs such as hernias, amputations, debridements, vesicolithotomy, total hip replacements, tibial nailing or plating, external fixators, caesarian sections and hysterectomies)

Excluded patients: patients with systemic disease such as uncontrolled diabetes mellitus and hypertension, congestive cardiac failure, severe anaemia, pulmonary oedema, coagulopathies and vertebral column deformities

Patients randomized to:

  • Pencil point (100, 50%)

  • Quincke (100, 50%)

2. No patients were excluded

3. Main characteristics of patients:

  • Age (mean, SEM): pencil point group: 45.9, 2.81; Quincke group: 40.9, 2.05

  • Weight (mean, SEM): pencil point group: 63.9, 3; Quincke group: 61.7, 2.13

  • Gender ‐ male (number): pencil point group: 65; Quincke group: 70

Interventions

  1. 25 G pencil point needle

  2. 25 G Quincke needle

Co‐intervention: needle directed cephalic slightly upwards towards umbilicus

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH: postural headache, aggravated by standing, or sitting up, and relieving by lying down

  2. Characteristics of headache: severity, localization, character, duration, presence or absence of associated symptoms

  3. Factors: grade the dural click as distinct or indistinct, speed of CSF back flow was immediate, delayed or slow, aspiration of CSF as easy, slow or impossible, ease of injection as acceptable or unacceptable

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Two groups consisting 100 patients each were randomly chosen". (page 1)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Several outcomes unreported in results section: speed of CSF back flow, aspiration of CSF, ease of injection

Other bias

Low risk

No other biases were identified

Corbey 1997

Methods

  • Design: parallel‐group, 2 arms

  • Country: Denmark

  • Multisite: no

  • Needle tip used: Quincke vs Whitacre

  • Needle diameter used: 27 G

  • Number of attempts: unknown

  • Procedure: spinal anaesthesia

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: unknown

  • Type of anaesthetic: Hyperbaric lignocaine 75‐100 mg, or hyperbaric bupivacaine 12.5‐15 mg,

Participants

1. 200 patients enrolled (less than 45 years of age, presenting for daycare surgery on the lower half of the body to be performed under spinal anaesthesia)

Excluded patients: unclear

    • Patients randomized to:

      • 27 G Quincke (100, 50%)

      • 27 G Whitacre (100, 50%)

2. 9 patients failed to return their questionnaires and 2 patients were recorded as failures

3. Main characteristics of patients:

  • Age (range): Quincke group: 31. 77 to 32.1; Whitacre group: 31.4 to 32

  • Weight (mean, SEM): no reported

  • Gender ‐ male (number): no reported

Interventions

Spinal anaesthesia with either a 27 G Quincke needle or 27 G Whitacre

  • 27‐gauge Quincke (external diameter 0.41 mm Becton‐Dickinson [B‐D] Meylan, Spain)

  • 27‐gauge Whitacre spinal needle (external diameter 0.41 mm [BD] Spain).

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH: postural headache, aggravated by standing, or sitting up, and relieving by lying down

  2. Postdural puncture‐related headache (PDPR‐H)

  3. Non‐specific headache

  4. Grading of severity of headache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The patients were randomly allocated to receive spinal anaesthesia" (page 780)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "Patients were not aware of which needle had been used to perform the anaesthesia". (page 780)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "The replies to the questionnaires were assessed by one of the authors who was not aware of which needle had been used to perform the anaesthesia". (page 780)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Crock 2014

Methods

  • Design: 4‐period cross‐over, blinded

  • Country: Australia

  • Multisite: no

  • International: no

  • Needle tip used: 22 G or 25 G standard cutting point

  • Needle diameter used: 22 G or 25 G

  • Number of attempts: single needle insertion 94%

  • Procedure: leukaemia treatment

  • CSF collection and methotrexate intrathecal (except in 4 procedures)

  • Site of the puncture: not stated

  • Training level of those who administered the puncture: experienced doctor

  • Median or paramedian technique: not stated

Participants

1. 133 children having LP as part of their standard treatment protocol for leukaemia, recruited during visits to the Day Surgery Unit of the Royal Children’s Hospital. Aged 4 to 15 years at the time of first procedure.

Exclusion criteria: excluded if they had insufficient LPs remaining in their planned treatment, had significant coexisting medical problems causing headache or were routinely using 25 G needles at parental request, or if there were significant social or communication problems.

3. 40 were excluded for meeting exclusion criteria

  • Insufficient LPs remaining (24)

  • Communication problems (10)

  • Using 25 G for all procedures (2)

  • Continuous headache (1)

  • Family declined to take part (3)

4. 93 were allocated to a random sequence of 4 LPs, 2 with 22 G (A) and 2 with 25 G (B), and completed 341 LPs

  • Random sequence of 4 LPs: 2 with 22 G and 2 with 25 G

  • Analysis grouped interventions with 22 G and 25 G

2. No randomized patients were excluded

3. 18 patients lost to follow‐up: 2 children had their last LP after their 16th birthday (excluded). 16 did not complete all 4 procedures for reasons such as moving interstate or finishing their treatment protocol, giving a total of 341 procedures (167 with the 22 G and 174 with the 25 G needle)

4. Main characteristics of patients (not specifying groups):

  • Age: median 6.5 years (IQR 4.6 to 9.7)

  • Percentage/number of men: 63 (68%)

  • Time between procedures (median, IQR): 49 (7 to 336)

Interventions

  1. 25 G (intervention): under general anaesthesia, lumbar puncture using 25 G for collection of CSF and then administered methotrexate intrathecal. LP position not stated. The needle was inserted with the orientation of the bevel parallel to the long axis of the dural fibres.

  2. 22 G (control): under general anaesthesia, lumbar puncture using 22 G for collection of CSF and then administered methotrexate intrathecal. LP position not stated. The needle was inserted with the orientation of the bevel parallel to the long axis of the dural fibres.

Outcomes

Primary outcomes:

  1. The presence of LP headache, defined as occurring within 7 days after the procedure, being worse within 15 minutes of standing up and improving within 30 minutes of lying down

Secondary outcomes: assessed by a 1‐page questionnaire and telephone interview on days 1, 3 and 7 following the procedure

  1. Presence of any headache within 7 days

  2. CSF collection time

  3. Total procedure time

  4. Number of failed needle attempts

  5. Impact of headache on the family and the child

Notes

  1. Trial registration: Australia and New Zealand CTR 12605000052639

  2. Funder: Perpetual philanthropy

  3. Role of funder: Funding for this project. "No person associated with the funding body had any role or involvement in any aspect of the study at any time" (page 206)

  4. A priori sample size estimation: no

  5. Conducted: May 2005 to May 2007

  6. Declared conflicts of interest: yes (page 206)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The treatment allocation was computer‐generated by an independent statistician." (page 204)

Allocation concealment (selection bias)

Low risk

Quote: "Patients were allocated a sequential study number which corresponded to a large envelope containing four smaller sealed envelopes, labelled a, b, c and d, containing details of the needle sizes to be used for four procedures" (page 204)

Blinding of participants (performance bias)

Low risk

Quote: "All LPs were performed under general anaesthesia by the same experienced doctor (CC) who was given the relevant sealed envelope immediately before the procedure. This doctor was not involved in data collection after the procedure. All other staff and study participants were blinded to the needle gauge." (page 204)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "A study researcher blinded to the needle size recorded the time from first needle insertion to successful commencement of CSF collection and the time required for collection of 22 drops of CSF (approximately 1 mL) (…) Following each procedure, parents were given a one‐page questionnaire to take home which asked them to record details of any headache in the child on days 1, 3 and 7 following the procedure (…) A researcher also phoned families on days 1, 3 and 7 after each procedure to ensure the data were recorded, and confirm the nature of any headache." (page 204)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

8.3% (31 out of 372 procedures) were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

De Andres 1999

Methods

  • Design: parallel‐group (2 arms)

  • Country: Spain

  • Multisite: no

  • International: no

  • Needle type design used: Atraucan 26 vs Whitacre 27

  • Needle diameter used: 26 vs 27

  • Procedure: subarachnoid anaesthesia

  • Number of attempts: 1.4 vs 1.5 attempts

  • Site of the puncture: unknown

  • Training level of those who administered the puncture: experienced anaesthesiologists

  • Median or paramedian technique: midline approach

  • Type of anaesthesia: 3 mL of 0.5% bupivacaine

  • Patient position: lateral position

Participants

1. 158 patients enrolled during a 12‐month period (ASA I and II, aged from 20 to 40 years, undergoing lower limb orthopaedic surgery)

Exclusion criteria: presence of hypovolaemia, coagulation disorders, infection at the puncture site, use of general anaesthesia, history of headaches, chronic back pain or pregnancy

Patients randomized to:

  • 26 G Atraucan group: 79 patients (%)

  • 27 G Whitacre group: 79 patients (%)

2. No patients were excluded from further analysis

3. Main characteristics of patients:

  • Age (mean, SD): Atraucan group: 26.8, 7.2; Whitacre group: 27.4, 7.8

  • Weight (mean, SD): Atraucan group: 75.8, 18.4; Whitacre group: 77.4, 18.5

  • Height (mean, SD): Atraucan group: 168, 18.8; Whitacre group: 172, 13.6

Interventions

  • 26 G Atraucan: B. Braun Medical, Melsungen Germany

  • 27 G Whitacre group: Becton Dickinson, Madrid, Spain

Outcomes

Outcomes were not classified as primary or secondary

  1. Technical parameters

  2. Quality of analgesia

  3. Headache (nonspecific, PDPH)

  4. Headache associated symptoms

  5. Other postoperative side effects

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "On arrival at the operating room, the patients were assigned to one of two groups using a randomization table: (…)." (page 548)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "After surgery, close follow‐up of patients was performed by an investigator blinded to the study protocol". (page 549)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Unclear risk

Information about non‐specific headaches is unclear

Other bias

Low risk

No other biases were identified

Despond 1998

Methods

  • Design: parallel‐group (2 arms) (a third arm, 20 patients, chose general anaesthesia)

  • Country: Canada

  • Multisite: no

  • International: no

  • Needle type design used: Quincke vs Whitacre

  • Needle diameter used: 27

  • Procedure: spinal anaesthesia

  • Number of attempts (1 attempt): 90 vs94

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline approach

  • Type of anaesthesia: 0.5% hyperbaric lidocaine

  • Patient position: sitting position

Participants

1. 200 patients ASA I and II, aged 18 to 45 years and scheduled for knee arthroscopy were randomly assigned to 2 groups

Unclear if patients were enrolled but not randomized

Exclusion criteria: history of migraine headaches, previous PDPH

Patients randomized to:

  • Quincke group: 100 patients (50%)

  • Whitacre group: 100 patients (50%)

2. 6 patients were excluded from analysis because exclusion criteria had been missed or they could not be contacted

Patients analysed:

  • Quincke group: 97 patients (48.5%)

  • Whitacre group: 97 patients (48.5%)

3. Main characteristics of patients:

  • Age (mean): Quincke group: 32.5; Whitacre group: 31.7

  • Men (number): Quincke group: 74; Whitacre group: 71

Interventions

  • 27 G Quincke: Becton Dickinson

  • 27 G Whitacre group: Becton Dickinson

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache

  2. Severity of headache (VAS scores)

  3. Satisfaction with technique

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Quote: "…were randomly assigned to two groups." (page 1107)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "The interview was conducted by an anaesthetist unaware of the anaesthetic technique used..." (page 1107)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

6 patients (3%) were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Devcic 1993

Methods

  • Design: factorial 2 x 2 (needle x fentanyl)

  • Country: USA

  • Multisite: no

  • Needle tip used: 24 G Sprotte vs 25 G Quincke

  • Needle diameter used: 24 vs 25

  • Number of attempts: unknown

  • Procedure: spinal anaesthesia

  • Site of the puncture: L2‐5

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: hyperbaric 0.75% bupivacaine local anaesthetic with/without 20 µg of fentanyl

  • Patient position: sitting or lateral position

Participants

1. 200 patients enrolled (healthy obstetric patients requiring caesarean section)

Exclusion criteria: patients in whom labour epidural analgesia had been attempted or performed previously, or in whom a spinal anaesthetic had been attempted with other needles

4 patients in the Sprotte group (3 Sprotte with fentanyl and 1 Sprotte with plain local anaesthetic) and 2 in the Quincke group (1 randomized to receive fentanyl and 1 Sprotte with plain local bupivacaine) were not available for follow‐up

  • Patients randomized to:

    • 24 G Sprotte + fentanyl: 47 (94%)

    • 24 G Sprotte only: 49 (98%)

    • 25 G Quincke + fentanyl: 49 (98%)

    • 25 G Quincke only: 49 (98%)

2. 6 (6%) patients randomized were excluded because exclusion criteria had been missed or because they could not be contacted

  • Patients analysed:

    • 24 G Sprotte + fentanyl: 47

    • 24 G Sprotte only: 49

    • 25 G Quincke + fentanyl: 49

    • 25 G Quincke only: 49

3. Main characteristics of patients:

  • Age (mean, SD):

    • 24 G Sprotte + fentanyl: 28.2, 5.8

    • 24 G Sprotte only: 29.5, 4.4

    • 25 G Quincke + fentanyl: 28.3, 5.6

    • 25 G Quincke only: 28.7, 5.5

  • Weight (mean, SD):

    • 24 G Sprotte + fentanyl: 76.2, 15.8

    • 24 G Sprotte only: 78.3, 15.4

    • 25 G Quincke + fentanyl: 82.6, 16.1

    • 25 G Quincke only: 79.9, 18.1

  • Height (mean, SD):

    • 24 G Sprotte + fentanyl: 165.1, 8.4

    • 24 G Sprotte only: 163.9, 7.9

    • 25 G Quincke + fentanyl: 165.3, 7.6

    • 25 G Quincke only: 163.9, 7

Interventions

  1. 24 G Sprotte + fentanyl

  2. 24 G Sprotte only

  3. 25 G Quincke + fentanyl: needle bevel was oriented parallel to the longitudinal fibres

  4. 25 G Quincke only: needle bevel was oriented parallel to the longitudinal fibres

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Severity of headache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "This randomized, blinded study (…)." (page 222)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "all patients were evaluated daily during the first 4 postoperative days by the designated nurse, who was blinded to the type of needle and medication used (...) Investigators conducting telephone follow‐up were blinded to the type of needle and anesthetic solution used". (page 223)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

4 patients (8%) were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Fernandez 1993

Methods

  • Design: parallel‐group (2 arms). A third arm, 20 patients, chose general anaesthesia).

  • Country: Argentina

  • Multisite: no

  • International: no

  • Needle type design used: Quincke vs Whitacre

  • Needle diameter used: 25 vs 24

  • Procedure: anaesthesia

  • Number of attempts (first): 86% vs 84%

  • Site of the puncture: L2‐3

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline approach

  • Type of anaesthesia: 0.5% hyperbaric bupivacaine

  • Patient position: sitting position

Participants

1. 80 patients undergoing different surgical procedures and receiving regional anaesthesia were randomized. Unclear if patients were enrolled but not randomized.

Patients randomized to:

  • Quincke group: 40 patients (50%)

  • Whitacre group: 40 patients (50%)

2. No patients were excluded from analysis

3. Main characteristics of patients:

  • Age (mean, SD): Quincke group: 37, 21; Whitacre group: 35, 28

  • Men (number): Quincke group: 28; Whitacre group: 26

  • Weight (mean, SD): Quincke group: 72, 18; Whitacre group: 75.14

Interventions

  • 25 G Quincke: no details provided

  • 24 G Whitacre group: no details provided

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache (any, PDPH)

  2. Severity of headache

  3. Duration of headache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Individuals were randomly assigned to receive…" (page 241)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Fernandez 2003

Methods

  • Design: parallel‐group (2 arms)

  • Country: Spain

  • Multisite: no

  • Needle tip used: 27 G Whitacre/Pencan vs 27 G Quincke/Spinocan

  • Needle diameter used: 27 G

  • Number of attempts: 1 to 2 attempts (easy technique): 27 G Whitacre: 84.8% vs 27 G Quincke: 78.8%

  • Procedure: spinal anaesthesia for lower abdominal surgery

  • Site of the puncture: L2‐3, L3‐4, L4‐5

  • Training level of those who administered the puncture: experienced anaesthesiologists

  • Median or paramedian technique: medial

  • Type of anaesthetic: bupivacaine 0.5% with glucose 8% (bupivacaine 0.5% hiperbaric; Inibsa laboratories)

Participants

1. 1555 patients enrolled (ASA I‐II patients undergoing lower abdominal surgery and hospitalization no more than 24 hours)

Exclusion criteria: history of PDPH in previous surgeries

Number of patients randomized per group: unclear

2. 33 patients randomized were excluded due to (unclear numbers by group):

  • Inability to follow‐up

  • Prolonged bed rest

  • Re‐operations

  • Etc. (not specified)

3. 1522 patients were analysed in 2 groups:

  • Group I: 27 G Whitacre (N = 748)

  • Group II: 27 G Quincke (N = 774)

4. No patients were lost to follow‐up

4. Main characteristics of patients:

  • Age (mean, SD): 27 G Whitacre (50.08, 16.23) vs 27 G Quincke (49.59, 14.4)

  • Gender ‐ female (number): 27 G Whitacre (464) vs 27 G Quincke (465)

  • Weight (mean, SD): 27 G Whitacre (69.8, 12.3) vs 27 G Quincke (70.1, 12.4)

  • Height (mean, SD): 27 G Whitacre (164.5, 11.5) vs 27 G Quincke (165.02, 9.4)

Interventions

  1. Whitacre group: Pencan 27 G, pencil point needle (B. Braun Melsungen AG)

  2. Quincke group: Spinocan 27 G, needle bevel cutting (B. Braun Melsungen AG)

  3. Quincke needle type was introduced with the bevel parallel to the longitudinal axis of the column and the Whitacre needle with the hole facing downwards

  4. Co‐intervention: loracepam 1 mg oral, night before surgery

Outcomes

Outcomes were not classified as primary or secondary

  1. Incidence of PDPH

  2. Technical difficulties: number of attempts

  3. Successful block

  4. Severity of headache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: not stated

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "Distribution of patients in each group were randomly using the last two digits of their medical history" (page 183)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Once the patient had started mobilisation was visited by a team member who did not know the type of needle used and asked specifically for headache occurrence." (page 183)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Flaatten 2000

Methods

  • Design: parallel‐group (2 arms)

  • Country: Norway

  • Multisite: no

  • Needle tip used: pencil vs diamond

  • Needle diameter used: 27 G

  • Number of attempts (mean): 1.09 vs 1.27

  • Procedure: spinal or epidural anaesthesia

  • Site of the puncture: unknown

  • Training level of those who administered the puncture: consultant anaesthesiologist

  • Median or paramedian technique: unknown

  • Type of anaesthetic: not standardized

  • Patient position: sitting or lateral supine position

Participants

1. 313 patients aged 18 to 55 years were enrolled (scheduled for non‐obstetric outpatient surgery below the umbilicus to be performed during spinal anaesthesia)

Exclusion criteria: unclear

Patients randomized to:

  • 27 G Pencan group:158 (50.4%)

  • 27 G Quincke group: 155 (49.5%)

2. 12 patients were excluded from analysis

  • No CSF found: 2

  • Too old: 2

  • Drunk during follow‐up: 1

  • Lost to follow‐up: 7

3. 301 patients were analysed (lost to follow‐up: 3.83%)

  • 27 G Pencan group: 153

  • 27 G Quincke group: 148

3. Main characteristics of patients:

  • Age (mean, SD): 27 G Pencan: 37.2, 9.8; 27 G Quincke: 37.8, 10.7

  • Gender ‐ male (number): 27 G Pencan: 101; 27 G Quincke: 90

  • Arthroscopy (number, %): 27 G Pencan: 94, 63.5%; 27 G Quincke: 103, 67.3%

Interventions

1. 27 G Pencan group: 0.40 mm O.D. B Braun, Germany

2. 27 G Quincke group: Spinocan 27 G, B. Braun, Germany. The bevel of the Quincke‐type spinal needle was kept parallel to the longitudinal direction of the dural sac.

Outcomes

Outcomes were not classified as primary or secondary

  1. Postoperative backache

  2. Headache

  3. PDPH

  4. Duration of headache (days)

  5. Intensity scale (NRS)

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Randomisation was performed using the sealed envelope technique.…" (page 643)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Randomisation was performed using the sealed envelope technique.…" (page 643)

Blinding of participants (performance bias)

Low risk

Quote: "All patients were blinded to the choice of spinal needle, and only the needle size of the spinal needle was documented in the anaesthetic record." (page 644)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "All patients were followed up by a single anaesthesiologist (HF) also blinded to the choice of spinal needle." (page 644)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

3.83% patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Fox 1996

Methods

  • Design: factorial 2 x 2 (needle x temperature of the contrast agent)

  • Country: Germany

  • Multisite: no

  • Needle tip used: pencil vs diamond

  • Needle diameter used: 21 G vs 22 G

  • Number of attempts: unknown

  • Procedure: myelography

  • Site of the puncture: unknown

  • Training level of those who administered the puncture: experienced neuroradiologists

  • Patient position: sitting

Participants

1. 412 patients undergoing thoracic/cervical or lumbar myelographies were enrolled

Exclusion criteria: unclear

Patients randomized to:

  • 21 G Sprotte group: 206 patients (50%)

  • 22 G Quincke group: 206 patients (50%)

Also patients inside each group were randomized to:

  • 37 °C warm cold contrast agent

  • 21 °C warm cold contrast agent

2. No patients were excluded from analysis

3. Main characteristics of patients:

  • Age (mean, SD): 21 G Sprotte group: 53.4, 7.3; 22 G Quincke group: 54.8, 7.4

  • Gender ‐ male (number): 21 G Sprotte group: 104; 22 G Quincke group: 107

  • Lumbar myelography (number): 21 G Sprotte group: 110; 22 G Quincke group: 120

  • Number of unsuccessful punctures: 21 G Sprotte group: 10; 22 G Quincke group: 9

Interventions

  1. 21 G Sprotte group: Fa.Pajunkâ, Außendurchmesser: 0.8 mm

  2. 22 G Quincke group: Fa. Becton‐Dickinson, Außendurchmesser: 0.7 mm

  3. Co‐intervention: after myelography, all patients were prescribed bed rest for at least 2 hours without special storage recommendation and were recommended additional fluid intake of 2 to ‐3 L

Outcomes

Outcomes were not classified as primary or secondary

  1. Headaches, their duration, intensity and character

  2. Nausea, vomiting, tinnitus, dizziness and neck stiffness

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: August 1995 to July 1996

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "In a prospective randomized trial the incidence of complaints after lumbar puncture…" (page 922)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Geurts 1990

Methods

  • Design: parallel‐group (2 arms)

  • Country: Netherlands

  • Multisite: no

  • Needle tip used: unknown

  • Needle diameter used: 25 vs 29

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: L 3‐4 or L 4‐5

  • Training level of those who administered the puncture: experienced anaesthesiologists

  • Median or paramedian technique: unknown

  • Type of anaesthetic: 2.5 ml to 4.0 ml of hyperbaric bupivacaine 0.5%

  • Patient position: lateral position

Participants

1. 40 patients healthy ASA I patients under 40 years of age were enrolled. Indications for surgery varied, but all operations were subumbilical.

Exclusion criteria: patients complaining of pre‐existing headache or backache

Patients randomized to:

  • 25 G group: 40 patients (50%)

  • 29 G group: 40 patients (50%)

2. No patients were excluded from analysis

3. Main characteristics of patients:

  • Age (mean, SD): 25 G group: 27.1, 5.9; 29 G group: 27.9, 7

  • Gender ‐ male (number): 25 G group: 31; 29 G group: 23

  • Lumbar myelography (number): 21 G Sprotte group: 110; 22 G Quincke group: 120

  • Arthroscopy and surgery of the knee (number): 21 G Sprotte group: 19; 22 G Quincke group: 13

Interventions

  1. 25 G group: the bevel of the needle was kept parallel to the dural fibres

  2. 29 G group: no attention was paid to the direction of the bevel

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Atypical headache

  3. Backache

  4. Differences in mean block height

  5. Volumes of bupivacaine used

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "a restricted randomised double‐blind study to ensure equal numbers in each group was initiated…" (page 350).

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The use of a 0.90 mm introducer needle ensured that the patients were unable to differentiate between the two spinal needles." (page 350)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Postoperatively, patients were visited by two of the authors (MCH and RMW), who had no knowledge of which needle size had been used for spinal anaesthesia." (page 350)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Gonzalez 2000

Methods

  • Design: parallel‐group (2 arms)

  • Country: Mexico

  • Multisite: no

  • Needle tip used: diamond vs pencil

  • Needle diameter used: 26 vs 25

  • Number of attempts = (1): all patients

  • Procedure: anaesthesia

  • Site of the puncture: L 2‐3 or L 3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline

  • Type of anaesthetic: bupivacaine 0.5%, 3 ml

  • Patient position: lateral position

Participants

1. 308 patients aged 18 to 45, ASA I, undergoing surgery in lower limbs

Exclusion criteria: column injuries, cognitive or coagulation comorbidities, infection in site of lumbar puncture

Patients randomized to:

  • 26 G Quincke group: 154 patients (50%)

  • 25 G Whitacre group: 154 patients (50%)

2. No patients were excluded from analysis

3. Main characteristics of patients:

  • Age (mean, SD): 26 G Quincke group: 28.6, 6.72; 25 G Whitacre group: 30.5, 7.1

  • Gender ‐ male (number): 26 G Quincke group:111; 25 G Whitacre group: 111

  • Ambulatory patients (number): 26 G Quincke group: 72; 25 G Whitacre group: 64

Interventions

  1. 26 G Quincke group: no further details

  2. 25 G Whitacre group: no further details

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Acceptance of anaesthetic technique in the future

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were randomly assigned to one of two groups…" (page 162)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Grover 2002

Methods

  • Design: parallel‐group (2 arms)

  • Country: India

  • Multisite: no

  • Needle tip used: diamond

  • Needle diameter used: 25 vs 29

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: L 3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: 2.5 ml to 3.5 ml of 0.5% bupivacaine in 8% dextrose

  • Patient position: unknown

Participants

1. 100 ASA Grade I and II of either sex in the age group between 25 to 45 years, who were to receive spinal anaesthesia to undergo subumbilical surgery

Exclusion criteria: obstetric patients, patients with abnormalities of spine, soft tissue infection at the site of needle insertion, acute ear infection and respiratory tract infection, coagulation disorders and neurological symptoms

Patients randomized to:

  • 25 G Quincke group: 50 patients (50%)

  • 29 G Quincke group: 50 patients (50%)

2. No patients were excluded from analysis

3. Main characteristics of patients:

  • Age (mean, SD): 25 G Quincke group: 34, 7.2; 29 G Quincke group: 33, 7.35

  • Gender ‐ male (number): 25 G Quincke group: 27; 29 G Quincke group: 31

  • Educational status/illiterate (number): 25 G Quincke group: 20; 29 G Quincke group: 19

Interventions

  1. 25 G Quincke group: no additional details

  2. 29 G Quincke group: no additional details

Co‐intervention: patients were premedicated with tablet diazepam 5 mg a night before and 5 mg on the morning of surgery. Morphine sulphate 0.15 mg/kg and promethazine 0.5 mg/kg was also administered intramuscularly to all patients 45 minutes before anaesthesia.

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Severity of PDPH

  3. Backache, atypical headache

  4. Number of redirection of the needle

  5. Complications

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were randomly divided into two groups…" (page 1)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "All the patients were visited at the end of 24 hours and then on the third and fourth post‐operative day by an anaesthetist who was not present during the performance of spinal anaesthesia." (page 2)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Hafer 1997

Methods

  • Design: parallel‐group (4 arms)

  • Country: Germany

  • Multisite: no

  • Needle tip used: diamond vs pencil

  • Needle diameter used: 26 vs 27

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: L 3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: isobaric bupivacaine 0.5% or hyperbaric mepivacaine 4%

  • Patient position: sitting position

Participants

1. 493 ASA Grade I to III patients undergoing orthopaedic surgery of the lower limbs were included

19 patients receive 2 surgeries, therefore the authors included 512 procedures in this study. However, 12 patients were excluded due to anatomical factors (1 procedure).

500 procedures randomized to:

  • 26 G Quincke group: 125 (25%)

  • 27 G Quincke group: 125 (25%)

  • 26 G Atraucan group: 125 (25%)

  • 27 G Whitacre group: 125 (25%)

Also patients were assigned to different regimes of mobilization (not analysed in the present review)

2. No patients were excluded from analysis

3. Main characteristics of patients:

  • Age (mean, SD): 26 G Quincke group: 41.7, 17.8; 27 G Quincke group: 40.7, 17.1; 26 G Atraucan group: 39.1, 16.8; 27 G Whitacre group: 42.5, 17.3

  • Gender ‐ male (number): 26 G Quincke group: 67; 27 G Quincke group: 68; 26 G Atraucan group: 70; 27 G Whitacre group: 68

  • Height (mean, SD): 26 G Quincke group: 172.3, 10.4; 27 G Quincke group: 172.1, 10; 26 G Atraucan group: 172.5, 9.6; 27 G Whitacre group: 172.8, 9.8

  • Weight (mean, SD): 26 G Quincke group: 76.1, 15.3; 27 G Quincke group: 73.2, 14; 26 G Atraucan group: 74.6, 15; 27 G Whitacre group: 76.1, 14

Interventions

  1. 26 G Quincke group: no further details were provided

  2. 27 G Quincke group: no further details were provided

  3. 26 G Atraucan group: no further details were provided

  4. 27 G Whitacre group: no further details were provided

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Other headaches

  3. Back pain

  4. Complications

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: 1994 to 1996

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "According with a random list patients were assigned to one of four groups" (page 861)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "Examiners and patients had no knowledge of the needle type used (double‐blind)." (page 861)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Examiners and patients had no knowledge of the needle type used (double‐blind)." (page 861)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Harrison 1993

Methods

  • Design: parallel‐group (2 arms)

  • Country: Canada

  • Multisite: no

  • Needle tip used: unclear

  • Needle diameter used: 22 G versus 27 G

  • Number of attempts: unknown

  • Procedure: myelography

  • Site of the puncture: upper lumbar

  • Training level of those who administered the puncture: radiology residents

  • Median or paramedian technique: unclear

  • Patient position: supine position

Participants

1. 128 patients referred to lumbar, thoracic, cervical or total column myelography were included

128 patients assigned to:

  • 22 G group: 64 (50%)

  • 25 G group: 64 (50%)

2. 15 patients were lost to follow‐up and excluded from analysis

3. Main characteristics of patients:

  • Age (mean): 22 G group: 52.9; 25 G group: 53.4

  • Gender ‐ male (number): not reported

  • Height (mean, SD): not reported

  • Weight (mean, SD): not reported

Interventions

  1. 22 G group: no further details were provided

  2. 25 G group: no further details were provided

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache after lumbar puncture

  2. Severity of headache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: 1989 to 1990

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

High risk

Quote: "Patients were numbered sequentially: in even‐numbered patients a 22 gauge needle was used and for odd‐numbered patients, a 25 gauge needle " (page 487)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

11% of patients (15) were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Hopkinson 1997

Methods

  • Design: parallel‐group (4 arms)

  • Country: UK

  • Multisite: yes

  • Needle tip used: 25 G Whitacre, 25 G Polymedic, 24 G Sprotte, 24 G Polymedic

  • Needle diameter used: 25 vs 24

  • Number of attempts (= 1): 123 vs 134 vs 121 vs 126

  • Procedure: anaesthesia

  • Site of the puncture: unknown

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: unknown

  • Type of anaesthetic: hyperbaric 0.5% bupivacaine

  • Patient position: decided by anaesthetist

Participants

1. 688 women undergoing caesarean section in whom spinal anaesthesia was clinically indicated

Exclusion criteria: anticoagulation therapy, aortic valve disease, NYHA class 3 or 4 cardiac symptomology, sepsis at the site of injection, severe pre‐eclampsia and systemic hypotension

Patients randomized to:

  • 25 G Whitacre group: 170 (24.7%)

  • 25 G Polymedic group: 170 (24.7%)

  • 24 G Sprotte group: 173 (25.1%)

  • 24 G Polymedic group: 168 (24.4%)

2. 7 patients were not studied because 1 withdrew and 5 were entered twice

A further 16 were excluded from the analysis of headache due to protocol deviations

Patients analysed (3.34% lost to follow‐up):

  • 25 G Whitacre group: 164

  • 25 G Polymedic group: 167

  • 24 G Sprotte group: 170

  • 24 G Polymedic group: 164

3. Main characteristics of patients:

  • Age (mean, SD): 25 G Whitacre group: 28.5, 5.3; 25 G Polymedic group: 28.8, 5.02; 24 G Sprotte group: 29.7, 5.33; 24 G Polymedic group: 28.2, 5.13

  • Height (mean, SD): 25 G Whitacre group: 160.7, 7.41; 25 G Polymedic group: 160.6, 8.02; 24 G Sprotte group: 162, 7.19; 24 G Polymedic group: 160.8, 7.08

  • Weight (mean, SD): 25 G Whitacre group: 74.2, 12.8; 25 G Polymedic group: 74.9, 14.36; 24 G Sprotte group: 76.8, 14.9; 24 G Polymedic group: 76.4, 14.3

Interventions

  1. 25 G Whitacre with a Yale spinal introducer (Becton Dickinson, NJ, USA)

  2. 24 G Sprotte (Rüsh, Rommelshausen, Germany). Used their own introducer packed with the needle.

  3. 24 G Polymedic (Te Ma Na Sar, Bondy, France). Used their own introducer packed with the needle.

  4. 25 G Polymedic (Te Ma Na Sar, Bondy, France). Used their own introducer packed with the needle.

Outcomes

Outcomes were not classified as primary or secondary

  1. Any headache

  2. PDPH

  3. Number of attempts to achieve satisfactory dural puncture

  4. Paraesthesia

  5. Inability to locate the subarachnoid space

  6. Failure to achieve an adequate block

  7. Hypotension

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Randomisation was achieved using sealed envelopes, which contained the needle to be used as well as the documentation" (page 1006)

Allocation concealment (selection bias)

Low risk

Quote: "Randomisation was achieved using sealed envelopes, which contained the needle to be used as well as the documentation" (page 1006)

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "all patients were seen within 48 h of surgery by a member of the study team who had not been involved with the performance of the block" (page 1007)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

3.34% of patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Imarengiaye 2002

Methods

  • Design: parallel‐group (2 arms)

  • Country: Nigeria

  • Multisite: no

  • Needle tip used: 25 G Quincke vs 24 G Gertie Marx

  • Needle diameter used: 25 vs 24

  • Number of attempts (= 1): 18 vs 19

  • Procedure: anaesthesia

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: unknown

  • Type of anaesthetic: 0.5% bupivacaine

  • Patient position: sitting position

Participants

1. 60 women ASA I or II scheduled for elective caesarean section were enrolled

Exclusion criteria: abnormal lumbar spaces, coagulopathy, infection, pre‐eclampsia or obesity

Patients randomized to:

  • 25 G Quincke group: 30 (50%)

  • 24 G Gertie Marx group: 30 (50%)

2. No patients were excluded at follow‐up

3. Main characteristics of patients:

  • Age (mean, SD): 25 G Quincke group: 31.6, 3.9; 24 G Gertie Marx group: 32.5, 3.4

  • Height (mean, SD): 25 G Quincke group: 162.8, 3.5; 24 G Gertie Marx group: 161.1, 4.6

  • Weight (mean, SD): 25 G Quincke group: 77.7, 9.2; 24 G Gertie Marx group: 77, 10.6

Interventions

  1. 25 G Quincke Needle; the needle was introduced with the injection orifice parallel to the dural fibres

  2. 24 G Gertie Marx (IMD, Inc UT, USA, length 127 mm)

Outcomes

Outcomes were not classified as primary or secondary

  1. Number of attempts at successful identification of the spinal space

  2. Intraoperative complications

  3. PDPH

  4. No ‐ PDPH and backache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "They were randomized, pulling out of a hat method (…)". (page 379)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "All patients and the assessor of postoperative complications but not the attending anesthetists were blinded to the needle used" (page 380)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Postoperatively, the patients were visited daily for five days by an anaesthetist not involved in the perioperative care (..)" (page 1007)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Imbelloni 1997

Methods

  • Design: parallel‐group (2 arms)

  • Country: Brazil

  • Multisite: no

  • Needle tip used: Atraucan versus Quincke

  • Needle diameter used: 26 vs 27

  • Number of attempts (> 5): 14 versus 19

  • Procedure: anaesthesia

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: median or paramedian

  • Type of anaesthetic: unclear

  • Patient position: lateral or sitting

Participants

1. 693 patients under 50 years undergoing spinal anaesthesia were included

Exclusion criteria: patients with diseases that could affect CSF pressure were excluded from the study

Patients divided into 2 groups:

  • 26 G Atraucan group: 150 (21.6%)

  • 27 G Quincke group: 543 (78.3%)

2. No patients reported as lost to follow‐up

3. Main characteristics of patients:

  • Age (mean, SD): 26 G Atraucan group: 33.8, 9.31; 27 G Quincke group: 34.1, 9.97

  • Height (mean, SD): 26 G Atraucan group: 167.2, 9.06; 27 G Quincke group: 168.2, 9.31

  • Weight (mean, SD): 26 G Atraucan group: 67.08, 12.09; 27 G Quincke group: 68.6, 12.2

Interventions

  1. 26 G Atraucan (Braun Melsugen, 8.8 cm)

  2. 27 G Quincke (Becton‐Dickinson, 8.89 cm)

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Severity of headache

  3. Number of attempts to achieve satisfactory dural puncture

  4. Backache

  5. Failure to achieve an adequate block

  6. Satisfied with puncture

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

High risk

Quote: "693 patients younger than 50 years, submitted to spinal anesthesia, were divided into two groups corresponding to each type of disposable needle used" (page 3)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias.

Blinding of participants (performance bias)

Low risk

Quote: "The patients did not know which type of needle to use" (page 3)

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were reported as lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Kang 1992

Methods

  • Design: parallel‐group (2 arms)

  • Country: USA

  • Multisite: no

  • Needle tip used: 26 G Quincke vs 27 G Quincke

  • Needle diameter used: 26 vs 27

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: L3‐4, L4‐5 or L5‐S1

  • Training level of those who administered the puncture: investigators

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: lidocaine 5% with glucose 7.5% or bupivacaine 0.75% in dextrose 8.25%

  • Patient position: unknown

Participants

1. 730 ambulatory surgery patients, 18 years or older, ASA I or II, and electing to receive spinal anaesthesia, were enrolled

Exclusion criteria: patients with history of migraine headache or chronic back pain

Number of patients randomized to each group: unclear

2. 72 patients (9.86%) were excluded at follow‐up

Patients analysed:

  • 26 G Quincke group: 322

  • 27 G Quincke group: 336

3. Main characteristics of patients:

  • Age (mean, SD): 26 G Quincke group: 38.3, 16; 27 G Quincke group: 38.6, 16.9

  • Height (mean, SD): 26 G Quincke group: 170.5, 9.5; 27 G Quincke group: 170.2, 9.7

  • Weight (mean, SD): 26 G Quincke group: 77.6, 15.7; 27 G Quincke group: 77, 15.8

  • Gender ‐ male (number): 26 G Quincke group: 158; 27 G Quincke group: 162

  • Procedures/knee and ankle arthroscopy (number): 26 G Quincke group: 234; 27 G Quincke group: 237

Interventions

  1. 26 G Quincke (Becton‐Dickinson, Rutherford, NJ), with the bevel entering the dura parallel to the longitudinal axis of the spinal cord

  2. 27 G Quincke (Becton‐Dickinson, Rutherford, NJ), with the bevel entering the dura parallel to the longitudinal axis of the spinal cord

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Duration of PDPH

  3. Back pain

  4. Satisfaction with spinal anaesthesia

  5. Willingness to it again in the future for a similar surgery

Notes

  1. Trial registration: not stated

  2. Funder: Gundersen Medical Foundation

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "were randomly assigned (…)". (page 734)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "In operating room, while patients were blinded to the needle size used (…)". (page 380)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "One of the nurse investigators (..), who had no knowledge of the patient´s needle assignment, made (…)" (page 1007)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

9.86% of patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Severity of headache and back pain are mentioned, but results are not reported. Adverse events, additional to PDPH, were not reported.

Other bias

Unclear risk

The role of the funder in this research is unclear

Kim 2011

Methods

  • Design: parallel‐group (2 arms)

  • Country: Korea

  • Multisite: no

  • Needle tip used: diamond

  • Needle diameter used: 23 vs 25

  • Number of attempts: first (60% vs 40%)

  • Procedure: anaesthesia

  • Site of the puncture: L3‐4 or L4‐5

  • Training level of those who administered the puncture: experienced nurse

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: 0.5% bupivacaine hydrochloride or 1% tetracaine with 0.1 mg to 0.2 mg epinephrine

  • Patient position: lateral position

Participants

1. 53 patients who underwent elective orthopaedic knee or hip surgery under spinal anaesthesia were enrolled (age > 60 years, ASA classes I–II, recumbent in bed for the first 24 hours postoperatively, and administration of intravenous patient‐controlled analgesia for the first 48 hours postoperatively)

Exclusion criteria: history of migraine headache, previous history of PDPH, cardiovascular or central nervous disease, and coagulation abnormality

Patients were randomized to:

  • 23 G Quincke group: 26 (49%)

  • 25 G Quincke group: 27 (51%)

2. 3 patients (5.66%) were excluded due to severe hypotension, heart problems after operation or refusal to participate in follow‐up

Patients analysed:

  • 23 G Quincke group: 25

  • 25 G Quincke group: 25

3. Main characteristics of patients:

  • Age (mean, SD): 23 G Quincke group: 68.2, 6.3; 25 G Quincke group: 68.5, 6.9

  • Height (mean, SD): 23 G Quincke group: 158.6, 7.3; 25 G Quincke group: 159.5, 7.9

  • Weight (mean, SD): 23 G Quincke group: 57.7, 7.6; 25 G Quincke group: 60.8, 8.5

  • Gender ‐ male (number): 23 G Quincke group: 9; 25 G Quincke group: 10

Interventions

  1. 23 G Quincke needles (Hakko, Chikuma, Japan). Bevel parallel to the longitudinal dural fibre.

  2. 25 G Quincke needles (Hakko, Chikuma, Japan). Bevel parallel to the longitudinal dural fibre.

  3. Co‐intervention: recumbent in bed for the first 24 hours postoperatively.

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Severity of PDPH

  3. Back pain

  4. Number of attempted lumbar punctures

Notes

  1. Trial registration: not stated

  2. Funder: none

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: December 2006 to October 2007

  6. Declared conflicts of interest: yes (none declared)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The 53 patients were randomly allocated to either the experimental group (…)" (page 1316)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "The patients were blinded to the intervention allocations. In addition, research assistants who were working as a nurse on the orthopedic nursing unit and measured postdural puncture headache and post‐operative back pain, were blinded to the intervention allocations (…)" (page 1316)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "The patients were blinded to the intervention allocations. In addition, research assistants who were working as a nurse on the orthopedic nursing unit and measured postdural puncture headache and post‐operative back pain, were blinded to the intervention allocations (…)" (page 1316)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

5.66% of patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Kleyweg 1995

Methods

  • Design: parallel‐group (2 arms, standard and atraumatic)

  • Country: The Netherlands

  • Multisite: no

  • International: no

  • Needle type design used: diamond vs pencil

  • Needle diameter used: 20 G = 0.9 mm, 22 G = 0.7 mm

  • Procedure: lumbar puncture

Participants

1. 100 patients enrolled (Dutch patients, both sexes, > 18 years of age)

Patients randomized to:

  • 20 G standard needle (50 patients)

  • 22 G atraumatic needle (49 patients)

2. 1 randomized patient was excluded due to:

  • Already had lumbar surgery (1)

3. 0 patients lost to follow‐up

4. Main characteristics of patients:

  • Age: 20 G (mean 43, range 20 to 79), 22 G (mean 47, range 15 to 78)

  • Gender: female 57/male 42; 20 G 31 female, 19 male; 22 G 26 female, 23 male

Interventions

  1. Atraumatic 22 G group (intervention)

  2. Standard 22 G group (control)

Outcomes

Outcomes were not classified as primary or secondary

  1. Incidence of PDPH in standard group

  2. Side effects

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: April 1992 to January 1993

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

At random allocation a few minutes before lumbar puncture, through telephone via the trial bureau

Allocation concealment (selection bias)

Low risk

Allocation was controlled by a central and independent randomization unit. The allocation sequence was unknown to the investigators.

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

The outcome was assessed by a medical doctor not involved in the lumbar puncture and blinded to the intervention type

Incomplete outcome data (attrition bias)
All outcomes

Low risk

1 patient excluded from the study

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Kokki 1996

Methods

  • Design: parallel‐group (2 arms)

  • Country: Finland

  • Multisite: no

  • Needle tip used: diamond

  • Needle diameter used: 25 vs 29

  • Number of attempts: 1.2 vs 1.4

  • Procedure: anaesthesia

  • Site of the puncture: L3‐4 or L4‐5

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: isobaric or hyperbaric bupivacaine 0.5% at a dose of 0.3 mg/kg‐I was used for children under 7 years old. Older children were given hyperbaric lignocaine 5% at a dose of 1 mg/kg‐l.

  • Patient position: lateral position

Participants

1. 60 ASA physical status 1 and 2 children aged one to 13 years, scheduled for day case operations of the lower abdomen, genital area or lower extremities, were enrolled

Patients were randomized to:

  • 25 G Quincke group: 30 (50%)

  • 29 G Quincke group: 30 (50%)

2. No patients were excluded at follow‐up

3. Main characteristics of patients:

  • Age, months (mean, SD): 25 G Quincke group: 86, 48; 29 G Quincke group: 80, 34

  • Height (mean, SD): 25 G Quincke group: 121, 27; 29 G Quincke group: 120, 17

  • Weight (mean, SD): 25 G Quincke group: 27, 14; 29 G Quincke group: 24, 11

  • Gender ‐ male (number): 25 G Quincke group: 21; 29 G Quincke group: 23

Interventions

  1. 25 G Quincke 89 mm long needle (Vygon, France). Needle bevel was parallel to the longitudinal dural fibres.

  2. 29 G Quincke 89 mm long needle (Vygon, France). Needle bevel was parallel to the longitudinal dural fibres.

Co‐intervention: at the end of the operation the children were given ibuprofen 10 mg/kg‐1 as a suppository for pre‐emptive pain therapy

Outcomes

Outcomes were not classified as primary or secondary

  1. Spinal puncture time

  2. Time for CSF to appear at the needle hub

  3. Injection time of the local anaesthetic

  4. Postoperative complaints

  5. PDPH

  6. Non‐PDPH

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: " The children were randomly allocated (…)" (page 116)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Kokki 1998

Methods

  • Design: parallel‐group (4 arms), open, randomized, prospective design

  • Country: Finland

  • Multisite: no

  • Needle type design used: diamond vs pencil

  • Needle diameter used: 25 G vs26 G vs 24 G vs 27 G

  • Procedure: anaesthesia

  • Number of attempts: unclear

  • Site of the puncture: L3‐4 or L4‐5, L5‐S1

  • Training level of those who administered the puncture: experienced anaesthetist

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: isobaric or hyperbaric bupivacaine 5 mg ml‐1

  • Patient position: lateral position

Participants

1. 200 patients enrolled (ASA I‐II children, aged 2 to 128 months, and scheduled for day care surgery)

Exclusion criteria: known contraindication to spinal puncture, such as an increased intracranial pressure, haemorrhagic diathesis or infection at the puncture site. Children with neurologic disorders or allergy to bupivacaine or other local anaesthetics were also excluded.

Patients randomized to:

  • 25 G Quincke (50)

  • 26 G Atraucan (50)

  • 24 G Sprotte (50)

  • 27 G Whitacre (50)

2. 5 patients randomized were excluded due to:

  • Needle too short for spinal puncture (5)

3. 1 patients lost to follow‐up:

  • Not returning questionnaire (1)

4. Main characteristics of patients:

  • Median age in months

    • 25 G Quincke (50)

    • 26 G Atraucan (44)

    • 24 G Sprotte (50)

    • 27 G Whitacre (38)

  • Number of (women/men):

    • 25 G Quincke (12/38)

    • 26 G Atraucan (6/44)

    • 24 G Sprotte (7/43)

    • 27 G Whitacre (12/38)

Interventions

  1. 25 G Quincke group: Vygon, France, 50 mm long

  2. 26 G Atraucan group: B. Braun, Germany, 25 mm long

  3. 27 G Whitacre group: Becton‐Dickinson, USA, 37 mm long

  4. 24 G Sprotte group: Pajunk, Germany, 35 mm long

Outcomes

Outcomes were not classified as primary or secondary

  1. Incidence of PDPH

  2. Post‐puncture complaints

  3. Severity of PDPH

  4. Non‐PDPH subsequent to lumbar puncture

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not reported

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The patients were randomly allocated to receive spinal anaesthesia with either (…)" (page 1077)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The parents were blinded to the needle used." (page 1077)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

6 patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Kokki 1999

Methods

  • Design: parallel‐group (2 arms), open, randomized, prospective design

  • Country: Finland

  • Multisite: no

  • Needle type design used: diamond vs pencil

  • Needle diameter used: 22 G

  • Procedure: lumbar puncture

  • Number of attempts: unclear

  • Site of the puncture: L2‐L3, L3‐L4, L4‐L5

  • Training level of those who administered the puncture: paediatricians with previous experience with spinal punctures

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: fentanyl cream

  • Patient position: lateral decubitus position, sitting position

Participants

1. 57 patients enrolled (ASA I‐II children, aged 8 months to 15 years, with cancer or neurological symptoms having a diagnostic and/or therapeutic LP)

Exclusion criteria: unclear

Patients randomized to:

  • 22 G Quincke (29)

  • 22 G Whitacre (28)

  • 48 lumbar punctures were performed with 22 G Quincke, 50 with 22 G Whitacre

2. No exclusions

3. No losses to follow‐up:

4. Main characteristics of patients:

  • Median age in months

    • 22 G Quincke (75)

    • 22 G Whitacre (86)

  • Number of (females/males):

    • 22 G Quincke (15/14)

    • 22 G Whitacre (18/10)

Interventions

  1. 22 G Quincke group: Becton‐Dickinson, Meylan, Spain, 50 mm long

  2. 22 G Whitacre group: Becton‐Dickinson, Meylan, Spain, 37 mm long

Outcomes

Outcomes were not classified as primary or secondary

  1. Incidence of PDPH

  2. Post‐puncture complaints

  3. Severity of PDPH

  4. Other complaints

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not reported

  6. Declared conflicts of interest: no

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The 53 patients were randomly allocated to either the experimental group (…)Those children having repeated LPs remained in the same needle group throughout the study" (page 1316)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "The patients were blinded to the intervention allocations. In addition, research assistants who were working as a nurse on the orthopedic nursing unit and measured postdural puncture headache and post‐operative back pain, were blinded to the intervention allocations (…)" (page 1316)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "The patients were blinded to the intervention allocations. In addition, research assistants who were working as a nurse on the orthopedic nursing unit and measured postdural puncture headache and post‐operative back pain, were blinded to the intervention allocations (…)" (page 1316)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

5.66% of patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Kokki 2000

Methods

  • Design: parallel‐group (2 arms), open, randomized

  • Country: Finland

  • Multisite: no

  • Needle type design used: pencil point and cutting point

  • Needle diameter used: a 50 mm long 25 G needle was used in children up to 7 years and a 90 mm long 27 G needle for older children

  • Procedure: anaesthesia

  • Number of attempts (1 to 2): 97%

  • Site of the puncture: unknown

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: hyperbaric bupivacaine 5 mg ml‐1 (MarcainA, Astra, Sodertelje, Sweden) was used at a dose of 0.4 mg kg‐1 in children up to 7 years and at a dose of 0.3 mg kg‐1 in older children

  • Patient position: unknown

Participants

1. 215 patients enrolled (ASA I‐II children, aged 1 to 18 years, undergoing surgery below the umbilicus)

    • Patients randomized to:

      • Pencil point (106)

      • Cutting point (109)

2. 1 patient randomized was excluded from the complication analysis

4. Main characteristics of patients:

    • Median age in years: pencil point group: 9; cutting point group: 8

    • Number of females/males: pencil point group: 36/70; cutting point group: 40/69

    • Number of ASA I/II: pencil point group: 82/27; cutting point group: 84/22

Interventions

  1. Pencil point group: Pencan, B‐Braun, Melsungen, Germany, duration: 48 seconds

  2. Cutting point group: Yale, Becton‐Dickinson, Madrid, Spain. Duration: 40 seconds

  3. Co‐intervention: each child was premedicated with diazepam and fentanyl cream was used at the puncture sites

Outcomes

Outcomes were not classified as primary or secondary

  1. Incidence of PDPH

  2. Post‐puncture complaints

  3. Severity of PDPH

  4. Any headache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: December 1997 to January 1999

  6. Declared conflicts of interest: no

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The random allocation schedule was generated by a computer and concealed until the patient arrived in the operating theatre (…)" (page 211)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to assess this item as low or high risk

Blinding of participants (performance bias)

Low risk

Quote: "Patients, parents and post‐anaesthesia care unit (PACU) nurses were unaware of the type of needle used. (…)" (page 211)

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Quote: "using an open‐randomised, parallel‐groups, and prospective design (…)" (page 211)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

1 patient was lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Kuusniemi 2013

Methods

  • Design: parallel‐group (2 arms)

  • Country: Finland

  • Multisite: no

  • International: no

  • Needle type design used: Quincke vs Whitacre

  • Needle diameter used: 27

  • Procedure: anaesthesia

  • Number of attempts (first): 25 vs 24

  • Site of the puncture: L2‐3

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline approach

  • Type of anaesthesia: 0.5% plain bupivacaine

  • Patient position: lateral position

Participants

1. 60 consecutive outpatients (ASA) physical status I–III, ages ranging between 18 and 60 years, scheduled for unilateral lower limb surgery, with spinal block being used as the sole anaesthetic without any intraoperative sedation were enrolled

Exclusion criteria: previous history of intolerance to the study drug or related compounds and existing contraindications for spinal anaesthesia, patients with a body mass index (BMI) of 30 kg/m2, those with a history of alcoholism, drug abuse, or psychological or other emotional problems, patients who were pregnant or lactating

Patients randomized to:

  • Quincke group: 30 patients (50%)

  • Whitacre group: 30 patients (50%)

2. No patients were excluded from analysis

3. Main characteristics of patients:

  • Age (mean, SD): Quincke group: 45, 9.1; Whitacre group: 42, 11.4

  • Men (number): Quincke group: 8; Whitacre group: 11

  • Weight (mean, SD): Quincke group: 70, 11.6; Whitacre group: 70, 11.2

Interventions

  • 27 G Quincke: Yale/Becton–Dickinson

  • 27 G Whitacre group: Becton–Dickinson

In both groups a 20 G introducer was applied

Outcomes

Primary outcome:

  1. Spread of spinal anaesthesia

Secondary outcomes:

  1. Patient satisfaction

  2. Adverse effects: headache, PDPH, backache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: not stated

  6. Declared conflicts of interest: yes (page 230)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "using a sealed envelope technique, the patients were randomized to two groups". (page 225)

Allocation concealment (selection bias)

Low risk

Quote: "using a sealed envelope technique, the patients were randomized to two groups" (page 225)

Blinding of participants (performance bias)

Low risk

Quote: "patients, nurses, and the anesthetist performing the motor and sensory block assessments were blinded for the spinal needle type used". (page 225)

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Lavi 2006

Methods

  • Design: parallel‐group (2 arms), prospective, randomized trial

  • Country: Israel

  • Multisite: no

  • International: no

  • Needle type design used: 22 G Quincke traumatic needle, 22 G Whitacre atraumatic needle

  • Needle diameter used: 22 G

  • Procedure: lumbar puncture

  • Patient position: patients were lying on their side and received local anaesthesia prior to the procedure

Participants

1. 63 patients enrolled (consecutive patients older than 18 years scheduled for a diagnostic or therapeutic lumbar puncture as a part of their routine clinical management)

    • 58 patients randomized to:

      • 22 G Quincke traumatic (N = 29)

      • 22 G Whitacre atraumatic (N = 29)

2. 5 patients randomized were excluded due to:

      • Low platelet count

      • Abnormal brain CT scan

      • History of recent lumbar puncture

3. 0 patients lost to follow‐up

4. Main characteristics of patients:

    • Mean age

      • 22 G Quincke traumatic: 49 years

      • 22 G Whitacre atraumatic: 42 years

    • Number (%) of women:

      • 22 G Quincke traumatic: 17 (59)

      • 22 G Whitacre atraumatic: 16 (55)

    • Percentage/number of postures during the lumbar puncture: lying on side, directed parallel to patient's axis

    • Other characteristics: PDPH was more prevalent in patients with lower BMI (< 20, 37.5%; BMI 20 to 30, 13.5%)

Interventions

  1. Quincke traumatic group: 22 G, 90 mm, TSK Japan

  2. Whitacre atraumatic group: 22 G, 0.70 mm, 103 mm, Polymedic, E.C. Japan

Outcomes

Outcomes were not classified as primary or secondary

A. Incidence of PDPH

B. Adverse events: not reported

C. Severity PDPH

D. Any headache subsequent to a lumbar puncture: not reported

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: July to December 2004

  6. Declared conflicts of interest: no (page 1492)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were randomly assigned to undergo LP with a standard (...).Patients were randomized only once. Therefore, those who required repeated LPs had them done with the same needle type." (page 1492)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "The study was blinded to the patient. However, because the different needles have different structures, the physician knew which needle was used and could not be blinded to the needle." (page 1492)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Follow‐up was performed by a physician, blinded to the randomization, on days 2 (...)". (page 1492)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Lynch 1992a

Methods

  • Design: parallel‐group (2 arms)

  • Country: Germany

  • Multisite: no

  • International: no

  • Needle type design used: Quincke vs Whitacre

  • Needle diameter used: 25 vs 22

  • Procedure: anaesthesia

  • Number of attempts: unknown

  • Site of the puncture: L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: median approach

  • Type of anaesthesia: 0.5% hyperbaric bupivacaine

  • Patient position: lateral or sitting position

Participants

1. 300 patients (ASA I or II) aged 15 to 40 years (196 male, 104 female) undergoing elective orthopaedic procedures were enrolled

Exclusion criteria: migraine or chronic severe headache, infection, local anaesthetic allergy or a preference for general anaesthesia

Patients randomized to:

  • Quincke group: 150 patients (50%)

  • Whitacre group: 150 patients (50%)

2. No patients were excluded from analysis

3. Main characteristics of patients:

  • Age (mean, SD): Quincke group: 25, 1; Whitacre group: 27.8, 1

  • Men (number): Quincke group: 95; Whitacre group: 101

  • Weight (mean, SD): Quincke group: 73, 1; Whitacre group: 73.8, 1

Interventions

  • 29 G Quincke: Spinocan, Braun

  • 22 G Whitacre group: Becton Dickinson or Monoject

All punctures were done with a 20 G introducer (Braun, Germany)

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Severity of PDPH

  3. Backache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were allocated randomly to have (…)" (page 58)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported. Presence of associated symptoms is mentioned in methods, but not reported.

Other bias

Low risk

No other biases were identified

Mayer 1992

Methods

  • Design: parallel‐group (2 arms)

  • Country: Canada

  • Multisite: yes (2 sites)

  • Needle type design used: 27 G Quincke vs 24 G Sprotte

  • Needle diameter used: 27 vs 24

  • Procedure: spinal anaesthesia

  • Number of attempts: 1.7 vs 1.6

  • Site of the puncture: L2‐3, L3‐4

  • Training level of those who administered the puncture: staff, fellows and residents under supervision

  • Median or paramedian technique: unknown

  • Type of anaesthetic: hyperbaric 0.75% bupivacaine with 8.25% dextrose or preservative‐free morphine (0.2 mg) was added to the syringe containing bupivacaine

  • Patient position: sitting or lateral position

Participants

1. 298 patients enrolled (patients consenting to spinal anaesthesia for elective and emergency caesarean section)

    • Patients randomized to:

      • 27 G Quincke group: (147, 49.3%)

      • 24 G Sprotte group: (151, 50.7%)

3. Losses to follow‐up or exclusions: not reported

2. Main characteristics of patients:

  • Age (mean, SD): 27 G Quincke group: 30.3, 5; 24 G Sprotte group: 30.5, 4.5

  • Height (mean, SD): 27 G Quincke group: 160.8, 6.1; 24 G Sprotte group: 161.9, 6.5

  • Weight (mean, SD): 27 G Quincke group: 73.7, 10.7; 24 G Sprotte group: 75.1, 12.9

Interventions

  1. Quincke group: 27 G needle, Becton‐Dickinson, Rutherford, NJ

  2. Sprotte group: 24 G needle, Pajunk, Geisingen, Germany

  3. Co‐intervention: an introducer was used in all patients

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Number of attempts at puncture

  3. Adverse events (paraesthesias)

  4. Severity of PDPH

  5. Headache different from PDPH

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The needle to be used was assigned in a random manner: (…)". (page 58)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

McGann 1992

Methods

  • Design: parallel‐group (2 arms)

  • Country: UK

  • Multisite: no

  • International: no

  • Needle type design used: unknown

  • Needle diameter used: 22 vs 26

  • Procedure: myelography

  • Number of attempts: unknown

  • Site of the puncture: unknown

  • Amount of CSF removed: 7 ml

  • Injection: 17 ml of Iohexol

  • Patient position: sitting position

Participants

1. 160 patients attending for myelography were included. Further details were not provided.

Exclusion criteria: patients with marked obstruction of CSF flow

Number of patients randomized by arm: unknown

2. 14 patients (8.75%) were excluded from analysis due to incomplete follow‐up or death

Patients analysed:

  • 22 G group: 75 patients

  • 26 G group: 71 patients

3. Main characteristics of patients (in general):

  • Males (number): 75

Interventions

  • 20 G group: no details were provided

  • 26 G group: no details were provided

After the study, patients rested in bed with head elevated for 24 hours and were encouraged to consume fluids

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache (PDPH)

  2. Severity of PDPH

  3. Procedure tolerability

  4. Other symptoms

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: unclear

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "were randomized to undergo (..)". (page 1102)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "The patients were questioned by an independent observer at 24 hours (…)". (page 1102)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

8% of patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Morros‐Vinoles 2002

Methods

  • Design: parallel‐group (2 arms)

  • Country: Spain

  • Multisite: no

  • Needle tip used: Sprotte

  • Needle diameter used: 27 G vs 29 G

  • Number of attempts (1): 78.5% vs 71.2%

  • Procedure: anaesthesia

  • Site of the puncture: L3‐4

  • Training level of those who administered the puncture: experienced anaesthesiologists

  • Median or paramedian technique: median

  • Type of anaesthesia used: 0.5% bupivacaine

  • Patient position: unclear

Participants

1. 389 patients undergoing orthopaedic surgery or general surgery were enrolled

Exclusion criteria: refusal of technique, allergy to anaesthesia, neurological comorbidities or coagulation conditions

Patients randomized to:

  • Sprotte 27 G group: 189 (48.5%)

  • Sprotte 29 G group: 200 (51.4%)

2. 12 patients (3%) were excluded from analysis, due to protocol deviations

Patients analysed:

  • Sprotte 27 G group: 186

  • Sprotte 29 G group: 191

Telephone interview was complete in (lost to follow‐up: 10%):

  • Sprotte 27 G group: 175

  • Sprotte 29 G group: 184

3. Main characteristics of patients:

  • Age (mean, SD): Sprotte 27 G group: 41, 13; Sprotte 29 G group: 43, 13

  • Height (mean, SD): Sprotte 27 G group: 171, 9; Sprotte 29 G group: 168, 15

  • Weight (mean, SD): Sprotte 27 G group: 76, 13; Sprotte 29 G group: 75, 12

  • Gender ‐ male (number): Sprotte 27 G group: 155; Sprotte 29 G group: 163

Interventions

  1. Grupo Sprotte G 27 (Sp27): 0.4 mm G 27 (Sprotte®, Pajunk®)

  2. Grupo Sprotte G 29 (Sp29): 0.33 mm G 29 (Sprotte®, Pajunk®)

  3. Co‐intervention: bed rest for 8 h and analgesia with metamizol 2 g (Nolotil®) IM/8h

Outcomes

Outcomes were not classified as primary or secondary

  1. Technical difficulties

  2. PDPH

  3. Severity of PDPH

  4. Back pain

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were randomized into two groups (..)" (page 449)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "patients were interviewed by telephone to the second and seventh day after surgery, by an anesthesiologist unaware of who and who and how the puncture was made, and following a specific and as a template for all patients (…)" (page 450)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

10% of patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Muller 1994

Methods

  • Design: parallel‐group (2 arms)

  • Country: Germany

  • Multisite: no

  • Needle tip used: 22 G Sprotte vs 20 G Quincke

  • Needle diameter used: 22 vs 20

  • Number of attempts (2 or more): 32 patients

  • Procedure: diagnostic LP

  • Site of the puncture: unknown

  • Training level of those who administered the puncture: resident

  • Median or paramedian technique: unknown

  • Amount of CSF extracted: 10 ml to 20 ml

  • Amount of injected volume: unclear

  • Patient position: sitting

Participants

1. 100 consecutive patients undergoing diagnostic LP were enrolled

Exclusion criteria: contraindications against any type of LP

Patients randomized to:

  • 22 G Sprotte group: 50 (50%)

  • 20 G Quincke group: 50 (50%)

2. 10 patients (10%) were excluded from analysis, due to protocol deviations

Patients analysed:

  • 22 G Sprotte group: 48

  • 20 G Quincke group: 42

3. Main characteristics of patients (only analysed patients):

  • Age (mean, SD): 22 G Sprotte group: 46, 16; 20 G Quincke group: 44, 16

  • Height (mean, SD): 22 G Sprotte group: 167, 8; 20 G Quincke group: 170, 9

  • Weight (mean, SD): 22 G Sprotte group: 69, 13; 20 G Quincke group: 73, 14

  • Gender ‐ male (number): 22 G Sprotte Group: 21; 20 G Quincke Group: 25

Interventions

  1. Sprotte G 22: (Pajunk GmbH, Feinwerk‐Medizintechnologie, Geisingen, Germany). The atraumatic cannula was used by an introducer 18 G.

  2. Quincke 20 G. Unclear if an introducer was used.

  3. Co‐intervention: after LP all patients were told to lie flat in bed for 6 hours, the first 30 minutes in the abdominal position, and to drink amply (1 L mineral water or tea)

Outcomes

Outcomes were not classified as primary or secondary

  1. Post‐puncture complaints

  2. PDPH

  3. Severity of PDPH

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The study was carried out as a prospective randomized blind study on a general neurological ward (..)" (page 376)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "The LP was carried out by a resident who was asked not to disclose the type of needle to the patient or to the masked examiner." (page 377)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "All examinations were carried out by an examiner who was unaware of the puncture technique and observations were recorded on standardised check‐lists (…)" (page 377)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

10% of patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Oberoi 2009

Methods

  • Design: parallel‐group (2 arms)

  • Country: India

  • Multisite: no

  • Needle type design used: 25 G Quincke, 25 G Whitacre

  • Needle diameter used: 25 G

  • Procedure: anaesthesia

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: unknown

  • Training level of those who administered the puncture: experienced anaesthesiologists

  • Median or paramedian technique: unknown

  • Type of anaesthetic: not reported

  • Patient position: unknown

Participants

1. 200 patients enrolled (obstetric female patients aged 20 to 35 belonging to ASA I undergoing elective or emergency lower segment caesarean section)

Patients randomized to:

  • 25 G Quincke (Q) (100)

  • 25 G Whitacre (W) (100)

2. Losses to follow‐up and exclusions were not reported

2. Main characteristics of patients:

  • Age (mean, SD): 25 G Quincke: 26.97, 3.8; 25 G Whitacre: 27.1, 4.22

  • Height (mean, SD): 25 G Quincke: 156.7, 4.31; 25 G Whitacre: 158.6, 3.94

  • Weight (mean, SD): 25 G Quincke: 63, 3.65; 25 G Whitacre: 65.1, 3.61

Interventions

  1. 25 G Quincke spinal needle group

  2. 25 G Whitacre spinal needle group

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Side effects

  3. Severity of PDPH: assessed with Corbey severity grading and VAS

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not reported

  6. Declared conflicts of interest: no

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The patients were randomly allocated to one of the two groups Q or W according to computer generated numbers". (page 420)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Post‐operatively, follow up was done up to 7 days after the surgery or till the time of discharge by an anaesthesiologist who had no knowledge of the spinal needle." (page 421)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Severity of post‐dural puncture headache was assessed according to Corbey severity grading and visual analogue scale (VAS). This information is not reported.

Other bias

Low risk

No other biases were identified

Pan 2004

Methods

  • Design: parallel‐group (2 arms)

  • Country: USA

  • Multisite: no

  • Needle tip used: 26 G Atraucan vs 25 G Whitacre

  • Needle diameter used: 26 vs 25

  • Number of attempts: 1.5 vs 1.6

  • Procedure: anaesthesia

  • Site of the puncture: L2‐3, L 3‐4 or L4‐5

  • Training level of those who administered the puncture: anaesthesiology residents or senior nurse anaesthetist students, with close supervision of attending anaesthesiologists, performed the spinal anaesthetic procedures

  • Median or paramedian technique: midline

  • Type of anaesthetic: 75 mg of 5% lidocaine in 7.5% dextrose injected intrathecal

  • Patient position: sitting position

Participants

1. 215 American Society of Anesthesiology Class I to II postpartum patients presenting for elective postpartum bilateral tubal ligations under spinal anaesthesia were enrolled

Patients randomized to:

  • 26 G Atraucan group: 109

  • 25 G Whitacre group: 106

2. 11 patients (5.1%) were excluded from analysis, because of loss to follow‐up, cancellation of surgery or inability to identify the sub‐arachnoid space

Patients analysed:

  • 26 G Atraucan group: 104

  • 25 G Whitacre group: 100

3. Main characteristics of patients:

  • Age (mean, SD): 26 G Atraucan group: 28.5; 25 G Whitacre: 28.5

  • Weight (mean, SD): 26 G Atraucan group: 76, 14; 25 G Whitacre: 78, 18

  • Height (mean, SD): 26 G Atraucan group: 164, 6; 25 G Whitacre: 162, 8

Interventions

  1. 26 G Atraucan spinal needles (B. Braun Medical, Bethlehem, PA) (outside diameter 0.45 mm; length 8.89 cm) were used with the bevel of the needles turned parallel to the longitudinal axis of the patient’s vertebral column

  2. 25 G Whitacre spinal needles (Becton‐Dickinson, Rutherford, NJ) (outside diameter 0.5 mm; length 8.89 cm) were used with the terminal orifice of the needle facing cephalad to the patient

Outcomes

Outcomes were not classified as primary or secondary

  1. Number of attempts

  2. Final sensory level of the spinal blockade

  3. Failure to obtain CSF

  4. Time for placement of spinal anaesthesia

  5. Amount of intraoperative analgesic supplement required

  6. PDPH

  7. Severity of PDPH

  8. Any headache

  9. Number of days of PDPH

Notes

  1. Trial registration: not stated

  2. Funder: this study was supported in part by an unrestricted education grant from B. Braun Medical, Inc.Medical Devices Company

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The patients were randomized by means of a computer‐generated random number table into either" (page 360)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Postoperatively, an investigator who was blinded to the group assignment interviewed the patients daily while in the hospital" (page 360)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

5% of patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Unclear risk

The role of funder is unclear

Pedersen 1996

Methods

  • Design: parallel‐group (2 arms)

  • Country: Norway

  • Multisite: no

  • Needle tip used: 22 G Quincke vs 22 G Whitacre

  • Needle diameter used: 22 G

  • Number of attempts: unknown

  • Procedure: myelography

  • Site of the puncture: L2‐3

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: unknown

  • Amount of CSF extracted: unknown

  • Amount of injected volume: Iohexol 15 ml

  • Patient position: unknown

Participants

1. 107 consecutive patients (inpatient and outpatient) referred to the Department of Radiology for lumbar myelography were enrolled

Number of patients randomized per arm: unclear

2. 7 patients (6.5%) were excluded from analysis because they were operated within the first 7 days or they did not returned the questionnaire

146 patients were analysed:

  • 22 G Quincke group: 53 patients

  • 22 G Whitacre group: 47 patients

3. Main characteristics of patients: 58 men, 42 women, age range: 20 to 82 years, mean: 50.5 years)

Interventions

  1. 22 G (0.7 mm) Quincke needle (Spinocan, B Braun Melsungen, Germany)

  2. 22 G Whitacre (Becton‐ Dickinson). Puncture was done first with a 19 G needle through the skin and subcutis

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache/PDPH

  2. Low back pain

  3. Nausea, dizziness

  4. Severity of PDPH

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "were randomized into two groups (..)" (page 184)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

6.5% of patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Peterman 1996

Methods

  • Design: parallel‐group (2 arms)

  • Country: USA

  • Multisite: no

  • Needle tip used: 22 G Quincke vs 22 G Whitacre

  • Needle diameter used: 22 G

  • Number of attempts: 1.36 vs 1.19

  • Procedure: myelography

  • Site of the puncture: unknown

  • Training level of those who administered the puncture: mix

  • Median or paramedian technique: mix

  • Amount of CSF extracted: unknown

  • Amount of injected volume: 10.56 vs 10.45

  • Patient position: unknown

Participants

1. 778 patients undergoing myelography from 26 April 1993 to 7 September 1994, at a large, tertiary care, academic hospital were eligible for this study

Of the 778 eligible patients, 340 consented to participate in the study

340 patients were randomized to:

  • 22 G Quincke: 173 patients (50.8%)

  • 22 G Whitacre: 167 patients (49.2%)

2. 26 patients received another needle than the randomized needle; additionally, 49 patients were not followed up. Authors include all data (as randomized) in the final analysis.

3. Main characteristics of patients:

  • Age (mean, SD): 22 G Quincke group: 55.6, 13.9; 22 G Whitacre group: 52.4, 13.7

  • BMI (mean, SD): 22 G Quincke group: 26.6, 4.7; 22 G Whitacre group: 27.4, 5.5

  • Gender ‐ male (number): 22 G Quincke group: 77; 22 G Whitacre group: 88

Interventions

  1. 22 G Whitacre spinal needle. Needle was passed through a short, 18G introducer needle to penetrate the skin and subcutaneous tissues.

  2. 22 G Quincke spinal needle (Becton Dickinson, Franklin Lakes, NJ)

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Headache severity

Notes

  1. Trial registration: not stated

  2. Funder: supported in part by Becton Dickinson, the Association of University Radiologists‐General Electric Radiology Research Academic Fellowship, and the National Institute of Neurologic Disorders and Stroke grant ROl NS 30928

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: April 1993 to September 1994

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The sequential order of Whitacre and Quincke needle assignments was randomly assigned by computer in blocks of 10 to ensure an equal number of patients in each needle group." (page 772)

Allocation concealment (selection bias)

Low risk

Quote: "When a patient consented to enter the study, the fluoroscopy technologist received the needle assignment from the chief radiologic technologist, who kept the randomization list." (page 772)

Blinding of participants (performance bias)

Low risk

Quote: "There was no formal masking of the research nurses or patients; however, there was probable masking in effect. At follow‐up, most patients did not seem to know their needle group assignment." (page 772)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "The principal investigator (S.B.P.), who was masked to the needle group assignment, coded the patient diagnosis by chart review." (page 772)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

14.4% of patients were lost to follow‐up. However, all randomized patients were included in the analysis.

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Unclear risk

The role of the funder in this research is unclear

Pippa 1995

Methods

  • Design: parallel‐group (2 arms)

  • Country: Italy

  • Multisite: no

  • Needle tip used: Quincke

  • Needle diameter used: 21 vs 25

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: L5‐S1

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: paramedian approach

  • Type of anaesthetic: 5 ml 0.5% plain bupivacaine + fentanyl 50 µg

  • Patient position: lateral

Participants

1. 160 ASA grade I or II patients undergoing orthopaedic surgery or manipulations to reduce lower limb fractures were included

Exclusion criteria: patients with a history of migraine or frequent headaches and neurological problems

Patients divided into 2 groups:

  • 21 G Quincke group: 80 (50%)

  • 25 G Quincke group: 80 (50%)

2. No patients reported as lost to follow‐up

3. Main characteristics of patients: not fully reported

Interventions

  1. 21 G Quincke: no further details reported

  2. 25 G Quincke: no further details reported

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Severity of headache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

High risk

Quote: "Patients were randomly allocated, on the basis of date (but not the year) of their birth, to receive spinal anaesthesia with either (...)" (page 560)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Two of the authors, who were unaware of the needle gauge employed, examined each patient on the first, second and third postoperative days and inquired about the occurrence of headache" (page 561)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were reported as lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Pittoni 1995

Methods

  • Design: parallel‐group (2 arms)

  • Country: Italy

  • Multisite: no

  • Needle tip used: 22 G Sprotte vs 25 G Sprotte

  • Needle diameter used: 22 vs 25

  • Number of attempts: 1 to 5 attempts

  • Procedure: anaesthesia

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: experienced anaesthesiologist

  • Median or paramedian technique: median

  • Type of anaesthesia: bupivacaine 1% in glucose 8%

  • Patient position: lateral position

Participants

1. 234 ASA I‐II outpatients undergoing elective arthroscopy of the knee joint

Exclusion criteria: contraindication to regional anaesthesia

Patients randomized to:

  • 22 G Sprotte group: 117 patients (50%)

  • 25 G Sprotte group: 117 patients (50%)

2. No patients were excluded from analysis

3. Main characteristics of patients:

  • Age (mean, SD): 22 G Sprotte group: 39, 15; 25 G Sprotte group: 37, 15

  • Height (mean, SD): 22 G Sprotte group: 171, 7; 25 G Sprotte group: 171, 9

  • Weight (mean, SD): 22 G Sprotte group: 75, 13; 25 G Sprotte group: 73, 12

  • Gender ‐ male (number): 22 G Sprotte group: 86; 25 G Sprotte group: 78

Interventions

  1. 22 G (0.7 mm) Sprotte needle (Pajunk, Geisingen, Germany)

  2. 25 G (0.7 mm) Sprotte needle (Pajunk, Geisingen, Germany). A 21 G introducer was used.

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache/PDPH ‐ backache

  2. Duration of PDPH

  3. Presence of associated symptoms

  4. Severity of PDPH

  5. Number of attempts

  6. Failed spinal anaesthesia

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were allocated randomly to receive (…)" (page 73)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "and were interviewed by one of the authors (blind with respect to needle size(…)" (page 74)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Prager 1996

Methods

  • Design: parallel‐group (2 arms + 1 in separated patients)

  • Country: USA

  • Multisite: no

  • Needle type design used: diamond vs pencil

  • Number of attempts: unknown

  • Procedure: myelography

  • Site of the puncture: L2‐3

  • Training level of those who administered the puncture: senior neuroradiologists

  • Median or paramedian technique: slightly off midline for most patients

  • Amount of CSF extracted: not collected

  • Amount of injected volume: iohexol (Omnipaque: Nycomed, New York, NY) (10 ml to 15 ml of 180 concentration for the lumbar spine and 10 ml of 300 concentration for the cervical spine)

  • Patient position: prone and slightly oblique on a fluoroscopy table with a pillow under the abdomen

Participants

1. 108 patients enrolled (patients referred for myelograms)

Exclusion criteria: inability to sit or stand, inability to reliably communicate, a situation that would tend to decrease the presence and reporting of spinal headache

108 patients randomized to:

  • Quincke group: 56 patients (51.85%)

  • Sprotte group: 52 patients (48.14%)

2. Main characteristics of patients:

  • Mean age:

    • Quincke: 57

    • Sprotte: 56

    • Gertie Marx: 57

  • Number of females/males: Gertie Marx: 13/17. Numbers not reported for the other groups.

Interventions

  1. Quincke group: 22 G bevel tip needle (Becton‐Dickinson, Franklin Lakes, NJ)

  2. Sprotte group: 22 G, pencil point (Pajunk, Geisingen, Germany)

  3. Co‐interventions: after myelogram bed rest with head of bed elevated 45 degrees for 6 hours after the procedure

Outcomes

Outcomes were not classified as primary or secondary

  1. Incidence of PDPH

  2. Severity of PDPH (1 to 10 scale)

  3. Blood patches required: Quincke 2, Sprotte 2

  4. Non‐spinal headache

  5. Extraarachnoid contrast material

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not reported

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "108 were randomized to a 22‐gauge" (page 1290)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "An observer contacted each subject by telephone 5‐14 days after the myelogram. The observer did not know which type of needle had been used on the subjects." (page 1290)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Rafique 2014

Methods

  • Design: parallel‐group (2 arms)

  • Country: Pakistan

  • Needle tip used: diamond

  • Needle diameter used: 25 G vs 27 G

  • Number of attempts: 1

  • Procedure: anaesthesia

  • Site of the puncture: site/unclear

  • Training level of those who administered the puncture: attending anaesthesiologist

  • Median or paramedian technique: unclear

  • Type of anaesthetic: unclear

  • Patient position: sitting or lateral supine position

Participants

1. 90 patients enrolled (female patients of 20 to 38 years old, undergoing caesarian sections)

Exclusion criteria: ASA above III

Number of patients randomized per arm: unclear

2.Number of patients excluded (who required more than one prick): unclear. 3 patients were excluded from analysis for unknown reasons.

Number of analysed patients:

  • Group I (25 G Quincke spinal needle): 44 (48%)

  • Group II (27 G Quincke spinal needle): 43 (47%)

3. No patients lost to follow‐up

4. Main characteristics of patients:

  • Age (mean, SD): group 1: 28 ± 4.5/group 2: 27 ± 3.1

Interventions

  1. Group 1: spinal anaesthesia with 25 G Quincke spinal needle

  2. Group 2: spinal anaesthesia with 27 G Quincke spinal needle

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Patient satisfaction

  3. Severity of headache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "ninety female patients of 20 to 38 years of age, undergoing caesarian sections were randomly distributed to either 25 or 27 gauge Quincke needle groups" (page 1)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The patients were interviewed first through third post‐operative days about the occurrence of headache and their satisfaction regarding spinal anesthesia." (page 1)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Rasmussen 1989a

Methods

  • Design: parallel‐group (2 arms)

  • Country: Denmark

  • Multisite: no

  • Needle tip used: unclear vs pencil

  • Needle diameter used: 20 vs 25

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: L3‐4

  • Training level of those who administered the puncture: anaesthetists

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: 0.5% bupivacaine

  • Patient position: lateral position

Participants

1. 200 admitted for elective total unilateral hip replacement were enrolled

Number of patients randomized per arm: unclear

2. 17 patients (8.5%) were excluded from analysis, in the pre and postoperative period. It was impossible to perform the spinal procedure with the prescribed 25 G needle in 4 patients; 7 had an incomplete block, of whom 5 had a supplementary general anaesthetic and 2 another spinal injection; 4 had major cardiovascular complications, 1 had a classical migraine first noticed postoperatively and another needed a further spinal anaesthetic on the second postoperative day because the artificial hip dislocated.

183 patients were analysed:

  • 20 G Mediplast group: 93 patients

  • 25 G Vygon group: 90 patients

3. Main characteristics of patients:

  • Age (mean, range): 20 G Mediplast group: 68.8, 45 to 88; 25 G Vygon group: 69.1, 21 to 82

  • Gender ‐ male (number): 20 G Mediplast group: 43; 25 G Vygon group: 44

Interventions

  1. 20 G Mediplast. No further details are provided.

  2. 25 G Vygon. No further details are provided.

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache/PDPH ‐ no PDPH

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The patients were randomly allocated in a double blind manner (..)" (page 184)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "The authors as well as the patients were blinded with respect to needle size" (page 571)

"Spinal anaesthesia was performed by the department anaesthetists, but did not include the authors." (page 571)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "The authors as well as the patients were blinded with respect to needle size" (page 571)

"The patients in study 1 were interviewed by one of the authors on the fourth day after surgery (...)" (page 571)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

8.5% of patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Rasmussen 1989b

Methods

  • Design: parallel‐group (2 arms)

  • Country: Denmark

  • Multisite: no

  • Needle tip used: unclear vs pencil

  • Needle diameter used: 20 vs 25

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: L3‐4

  • Training level of those who administered the puncture: anaesthetists

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: 0.5% bupivacaine

  • Patient position: lateral position

Participants

1. 200 patients aged between 20 and 40 years and admitted for either elective or acute orthopaedic, lower abdominal or urogenital surgery were enrolled

Number of patients randomized per arm: unclear

2. 7 patients (3.5%) were excluded. It was impossible to perform the spinal procedure with a 25 G needle in 1 patient; 2 needed a supplementary general anaesthetic, 1 another spinal anaesthetic, while 3 had a history of migraine first noticed postoperatively

193 patients were analysed:

  • 20 G Mediplast group: 98 patients

  • 25 G Vygon group: 95 patients

3. Main characteristics of patients:

  • Age (mean, range): 20 G Mediplast group: 29.2, 20 to 40; 25 G Vygon group: 29.7, 20 to 40

  • Gender ‐ male (number): 20 G Mediplast group: 80; 25 G Vygon group: 68

Interventions

  1. 20 G Mediplast. No further details are provided.

  2. 25 G Vygon. No further details are provided.

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache/PDPH ‐ no PDPH

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The patients were randomly allocated in a double blind manner (..)" (page 184)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "The authors as well as the patients were blinded with respect to needle size" (page 571)

"Spinal anaesthesia was performed by the department anaesthetists, but did not include the authors." (page 571)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "The authors as well as the patients were blinded with respect to needle size" (page 571)

"The patients in study 1 were interviewed by one of the authors on the fourth day after surgery (..)" (page 571)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

8.5% of patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Riley 2002

Methods

  • Design: parallel‐group (2 arms), randomized

  • Country: USA

  • Multisite: no

  • Needle type design used: pencil

  • Needle diameter used: 24 G

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline approach

  • Type of anaesthetic: 10 µg sufentanil

  • Patient position: sitting position

Participants

1. 73 patients enrolled (women in active labour who requested labour analgesia and accepted a combined spinal‐epidural technique)

Patients randomized to:

  • Gertie Marx group: 37, 50.6%

  • Sprotte group: 36, 49.4%

2. 6 (8.21%) patients lost to follow‐up because no cerebrospinal fluid was obtained with the Sprotte needle

Patients analysed:

  • Gertie Marx group: 37 patients

  • Sprotte group: 30 patients

3. Main characteristics of patients were not provided. Quote: "The two groups were similar with regard to cervical dilation, parity, height, weight, and initial pain score." (page 575)

Interventions

  1. Gertie Marx group: 24 G, 127 mm spinal needle (International Medical Development, Park City, Utah)

  2. Sprotte group: 24 G, 120 mm spinal needle (Pencan, B. Braun, Melsungen, Germany)

Outcomes

Outcomes were not classified as primary or secondary

  1. Incidence of PDPH

  2. Severity of PDPH: verbal 0 to 10 scale

  3. Epidural blood patch required

Notes

  1. Trial registration: not stated

  2. Funder: donation of the spinal needles from International Medical Devices, Park City, Utah

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: not reported

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were randomized to have the spinal component (..)" (page 574)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

8.21% of patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Saenghirunvattana 2008

Methods

  • Design: parallel‐group (2 arms)

  • Country: Thailand

  • Multisite: no

  • Needle tip used: diamond vs pencil

  • Needle diameter used: 27 vs 25

  • Number of attempts (1): 47 vs 15

  • Procedure: anaesthesia

  • Site of the puncture: unknown

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline or paramedian at the anaesthesiologist's discretion

  • Type of anaesthesia: hyperbaric 0.5% bupivacaine 2.5 ml to 3.5 ml

  • Patient position: lateral position

Participants

1. 91 patients undergoing spinal anaesthesia for operations in the departments of orthopaedics, general surgery and urology from August 2006 to October 2007 were enrolled

Patients randomized to:

  • 27 G Quincke: 59 patients (64.83%)

  • 25 G Pajunk group: 32 patients (35.16%)

2. No patients were excluded from analysis

3. Main characteristics of patients:

  • Age (mean, SD): 27 G Quincke group: 59.03, 18.8; 25 G Pajunk group: 58.34, 14.24

  • Height (mean, SD): 27 G Quincke group: 162.3, 6.92; 25 G Pajunk group: 163.06, 5.48

  • Weight (mean, SD): 27 G Quincke group: 61.9, 13.6; 25 G Pajunk group: 60.54, 10.61

Interventions

  1. 27 G Quincke (Becton‐Dickinson, Rutherford, NJ, USA or Dr. Japan Co, Tokyo, Japan)

  2. 25 G Pajunk (Pajunk, GmbH Medicin Technik, West Germany)

Outcomes

Outcomes were not classified as primary or secondary

  1. Number of attempts

  2. Surgeon rating

  3. Postoperative complication: headache, blurred vision

  4. Patient's comments

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: August 2006 to ‐October 2007

  6. Declared conflicts of interest: yes. Quote: "This study was carried out without any conflict of interest." (page S157)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The patients were randomly allocated into (…)" (page S157)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Santanen 2004

Methods

  • Design: parallel‐group (2 arms)

  • Country: Finland

  • Multisite: no

  • Needle tip used: 27 G Quincke vs 27 G Whitacre

  • Needle diameter used: 27

  • Number of attempts: unknown

  • Procedure: anaesthesia

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: unknown

  • Type of anaesthesia: hyperbaric bupivacaine 5 mg/ml‐1 (Bicain pond1, Orion Pharma Ltd, Espoo, Finland) 1.5 ml to 2.5ml

  • Patient position: lateral position

Participants

1. 676 outpatients (ASA physical status I‐II, aged 18 to 60 years) given spinal anaesthesia for elective day‐case surgery were enrolled

Exclusion criteria: use of oral opioids or regular use of nonsteroidal anti‐inflammatory drugs, history of allergy to any study medication, patient refusal, contraindication for spinal anaesthesia, abuse of drugs or alcohol, headache preoperatively on the morning of surgery and body mass index not within normal limits (17 to 28)

Number of patients randomized per arm: unclear

2. 54 patients (33 in the Quincke group and 21 in the Whitacre group) were excluded from the study for various reasons such as if they received midazolam for sedation (15/10), general anaesthesia was required because of insufficient spinal block (12/6), pethidine was required for postoperative shivering (2/2), or pain medication different from the study protocol had been given to the patient in the ward or at home (2/1)

Of the remaining 622 patients, 529 patients returned the questionnaire (85.1%) and were available for the final analysis

Total of exclusions: 147 (21.74%)

3. Patients analysed:

  • Group I: 27 G Quincke group: 259

  • Group II: 27 G Whitacre group: 270

4. Main characteristics of patients:

  • Age (mean, SD): 27 G Quincke group: 46, 34; 27 G Whitacre group: 42, 12

  • Height (mean, SD): 27 G Quincke group: 173, 9; 27 G Whitacre group: 172, 9

  • Weight (mean, SD): 27 G Quincke group: 74, 12; 27 G Whitacre group: 73, 13

  • Gender ‐ male (number): 27 G Quincke group: 127; 27 G Whitacre group: 122

Interventions

  1. 27 G (0.41 mm) Whitacre (Whitacre1, Becton Dickinson Ltd, Madrid, Spain)

  2. 27 G (0.41 mm) Quincke spinal needle (Yale1, Becton Dickinson Ltd). The bevel of the Quincke spinal needle was kept parallel to the dural fibres.

The choice of whether to use an introducer needle (22 G (0.7 mm) 30 mm long, Yale1 needle, Becton Dickinson Ltd) was left to the individual anaesthesiologist performing the spinal block.

Outcomes

Outcomes were not classified as primary or secondary

  1. Any headache

  2. PDPH

Notes

  1. Trial registration: not stated

  2. Funder: Novartis

  3. Role of funder: supply of Voltaren tablets given to the study patients for postoperative pain relief

  4. A priori sample size estimation: yes

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The randomization was computer‐generated and double‐blind except for the anaesthetist performing (…)" (page 475)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "The patients, surgeons, as well as the postoperative ward personnel did not know which spinal needle had been used." (page 475)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "The anaesthesiologist who analyzed patient outcome was unaware of the spinal needle type used." (page 475)

Incomplete outcome data (attrition bias)
All outcomes

High risk

21% patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Schmittner 2010

Methods

  • Design: parallel‐group (2 arms)

  • Country: Germany

  • Multisite: no

  • International: no

  • Needle type design used: Quincke

  • Needle diameter used: 25 vs 29

  • Procedure: subarachnoid anaesthesia

  • Number of attempts (1 attempt): 87.3% vs 84.9%

  • Site of the puncture: L3‐4

  • Training level of those who administered the puncture: experienced anaesthesiologists

  • Median or paramedian technique: midline approach

  • Type of anaesthesia: 1 mL of 0.5% bupivacaine

  • Patient position: sitting position

Participants

1. 216 patients ASA I to III, undergoing in‐house and ambulatory anorectal surgery, performed in lithotomy position, were enrolled

Exclusion criteria: contraindications against spinal anaesthesia, patients considered to be ASA status IV–I, operation techniques other than in lithotomy position and prior participation in the study.

After inclusion of 216 patients, the study was terminated when interim analysis showed unexpected high rates of PDPH in both study groups.

Patients randomized to:

  • 25 G Quincke group: 106 patients (49.07%)

  • 29 G Quincke group: 110 patients (50.93%)

2. No patients were excluded from further analysis

3. Main characteristics of patients:

  • Age (mean, SD): 25 G Quincke group: 51.6, 12.6; 29 G Quincke group: 45.5, 12.3

  • Weight (mean, SD): 25 G Quincke group: 82.7, 16.9; 29 G Quincke group: 79.3, 19.4

  • Height (mean, SD): 25 G Quincke group: 171.5, 8.5; 29 G Quincke group: 172.2, 10

Interventions

  • 25 G Quincke needle with introducer (Spinocan 0.53 × 88 mm − G 25 × 3 1/2, B. Braun, Melsungen, Germany)

  • 29 G Quincke needle with introducer (Spinocan 0.35 × 88 mm − G 29 × 3 1/2, B. Braun, Melsungen, Germany)

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Time to onset

  3. Duration of PDPH

Notes

  1. Trial registration: ISRCTN: 11431649

  2. Funder: B. Braun, Melsungen, Germany

  3. Role of funder: provision of needles

  4. A priori sample size estimation: yes

  5. Conducted: March to August 2008

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Upon arrival in the operating theatre the patients were randomly allocated 1:1 using sealed envelopes in blocks of 20 to receive a spinal saddle block with either a 25‐G or a 29‐G Quincke type spinal needle" (page 776)

Allocation concealment (selection bias)

Low risk

Quote: "Upon arrival in the operating theatre the patients were randomly allocated 1:1 using sealed envelopes in blocks of 20 to receive a spinal saddle block with either a 25‐G or a 29‐G Quincke type spinal needle" (page 776)

Blinding of participants (performance bias)

Low risk

Quote: "Study participants were blinded to the type of needle used." (page 776)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "A consultant anaesthesiologist who was blinded towards the needles used and who was not involved in the study assessed the incidence of PDPH" (page 776)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Schmittner 2011

Methods

  • Design: parallel‐group (4 arms) (we only extracted and analysed needle interventions)

  • Country: Germany

  • Multisite: no

  • Needle tip used: 27 G pencil‐point vs 27 G Quincke

  • Needle diameter used: 27

  • Number of attempts: mean: 1

  • Procedure: anaesthesia

  • Site of the puncture: L3‐4

  • Training level of those who administered the puncture: experienced anaesthesiologists

  • Median or paramedian technique: midline

  • Type of anaesthesia: 1.0 mL of hyperbaric bupivacaine 0.5% (Bucain 0.5% hyperbaric ®, Delta Select, Dreieich, Germany) for in‐house patients or 1.0 mL of hyperbaric mepivacaine 4% (Mecain 4% hyperbar ®, Delta Select, Dreieich, Germany)

  • Patient position: sitting position

Participants

1. 363 patients (male/female, 18 to 80 years; American Society of Anesthesiologists (ASA) physical grade I–III) undergoing in‐house and ambulatory anorectal surgery, performed in lithotomy position, were enrolled and randomized

Exclusion criteria: general contraindications against spinal anaesthesia, patients' history of recurrent headaches or a previous PDPH, patients considered to be ASA grade IV–VI, operation techniques other than in lithotomy position and prior participation in the study.

Patients randomized to:

  • Group A: 27 G PP needle, 10 min pre‐operative time in upright sitting position: 90 patients (24.8%)

  • Group B: 27 G Q needle, 10 min pre‐operative time in upright sitting position: 90 patients (24.8%)

  • Group C: 27 G PP needle, 30 min pre‐operative time in upright sitting position: 90 patients (24.8%)

  • Group D: 27 G Q needle, 30 min pre‐operative time in upright sitting position: 93 patients (25.6%)

2. No patients were excluded from further analysis

3. Main characteristics of patients (in general):

  • Sex ratio male/female: 219/144

  • Age (years): 46.61 (12.6)

  • Height: 173.09, 9.54

  • Weight: 80.46, 18.4

Quote: "The groups did not differ in their demographic data" (page 99)

Interventions

1. Group A: 27 G PP needle, 10 minutes pre‐operative time in upright sitting position. 27 G PP needle with introducer (Pencan ® 0.42 × 88 mm– G27 × 3½, B. Braun, Melsungen, Germany)

2. Group B: 27 G Q needle, 10 minutes pre‐operative time in upright sitting position. 27 G Q needle with introducer (Spinocan ® 0.42 × 88 mm–G27 × 3½, B‐Braun, Melsungen, Germany)

1. Group C: 27 G PP needle, 30 minutes pre‐operative time in upright sitting position. 27 G PP needle with introducer (Pencan ® 0.42 × 88 mm– G27 × 3½, B. Braun, Melsungen, Germany)

1. Group D: 27 G Q needle, 30 minutes pre‐operative time in upright sitting position. 27 G Q needle with introducer (Spinocan ® 0.42 × 88 mm–G27 × 3½, B‐Braun, Melsungen, Germany)

A vertical bevel direction was used.

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Performance of spinal anaesthesia

  3. Duration of PDPH

  4. Severity of PDPH

Notes

  1. Trial registration: ISRCTN 12262174

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: August 2008 until April 2009

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "upon arrival in the operating theatre, the patients were randomised via sealed envelopes in order to assign each patient into one of four study groups" (page 98)

Allocation concealment (selection bias)

Low risk

Quote: "upon arrival in the operating theatre, the patients were randomised via sealed envelopes in order to assign each patient into one of four study groups" (page 98)

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "A consultant anaesthesiologist who was blinded towards the needles used and who was not involved in the study assessed the incidence of PDPH" (page 99)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Schultz 1996

Methods

  • Design: parallel‐group (2 arms)

  • Country: Austria

  • Multisite: no

  • International: no

  • Needle type design used: Quincke vs Atraucan

  • Needle diameter used: 27 vs 26

  • Procedure: subarachnoid anaesthesia

  • Number of attempts (1 attempt): 87% vs 86%

  • Site of the puncture: L2‐3

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: median approach

  • Type of anaesthesia: 0.5% bupivacaine, 4% mepivacaine or lidocaine 5%

  • Patient position: sitting position

Participants

1. 388 ASA I‐III patients, aged 15 to 80 years, who were scheduled for subumbilical surgery, were enrolled

Exclusion criteria: obstetric patients

Patients randomized to:

  • 27 G Quincke group: 202 patients (52.06%)

  • 26 G Atraucan group: 186 patients (47.94%)

2. No patients were excluded from further analysis

3. Main characteristics of patients:

  • Males (number): 27 G Quincke group: 85; 26 G Atraucan group: 86

Interventions

  • 27 G Quincke: Becton Dickinson, Rutherford, NJ

  • 26 G Atraucan needle: Braun, Melsungen, Germany

Both needles were used with a 20 G introducer to facilitate puncture

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache (PDPH)

  2. Severity of headache

  3. Back pain

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "the patients were randomly assigned" (page 462)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Sears 1994

Methods

  • Design: parallel‐group (2 arms)

  • Country: USA

  • Multisite: no

  • Needle tip used: 24 G Sprotte vs 22 G Sprotte

  • Needle diameter used: 24 vs 22 25 vs 27

  • Number of attempts (first attempt): unknown

  • Procedure: spinal anaesthesia

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: experienced anaesthesiologists

  • Median or paramedian technique: midline

  • Type of anaesthesia: hyperbaric bupivacaine 0.75% or hyperbaric 5% lidocaine, with or without fentanyl and/or morphine 12.5 mg to 17.5 mg

  • Patient position: lateral position

Participants

1. 375 ASA physical status I and II caesarean section and postpartum tubal ligation patients at 4 hospitals participated in the study

Exclusion criteria: unclear

Patients randomized to:

  • 24 G Sprotte group: 186 patients (49.6%.

  • 22 G Sprotte group: 189 patients (50.4%)

2. No patients were excluded from further analysis

3. Main characteristics of patients:

  • Age (mean, SD): 24 G Sprotte group: 29.5, 5; 22 G Sprotte group: 27.5, 4.8

  • Height (mean, SD): 24 G Sprotte group: 163.1, 6.5; 22 G Sprotte group: 160.8, 6.3

  • Weight (mean, SD): 24 G Sprotte group: 79.3, 11.9; 22 G Sprotte group: 79.7, 10.9

Interventions

1. 22 G Sprotte needle

2. 24 G Sprotte needle

All patients received an infusion of at least 1000 mL of lactated Ringer's solution over 30 minutes prior to the block

Outcomes

Outcomes were not classified as primary or secondary

1. Complication: headache

2. PDPH

3. Severity of PDPH

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: January 2008 and December 2009

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were randomly assigned to receive" (page 43)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Patients were visited at least once by the anesthesiologist during the postoperative period, and nurses on the obstetrics floor were instructed to notify the anesthesiologist of any complication, including headache. In addition, patients were contacted by telephone 1 week or more after discharge by an investigator who was blinded to the type of needle used." (page 43)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Shah 2010

Methods

  • Design: parallel‐group (2 arms)

  • Country: India

  • Multisite: no

  • International: no

  • Needle type design used: Quincke vs Whitacre

  • Needle diameter used: 25 vs 27

  • Procedure: subarachnoid anaesthesia

  • Number of attempts (1 attempt): 92% to 61%

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: experienced anaesthesiologists

  • Median or paramedian technique: midline approach

  • Type of anaesthesia: 12.5 mg to 17.5 mg bupivacaine

  • Patient position: lateral position

Participants

1. 800 young patients (16 to 40 years old) with ASA risk I/II scheduled for endoscopic urological procedures under spinal anaesthesia between January 2008 and December 2009 were enrolled in this study

Exclusion criteria: history of headache, use of oral opioids or non‐steroidal anti‐inflammatory drugs, or contraindications to spinal anaesthesia

Patients randomized to:

  • 25 G Quincke group: 200 patients (25%)

  • 27 G Quincke group: 200 patients (25%)

  • 25 G Whitacre group: 200 patients (25%)

  • 27 G Whitacre group: 200 patients (25%)

2. No patients were excluded from further analysis

3. Main characteristics of patients:

  • Age (mean, SD): 25 G Quincke group: 30, 8.2; 27 G Quincke group: 27.8, 9.4; 25 G Whitacre group: 29, 7.7; 27 G Whitacre group: 28.31, 8.8

  • Weight (mean, SD): 25 G Quincke group: 59.3, 14.8; 27 G Quincke group: 57.3, 11.6; 25 G Whitacre group: 56.5, 13.3; 27 G Whitacre group: 59.5, 11.8

Interventions

  • Quincke 25 G (0.50 x 90 mm) Becton Dickinson (Madrid, Spain)

  • Quincke 27 G (0.40 x 90 mm) Becton Dickinson (Madrid, Spain)

  • Whitacre pencil point 25 G (0.50 x 90 mm) Becton Dickinson (Madrid, Spain)

  • Whitacre 27 G (0.40 x 90 mm) Becton Dickinson (Madrid, Spain)

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache (PDPH)

  2. Severity of headache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: January 2008 and December 2009

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Patients were randomly divided by computer‐generated random numbers into four groups of 200 patients each." (page 25)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Postoperatively, all patients were visited successively for three days by a staff member, who was unaware of the type of needle used, to inquire about headache." (page 25)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Shaikh 2008

Methods

  • Design: parallel‐group(3 arms)

  • Country: India

  • Multisite: no

  • Needle tip used: 25 G Quincke vs 27 G Quincke vs 27 G Whitacre

  • Needle diameter used: 25 vs 27

  • Number of attempts: 1

  • Procedure: anaesthesia

  • Site of the puncture: L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: unknown

  • Type of anaesthesia: 1.5 ml to 2.0 ml 0.75% hyperbaric bupivacaine

  • Patient position: sitting position

Participants

1. 480 American Society of Anesthesiologists physical status classification (ASA) I‐II women, aged 18 to 45 years, undergoing elective caesarean section, were enrolled

Exclusion criteria: patient refusal, contraindication to spinal anaesthesia for infectious haemodynamic, haemostatic or neurological reasons, emergency caesarean section, severe pre‐eclampsia or failure of the spinal anaesthesia. Patients with more than one attempt were excluded from the study.

Patients randomized to:

  • 25 G Quincke group: 168 patients (35%)

  • 27 G Quincke group: 160 patients (33%)

  • 27 G Whitacre group: 152 patients (32%)

2. No patients were excluded from further analysis

3. Main characteristics of patients:

  • Age (mean, SD): 25 G Quincke group: 25.8, 5.6; 27 G Quincke group: 26.4, 5.86; 27 G Whitacre group: 26.7, 4.45

  • Weight (mean, SD): 25 G Quincke group: 59.9, 8.37; 27 G Quincke group: 61.7, 8.45; 27 G Whitacre group: 63, 9.10

Interventions

  1. 25 G Quincke (group I). No further information was provided. The bevel of the Quincke spinal needles (group I and II) was kept parallel to the sagittal plane to prevent cutting of the dural fibres.

  2. 27 G Quincke (group II). No further information was provided. The bevel of the Quincke spinal needles (group I and II) was kept parallel to the sagittal plane to prevent cutting of the dural fibres.

  3. 27 G Whitacre (group III). No further information was provided.

Outcomes

Outcomes were not classified as primary or secondary.

  1. PDPH

  2. Non‐specific headaches

  3. Severity of PDPH

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: October 2005 to December 2006

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The patients were selected randomly by balloting." (page 10)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "Patient, surgeon and the assessor in the ward did not know which spinal needle was used." (page 10)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Postoperatively, all patients were assessed daily for 4‐days by an investigator, blinded to the type and size of the needle used.." (page 11)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Sharma 1995

Methods

  • Design: parallel‐group (2 arms)

  • Country: USA

  • Multisite: no

  • Needle tip used: 25 G Whitacre vs 26 G Atraucan

  • Needle diameter used: 25 vs 27

  • Number of attempts: 1

  • Procedure: anaesthesia

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: experienced

  • Median or paramedian technique: midline

  • Type of anaesthesia: 70 mg to 80 mg lidocaine 5% with glucose 7.5% (Astra Pharmaceutical, Westborough, PA)

  • Patient position: sitting position

Participants

1. 96 women (ASA I and II) scheduled for elective post‐partum tubal ligation under spinal anaesthesia were enrolled

Exclusion criteria: abnormal lumbar spaces due to deformities of the spine or obesity

Exclusion criteria: patient refusal, contraindication to spinal anaesthesia for infectious haemodynamic, haemostatic or neurological reasons, emergency caesarean section, severe pre‐eclampsia or failure of the spinal anaesthesia. Patients with more than one attempt were excluded from the study.

Patients randomized to:

  • 25 G Whitacre group: 46 patients (47.9%)

  • 26 G Atraucan group: 50 patients (52.1%)

2. No patients were excluded from further analysis

3. Main characteristics of patients:

  • Age (mean, SD): 25 G Whitacre group: 27, 5; 26 G Atraucan group: 28, 5

  • Weight (mean, SD): 25 G Whitacre group: 62, 4; 26 G Atraucan group: 61, 5

  • Height (mean, SD): 25 G Whitacre group: 154, 6; 26 G Atraucan group: 156, 8

Interventions

  1. 25 G Whitacre (Beeton‐Dickinson, Rutherford, NJ. OD ‐ 0.5 mm, length ‐ 8.89 cm)

  2. 26 G Atraucan (B. Braun Medical, Bethlehem, PA. OD ‐ 0.45 mm, length 8.89 cm)

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Non‐specific headaches

  3. Backache

  4. Severity of PDPH

  5. Technical issues: ease of needle insertion through the spinal ligaments, number of attempts at dural puncture, presence or absence of dural click, incidence of paraesthesia, and time for 2 CSF drops after the appearance of CSF at the end of the hub of the needle

Notes

  1. Trial registration: not stated

  2. Funder: B. Braun Medical, Inc

  3. Role of funder: supply of Atraucan spinal needles

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Patients were assigned randomly, using computer generated numbers." (page 707)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "All patients were evaluated daily throughout their hospital course by an observer blinded to group assignment and then interviewed by telephone one week after discharge from hospital for the presence of headache, backache, or any other complication". (page 707)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Shutt 1992

Methods

  • Design: parallel‐group (3 arms)

  • Country: UK

  • Multisite: yes

  • Needle tip used: 22 G Whitacre vs 25 G Whitacre vs 26 G Quincke

  • Needle diameter used: 22 vs 25 vs 26

  • Number of attempts (= 1): 105 patients

  • Procedure: anaesthesia

  • Site of the puncture: L3‐4

  • Training level of those who administered the puncture: mix

  • Median or paramedian technique: midline

  • Type of anaesthesia: 0.5% bupivacaine in 8% glucose 2 ml to 2.5 ml

  • Patient position: lateral position

Participants

1. 150 women of ASA grade I undergoing spinal anaesthesia for elective caesarean section were enrolled

Patients randomized to:

  • 22 G Whitacre group: 50 patients (33.3%)

  • 25 G Whitacre group: 50 patients (33.3%)

  • 26 G Quincke group: 50 patients (33.3%)

2. 6 patients (4%) were excluded from further analysis because of a failure to identify the subarachnoid space with the trial needle

3. Main characteristics of patients:

  • Age (mean): 22 G Whitacre group: 29.9; 25 G Whitacre group: 29.8; 26 G Quincke group: 28.8

  • Weight (mean, SD): 22 G Whitacre group: 62.7, 11.1; 25 G Whitacre group: 63.9, 11.2; 26 G Quincke group: 61.5, 11

  • Height (mean, SD): 22 G Whitacre group: 1.62, 0.8; 25 G Whitacre group: 1.62, 0.07; 26 G Quincke group: 1.61, 0.07

Interventions

  1. 22 G Whitacre. No additional details provided.

  2. 25 G Whitacre group: 25 G and 26 G needles were inserted through an introducer

  3. 26 G Quincke group: 25 G and 26 G needles were inserted through an introducer

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Non‐specific headaches

  3. Backache

  4. Dysuria

  5. Severity of PDPH

Notes

  1. Trial registration: not stated

  2. Funder: Vygon UK Ltd

  3. Role of funder: supply of Whitacre and Quincke spinal needles

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Each woman was allocated by random number selection to one of." (page 589)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "At 24 h also, the second "blind " anaesthetist visited the patient. His duty was to check that the questionnaire had been completed and to record the patient's temperature. If a headache had been reported, he completed a second questionnaire ascertaining the onset and distribution of the headache, the effect of posture and if there was any visual or auditory disturbance." (page 590)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

4% of patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Smith 1994

Methods

  • Design: parallel‐group (2 arms)

  • Country: UK

  • Multisite: no

  • Needle tip used: atraumatic needles

  • Needle diameter used: 25 G Whitacre vs 27 G Whitacre

  • Number of attempts: unclear

  • Procedure: anaesthesia

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: unknown

  • Type of anaesthesia: 0.5% bupivacaine

  • Patient position: lateral position

Participants

1. 212 women of ASA grade I undergoing spinal anaesthesia for elective caesarean section were enrolled

Patients randomized to:

  • 25 G Whitacre group: 104 patients (49.1%)

  • 27 G Whitacre group: 108 patients (50.9%)

2. No patients were excluded from further analysis

3. Main characteristics of patients:

  • Weight (mean, SD): 25 G Whitacre group: 66.4, 14.4; 27 G Whitacre group: 66.7, 14.9

  • Height (mean, SD): 25 G Whitacre group: 1.74, 0.15; 27 G Whitacre group: 1.60, 0.08

Interventions

  1. 25 G Whitacre group: no additional details provided

  2. 27 G Whitacre group: no additional details provided

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Backache

  3. Severity of PDPH

  4. Factors affecting easy of use

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were randomly allocated to receive a subarachnoid block using either a 25G or a 27G Whitacre (...)" (page 859)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Patients were interviewed daily on the 1st to 5th postoperative days, by an anaesthetist unaware of the needle size used (..)". (page 860)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

8 patients (3.7%) were excluded from analysis

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Srivastava 2010a

Methods

  • Design: parallel‐group (4 arms), randomized

  • Country: India

  • Multisite: no

  • International: no

  • Needle type design used: 27 G Quincke, 27 G Whitacre

  • Needle diameter used: not reported

  • Procedure: spinal anaesthesia

  • Random unit: patients

  • Analysis unit: patients

  • Definition PDPH: location of pain in the occipital/frontal areas of the head – exacerbation of symptoms while sitting or standing

Participants

1. 100 patients enrolled (either sex, age group 14 to 75, ASA I and II, admitted for elective or emergency lower segment caesarian section and other surgical procedures)

Losses at follow‐up and reasons for exclusions not reported

2. Patients randomized to:

  • 27 G Whitacre non‐obstetric (50

  • 27 G Quincke non‐obstetric (50)

3. Main characteristics of patients:

  • Mean age (SD): 27 G Whitacre no 38.43 (14.15); 27 G Quincke no 42.5 (14.11)

  • Numbers of males/females were not reported

  • Percentage of postures during the lumbar puncture: left lateral or sitting position (91% in sitting position)

Interventions

  1. 27 G Whitacre non‐obstetric group

  2. 27 G Quincke non‐obstetric group

Outcomes

Outcomes were not classified as primary or secondary

  1. Incidence of PDPH

  2. Onset of PDPH

  3. Intraoperative complications

  4. Severity of PDPH

  5. Any headache subsequent to lumbar puncture: not reported

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not reported

  6. Declared conflicts of interest: no

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were randomly allocated into four groups" (page 711)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "All the patients were blinded to the needle utilized. The anaesthetist conducting the procedure was not blinded as the two needles have different appearance making blinding impossible". (page 711)

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Srivastava 2010b

Methods

  • Design: parallel‐group (4 arms), randomized

  • Country: India

  • Multisite: no

  • International: no

  • Needle type design used: 27 G Quincke, 27 G Whitacre

  • Needle diameter used: not reported

  • Procedure: spinal anaesthesia

Participants

1. 100 patients enrolled (either sex, age group 14 to 75, ASA I and II, admitted for elective or emergency lower segment caesarian section and other surgical procedures)

Losses at follow‐up and reasons for exclusions not reported

2. Patients randomized to:

  • 27 G Whitacre obstetric (50)

  • 27 G Quincke obstetric (50)

3. Main characteristics of patients:

  • Mean age (SD): 27 G Whitacre 38.43 (14.15); 27 G Quincke 42.5 (14.11)

  • Percentage of postures during the lumbar puncture: left lateral or sitting position (91% in sitting position)

Interventions

  1. 27 G Whitacre obstetric group

  2. 27 G Quincke obstetric group

Outcomes

Outcomes were not classified as primary or secondary

  1. Incidence of PDPH

  2. Onset of PDPH

  3. Intraoperative complications

  4. Severity of PDPH

  5. Any headache subsequent to lumbar puncture: not reported

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not reported

  6. Declared conflicts of interest: no

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were randomly allocated into four groups" (page 711)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "All the patients were blinded to the needle utilized. The anaesthetist conducting the procedure was not blinded as the two needles have different appearance making blinding impossible". (page 711)

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Standl 2004

Methods

  • Design: parallel‐group (2 arms), randomized

  • Country: Germany

  • Multisite: yes (4 hospitals)

  • International: no

  • Needle type design used: hybrid vs pencil

  • Needle diameter used: 25 G

  • Procedure: spinal anaesthesia

Participants

1. 700 patients enrolled (ASA I/II/III patients were scheduled for lower abdominal or extremity surgery (orthopaedic, trauma, urology, visceral, gynaecology) and underwent the same protocol)

Patients randomized to:

  • 25 G Ballpen (339)

  • 25 G Sprotte (338)

23 randomized patients (15 group B, 18 group S) were excluded due to:

  • Missing data (23)

2. 0 patients lost to follow‐up

3. Main characteristics of patients:

  • Mean age (SD):

    • 25 G Ballpen 54 (18)

    • 25 G Sprotte 56 (17)

  • Number of females/males:

    • 25 G Ballpen 130/209

    • 25 G Sprotte 131/207

  • Number of postures during the lumbar puncture: lateral position (25 G Ballpen N = 3, 25 G Sprotte N = 4), sitting position (25 G Ballpen N = 336, 25 G Sprotte N = 334)

Interventions

  1. 25 G Ballpen needle group): Rüsch, Kernen, Germany

  2. 25 G Sprotte needle group: Pajunk, Geisingen, Germany

Outcomes

Outcomes were not classified as primary or secondary

  1. Incidence of PDPH

  2. Side effects

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: yes

  5. Conducted: not reported

  6. Declared conflicts of interest: no

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "according to a randomization protocol that was created by a computerized program for each study site". (page 513)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "During postoperative Day 2 and 4, all patients were visited by an anesthesiologist who was blinded to the type of spinal needle" (page 514)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

23 patients (3.2%) were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Strupp 2001

Methods

  • Design: prospective, randomized, double‐blind study, 2 arms

  • Country: Germany

  • Multisite: no

  • Needle type design used: diamond vs pencil

  • Needle diameter used: 22 G (0.80 mm)

  • Number of attempts: not reported

  • Procedure: lumbar puncture

  • Site of the puncture: not reported

  • Training level of those who administered the puncture: experienced neurologists

  • Median or paramedian technique: not reported

  • Type of anaesthetic: not reported

  • Patient position: sitting

Participants

1. 230 patients enrolled (who had a neurologic indication for an LP (e.g. MS, neuroborreliosis or other CNS infections), between 18 and 59 years, no recent headache (at least up to 1 week before LP, years; 2) no recent headache, i.e. at least up to 1 week), no evidence of increased intracranial pressure, no LP in the last 4 weeks, ability to be mobilized and no previous headache or other pain medication.

Patients randomized to:

  • 22 G Sprotte (115)

  • 22 G Quincke (115)

2. No exclusions or loses to follow‐up were reported

3. Main characteristics of patients:

  • 22 G Sprotte: mean age 39.8 (SD 12.8), 64 females

  • 22 G Quincke: mean age 40.7 (SD 11.5), 63 females

Interventions

  1. "atraumatic" Sprotte needle (22 G, 0.80 mm, 90 mm; Pajunk, Geisingen, Germany)

  2. "traumatic" Quincke needle (22 G, 0.80 mm, 90 mm; Braun, Melsungen, Germany)

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. PDPH intensity (mean pain score)

  3. PDPH severity

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: November 2000 to March 2001

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were allocated randomly to one or the other group according to Efron." (page 2311)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Unclear if patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Tabedar 2003

Methods

  • Design: prospective, randomized, double‐blind study, 2 arms

  • Country: Nepal

  • Multisite: no

  • Needle type design used: diamond vs pencil

  • Needle diameter used: 25 G and 26 G

  • Number of attempts: 1, 2 or more than 2

  • Procedure: midline approach

  • Site of the puncture: L2‐L3 or L3‐L4

  • Training level of those who administered the puncture: unclear

  • Median or paramedian technique: unclear

  • Type of anaesthetic: 2.9 ml 0.5% heavy bupivacaine

  • Patient position: sitting

Participants

1. 60 ASA I and II primi and multipara parturient undergoing elective caesarean section aged 19 to 40 years. Exclusion criteria: parturient refusal, weight more than 75 kg, eclampsia/pre‐eclampsia, bleeding disorders

Patients randomized to:

  • Quincke (30)

  • Eldor (30)

2. 6 (8.21%) patients lost to follow‐up because no cerebrospinal fluid was obtained with the Sprotte needle

3. Main characteristics:

  • Quincke: age 19 to 33

  • Eldor: age 19 to 35

Interventions

  1. 25 G Quincke: no further details were provided

  2. 26 G Eldor: no further details were provided

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache

  2. PDPH

  3. Attempts

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: not stated

  5. Conducted: not reported

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "60 ASA I and II primi and multipara parturient undergoing elective caesarean section aged 19‐40 years were randomly divided (...)" (page 264)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Tarkkila 1992

Methods

  • Design: randomized, prospective study, 2 arms

  • Country: Finland

  • Multisite: yes

  • Needle type design used: diamond vs pencil

  • Needle diameter used: 24 G, 25 G

  • Number of attempts: not reported

  • Procedure: spinal anaesthesia

  • Site of the puncture: not reported

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline lumbar puncture

  • Type of anaesthetic: lidocaine, hyperbaric bupivacaine, isobaric bupivacaine

  • Patient position: not reported

Participants

1. 300 co‐operative ASA I and II who had spinal anaesthesia for minor orthopaedic or urologic operations, and who were not expected to need a blood transfusion

Patients randomized to:

  • 25 G Quincke with bevel parallel (100)

  • 25 G Quincke with bevel perpendicular (100)

  • 24 G Sprotte (100)

2. 256 patients (86.5%) returned the second questionnaire and were included in the study

  • 12 patients were excluded due to failure

  • Patients analysed: 256

1. Main characteristics:

  • 25 G Quincke with bevel parallel, mean age: 43.5, 46 female

  • 25 G Quincke with bevel perpendicular, mean age 44.7, 44 female

  • 24 G Sprotte, mean age 40.3, 43 female

Interventions

  1. 25 G Quincke: no further details were provided

  2. 24 G Sprotte: no further details were provided

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Non‐PDPH

  3. Other complications

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: not stated

  5. Conducted: not reported

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The patients were randomized into three groups of equal size" (page 284)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

13.5% of patients lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Tarkkila 1994

Methods

  • Design: randomized, prospective study

  • Country: Finland

  • Multisite: no

  • Needle type design used: diamond

  • Needle diameter used: 25 G, 27 G, 29 G

  • Number of attempts: unknown

  • Procedure: spinal anaesthesia

  • Site of the puncture: unclear

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline

  • Type of anaesthetic: 0.5% hyperbaric bupivacaine or 5% hyperbaric lignocaine

  • Patient position: lateral

Participants

1. 300 patients undergoing surgery under spinal anaesthesia

Patients randomized to:

  • 25 G Quincke (100)

  • 27 G Quincke (100)

  • 29 G Quincke (100)

2. Patients analysed: 2% failure rate, thus 6 patients were excluded from analysis. 94% were interviewed postoperatively.

3. Main characteristics:

  • 25 G Quincke mean age 46, 44 female

  • 27 G Quincke mean age 44, 47 female

  • 29 G Quincke mean age 43, 46 female

Interventions

  1. 25 G Quincke (Becton Dickinson): no further details were provided

  2. 27 G Quincke (Becton Dickinson): no further details were provided

  3. 29 G Quincke (Becton Dickinson): no further details were provided

Outcomes

Outcomes were not classified as primary or secondary

  1. PDPH

  2. Backache

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: not stated

  5. Conducted: not reported

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Three hundred patients undergoing surgery under spinal anaesthesia were randomly allocated (...)". (page 723)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Quote: "All the spinal anaesthetics were performed by the authors"... "The patients were contacted by one of the authors one week after the surgery." (page 723)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

18 patients (6%) were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Thomas 2000

Methods

  • Design: parallel‐group (2 arms)

  • Country: UK

  • Multisite: no

  • International: no

  • Needle tip used: diamond vs pencil

  • Needle diameter used: 20 G

  • Number of attempts: mean 4

  • Procedure: diagnostic lumbar puncture

  • Site of the puncture: unclear

  • Training level of those who administered the puncture: senior physician

  • Median or paramedian technique: unclear

  • Amount of CSF extracted: unclear

  • Amount of injected volume: unclear

  • Patient position: lateral position

Participants

1. 116 patients enrolled (patients attending the investigation ward on a regional neurology unit for elective diagnostic lumbar puncture)

Not randomized (n = 15)

Consent refused (n = 8)

Incomplete training for senior house officers (n = 7)

99 patients randomized to:

  • Standard needle (49, 48.51%)

  • Atraumatic needle (50, 49.5%)

2. 2 patients (2%) did not receive the allocated intervention in each arm and they were excluded. 97 patients randomized to: standard needle (48, 46.56%); atraumatic needle (49, 47.53%)

6. Main characteristics of patients:

  • Age: atraumatic needle group: 39.6 (SD 11.5)

  • Standard needle group: 40 (SD 10.6)

  • Gender: atraumatic needle group: 65%/39 female and 35%/17 male; standard needle group: 77%/37 female and23%/11 male

Interventions

  1. Standard needle group: 20 G Quincke needle

  2. Atraumatic needle group: Sprotte or Pajunk needle

  3. Co‐intervention: all patients rested in bed for at least 4 hours after the procedure and fluid intake was encouraged

Outcomes

Outcomes were classified as primary or secondary

  1. Primary: incidence of moderate or severe headache at 1 week according to needle type (intention‐to‐treat)

  2. Secondary: incidence of moderate or severe headache at 1 week by successful needle type, incidence of headache at 24 hours and 1 week, incidence of backache at 24 hours and 1 week, and ease of use by operator

Notes

  1. Trial registration: not stated

  2. Funder: Glasgow Neurosciences Foundation

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: September 1998 and February 1999

  6. Declared conflicts of interest: yes, not reported (page 989)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Randomisation was done by a computer generated code stored in opaque envelopes that were serially numbered and sealed" (page 987)

Allocation concealment (selection bias)

Low risk

Quote: "Randomisation was done by a computer generated code stored in opaque envelopes that were serially numbered and sealed" (page 987)

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "One week after lumbar puncture, the patients were telephoned by a single observer who was blinded to needle allocation" (page 987)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

2 patients were lost to follow‐up (2%)

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Unclear risk

The role of funder is unclear

Tourtellotte 1972

Methods

  • Design: parallel‐group (2 arms)

  • Country: USA

  • Multisite: no

  • International: no

  • Needle tip used: 22 G vs 26 G needles

  • Needle diameter used: 22 G vs 26 G needles

  • Number of attempts: unclear

  • Procedure: diagnostic lumbar puncture

  • Site of the puncture: unclear

  • Training level of those who administered the puncture: unclear

  • Median or paramedian technique: unclear

  • Amount of CSF extracted: 20 ml

  • Amount of injected volume: unclear

  • Type of anaesthetic: unclear

  • Patient position: left lateral position

Participants

1. 100 patients enrolled (healthy volunteers rated normal on physical and neurological examinations)

    • 100 patients randomized to:

      • 22 G needle group (50, 50%)

      • 26 G needle group (50, 50%)

2. No randomized patients were excluded from the study

    • No patients lost to follow‐up

3. Main characteristics of patients:

    • Age: 22 G needle group and 26 G needle group: 23.2 years with a range of 20 to 41

    • Gender: 22 G needle group: 46% female/54% male

    • 26 G needle group: 34% female/66% male

Interventions

  1. 22 G needle group

  2. 26 G needle group

Outcomes

Outcomes were not classified as primary or secondary

  1. Post‐lumbar puncture complaints

  2. Post‐lumbar puncture complaints: minor complaints: headaches for only a short period immediately after the LP, minimal to mild, non‐postural headaches, unusual tiredness on the day of the LP, slight numbness and insomnia

  3. Post‐lumbar puncture complaints: major complaints: mild to severe postural headaches that were often incapacitating and accompanied by other complaints such as backaches, unusual tiredness, anorexia, nausea and vomiting, and weight loss

  4. Presence of postural headaches

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: no

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Members of each successive pair of incoming volunteers were randomly" (page 1)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "The subjects were blinded with respect to size of needle used. They were all interviewed by the same neurologist (W.W.T.), who was also blinded as to needle size" (page 2)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "They were all interviewed by the same neurologist (W.W.T.), who was also blinded as to needle size" (page 2)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Wiesel 1993

Methods

  • Design: parallel‐group (2 arms)

  • Country: Canada

  • Multisite: no

  • International: no

  • Needle type design used: Sprotte vs Quincke

  • Needle diameter used: 24 vs 27

  • Procedure: spinal anaesthesia

  • Number of attempts (1 attempt): 73.9% vs 66%

  • Site of the puncture: unknown

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline approach

  • Type of anaesthesia: unclear

  • Patient position: unknown

Participants

1. 96 patients less than 45 years of age undergoing elective or emergency surgery were enrolled

Exclusion criteria: obstetric patients

Number of patients randomized to each group: unclear

2. 3 patients were excluded from further analysis due to incomplete interviews

Patients analysed:

  • 24 G Sprotte group: 46 patients

  • 27 G Quincke group: 47 patients

3. Main characteristics of patients:

  • Age (mean, SD): 24 G Sprotte group: 32.4, 7.3; 27 G Quincke group: 34.2, 8

  • Males (number): 24 G Sprotte group: 27; 27 G Quincke group: 23

Interventions

  • 24 G Sprotte needle (8.89 cm; Pajunk, Germany)

  • 27 G Quincke needle (8.89 cm; Becton Dickinson, Franklin Lake, New Jersey)

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache (PDPH)

  2. Severity of headache

  3. Satisfaction of patient

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were randomized to receive spinal anesthesia with either the 24 gauge Sprotte needle or the 27 G Quincke needle." (page 608)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Low risk

Quote: "Patients were interviewed in person or by telephone (if discharged from the hospital) by an anesthetist not involved with the case or by a research nurse. Both were blinded to the spinal needle used" (page 608)

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Patients were interviewed in person or by telephone (if discharged from the hospital) by an anesthetist not involved with the case or by a research nurse. Both were blinded to the spinal needle used" (page 608)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Wilkinson 1991

Methods

  • Design: parallel‐group (2 arms)

  • Country: UK

  • Multisite: no

  • International: no

  • Needle tip used: 26 G versus 22 G

  • Needle diameter used: 26 G versus 22 G

  • Number of attempts: unclear

  • Procedure: myelography

  • Site of the puncture: unclear

  • Training level of those who administered the puncture: unclear

  • Median or paramedian technique: unclear

  • (For dx lumbar puncture or myelography only)

  • Amount of CSF extracted: unclear

  • Amount of injected volume: 10 ml iopamidol 300 (3.0 g iodine) were used for lumbar myelography and 15 ml (4.5 g iodine) for thoracic and cervical myelography

  • All lumbar punctures were performed with the patient in the left lateral decubitus position

Participants

1. 284 patients enrolled (patients referred for myelography)

    • Patients randomized to:

      • 22 G needle group (147, 51.7%)

      • 26 G needle group (137, 48.2%)

    • No patients were lost to follow‐up

    • No randomized patients were excluded from this study

2. 6 patients were excluded following failed lumbar puncture with 26 G needles

3. Main characteristics of patients:

    • Average age: 46.9 (range 13 to 86 years)

    • Percentage/number of females/males by group:

      • 26 G: female 118 (41.5%); male 166 (58.4%)

      • 22 G: female 59; male 78

Interventions

  1. Up to 2 ml of 1% lignocaine was injected intradermally using a 25 G needle and into the subcutaneous tissues using a 21 G needle

  2. The 26 G spinal needles were inserted coaxially through a 4 cm long 21 G needle used for local anaesthesia

All lumbar punctures were performed with the patient in the left lateral decubitus position

Patients were routinely ambulatory following the examination

Outcomes

Outcomes were not classified as primary or secondary

  1. Incidence of headaches: postural headaches as well as mild, moderate or severe headaches

  2. Incidence of adverse events: nausea, vomiting, dizziness and visual disturbance

  3. Type of myelogram

  4. Experience of radiologist

Notes

  1. Trial registration: not stated

  2. Funder: not stated

  3. Role of funder: not stated

  4. A priori sample size estimation: no

  5. Conducted: not reported

  6. Declared conflicts of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "The patients were randomly assigned to the 22 G or the 26 G needle group." (page 338)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "Patients were given a questionnaire to complete on discharge from hospital 24h after the myelogram. Late complications were obtained by telephone" (page 338)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

Low risk

All patient‐important outcomes were reported

Other bias

Low risk

No other biases were identified

Zela 1994

Methods

  • Design: parallel‐group (2 arms)

  • Country: Mexico

  • Multisite: no

  • International: no

  • Needle type design used: Whitacre vs Quincke

  • Needle diameter used: 25

  • Procedure: spinal anaesthesia

  • Number of attempts (1 attempt): unknown

  • Site of the puncture: L2‐3 or L3‐4

  • Training level of those who administered the puncture: unknown

  • Median or paramedian technique: midline approach

  • Type of anaesthesia: unclear

  • Patient position: unknown

Participants

1. 40 patients ASA I‐II, aged from 18 to 50 years, undergoing subumbilical surgery were enrolled

Exclusion criteria: history of headache, refusal of method, hypertension

Patients randomized to:

  • 25 G Whitacre Group: 20 patients (50%)

  • 25 G Quincke Group: 20 patients (50%)

2. No patients were excluded from further analysis

3. Main characteristics of patients:

  • Age (mean, SD): 25 G Whitacre group: 27, 18; 25 G Quincke group: 29, 17

  • Men (number): 24 G Sprotte group: 10; 27 G Quincke group: 10

Interventions

  • 25 G Whitacre needle: no details were provided

  • 25 G Quincke needle: no details were provided

Outcomes

Outcomes were not classified as primary or secondary

  1. Headache (PDPH)

  2. Severity of headache

Notes

  1. Trial registration: not stated

  2. Funder: Becton Dickinson and Company

  3. Role of funder: provision of needles

  4. A priori sample size estimation: no

  5. Conducted: not stated

  6. Declared conflicts of interest: not stated

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias. Quote: "(we) developed a clinical trial with 40 patients" (page 1)

Allocation concealment (selection bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of participants (performance bias)

Unclear risk

Insufficient information to score this item as low or high risk of bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Follow‐up to detect patients who developed PDPH was realized by an anesthesiologist different from the one who performed the procedure" (page 67)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No patients were lost to follow‐up

Selective reporting (reporting bias)

High risk

Adverse events, additional to PDPH, were not reported

Other bias

Low risk

No other biases were identified

Acronyms and abbreviations used in this table

ASA: American Society of Anesthesiologists; ASN: Atraucan spinal needle; BMI: body mass index; CI: confidence interval; c‐section: caesarean section; CSF: cerebrospinal fluid; G: gauge; IQR: interquartile range; L2‐3 to L3‐4: lumbar vertebrae 2‐3 to 3‐4; LP: lumbar puncture; NRS: numerical rating scale; NYHA: New York Heart Association; PDPH: post‐dural puncture headache; RCT: randomized controlled trial; SD: standard deviation; SEM: standard error of the mean; VAS: visual analogue scale; vs: versus; WSN: Whitacre spinal needle

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Ansaloni 2000

In this study, the authors did not evaluate the use of a specific type of needle or its gauge for the evaluation of PDPH.

Benedetti 1992

This study was excluded because it was performed without any random allocation process.

Braune 1992

This study is not a randomized controlled trial.

Browne 2005

This study was excluded because an intervention to treat PDPH is included.

Carrada 1997

This study was excluded because it was performed without any random allocation process.

Charuluxananan 2005

In this study, the units of randomization were anaesthesiologists in training (learning curve) and not a specific type of needle.

Das‐Neves 2001

This study was excluded because it was performed without any random allocation process.

Eldor 2003

This study was excluded because it was a letter to the editor.

Eshuis 1995

This study was excluded because it was a comment.

Flaatten 1998

This study was excluded because the unit of randomization was the procedure and not the patient.

Ginosar 2012

In this study, the authors used a pulsatile cerebrospinal fluid model to test a spinal needle.

Guclu 2006

This study was excluded because it was a letter to the editor.

Herbstman 1998

This study was excluded because an intervention to treat PDPH is included.

Huffnagle 1998

This study was excluded because the intervention assessed in this review was not addressed.

Jones 1994

This study was excluded because it did not use an adequate method of randomization (odd and even hospital record numbers).

Landau 2001

This study was excluded because it was performed without any random allocation process.

Lynch 1992

This study was excluded because it was performed without any random allocation process.

Malhotra 2007

This study was excluded because it was performed without any random allocation process.

Mardirosoff 2001

This study was excluded because it evaluated the duration of time sitting and spinal needle type on the maximal spread of local anaesthetics and not the presence of PDPH.

Mazze 1993

This study was excluded because the unit of randomization was the procedure and not the patient.

Merlo 1989

This study was excluded because it was performed without any random allocation process.

Nunes 1999

This study was excluded because it was performed without any random allocation process.

Pjevic 1993

This study is not a randomized controlled trial.

Quinn 2013

This study was excluded because it was a narrative review.

Russell 2002

This study was excluded because it evaluated different positions (oxford position, lateral and sitting positions) during spinal‐epidural anaesthesia and not the use of different types of needles.

Samayoa 2004

This study was excluded because it was performed without any random allocation process.

Shah 2002

This study is not a randomized controlled trial.

Sinikoglu 2013a

This study was excluded because it evaluated the effects of reinsertion of the stylet after a spinal anaesthesia procedure on PDPH and not the type or size of the needle.

Strupp 1998

This study was excluded because it evaluated the effects of reinsertion of the stylet after a spinal anaesthesia procedure on PDPH and not the type or size of the needle.

Strupp 2009

This study was excluded because it was a narrative review.

Thoren 1994

This study was excluded because it evaluated different types of anaesthesia techniques (sequential combined spinal epidural block versus spinal block) and not different types of needles.

Vallejo 2000

This study was excluded because the authors randomized the days on which each different needle would be used and not the patients.

Van Den Berg 2011

This study was excluded because it was performed without any random allocation process.

Vilming 2001

This study was excluded because it was performed without any random allocation process.

Wilhelm 1997

This study was excluded because it was not focused on the prevention of PDPH.

PDPH: post‐dural puncture headache

Characteristics of studies awaiting assessment [ordered by study ID]

Bano 2004

Methods

Single blinded, interventional, experimental study

Participants

A total of 100 females, aged 18 to 35 years, ASA physical status I and II, with singleton pregnancy undergoing elective or emergency caesarean section under spinal anaesthesia

Interventions

Participants were randomly allocated to receive spinal anaesthesia either by using 25 G Quincke or 25 G Whitacre needles. Patients were followed for 3 days postoperatively

Outcomes

The primary outcome was the assessment of headache and the relation to posture. Secondary outcomes were onset of headache, its duration, severity and response to the treatment

Notes

Buttner 1990

Methods

Prospective, randomized, double‐blind study

Participants

A total of 400 patients who received spinal anaesthesia for operation of the lower extremities

Interventions

Patients were randomly assigned to 2 groups (25 G Whitacre and a 25 G Quincke needles) and were interviewed postoperatively on days 1, 3, 5 and 7 to assess PDPH

Outcomes

The primary outcome was PDPH. Secondary outcomes were: duration of PDPH, non‐postural headache and the duration of non‐postural headache.

Notes

Castrillo 2015

Methods

Prospective, randomized and single‐blinded clinical trial

Participants

Patients older than 14 years were scheduled for a diagnostic or therapeutic lumbar puncture

Interventions

2 kinds of spinal needle: atraumatic or S‐type or traumatic or Q‐type

Outcomes

Development of PDPH according to the International Headache Association criteria

Notes

De Andres 1994

Methods

Prospective, randomized, double‐blind study

Participants

A total of 158 patients, ASA I and II, ranging in age from 20 to 40 years undergoing lower limb orthopaedic surgery

Interventions

Patients were randomly assigned to 2 groups (26 G Atraucan and 27 G Whitacre needles) for the realization of spinal anaesthesia

Outcomes

The primary outcome was: frequency and degree of PDPH. Secondary outcomes were: performance of the subarachnoid technique and intraoperative side effects.

Notes

Fama 2015

Methods

Prospective, randomized, experimental study in healthy participants

Participants

330 parturients scheduled for caesarean section

Interventions

25, 26 or 27 G pencil point, Whitacre type (with introducer) needles

Outcomes

Puncture failure rates, post‐dural puncture headache

Notes

Fyneface‐Ogan 2006

Methods

Prospective, single‐blind, randomized study

Participants

A total of 100 women undergoing elective and emergency caesarean delivery under spinal anaesthesia were recruited

Interventions

Patients were randomly allocated to receive spinal anaesthesia either by using 2 spinal needles (Becton Dickinson Whitacre sizes 25 G and 26 G needles)

Outcomes

Incidence of PDPH

Notes

Harrison 1994

Methods

Randomized, prospective study

Participants

A total of 113 patients referred for lumbar, thoracic, cervical or total column myelography

Interventions

Participants were numbered sequentially; in even‐numbered patients a 22 G needle was used and for odd‐numbered patients, a 25 G needle

Outcomes

The primary outcome was the incidence of headache following myelography. Secondary outcomes were: the influence of needle type, sex, myelogram type and operators.

Notes

Hong 2015

Methods

Prospective, randomized trial

Participants

149 patients undergoing lumbar transforaminal epidural steroid injection for radicular leg pain

Interventions

Whitacre and Quincke type needles

Outcomes

After final confirmation of intravascular injection with digital subtraction angiography, total procedure time and amount of radiation exposure during the procedure were measured

Notes

Jager 1995

Methods

Only title is available

Participants

Not known

Interventions

Not known

Outcomes

Not known

Notes

Jensen 1999

Methods

Prospective, randomized study

Participants

A total of 197 patients aged below 40 years were included in this study

Interventions

Participants were randomized to receive spinal analgesia using one of the following needles: Sprotte G24, Spinocan G27 or Atraucan G26

Outcomes

The primary outcome of this study was the incidence of postoperative complications including post‐dural puncture headache (PDPH)

Notes

Kaul 1996

Methods

Prospective, randomized study

Participants

A total of 90 adult patients who underwent elective surgical operations under spinal anaesthesia were evaluated

Interventions

Patients were randomly allocated to 3 groups of 30 each to receive spinal anaesthesia using 20‐ G, 22 G or 24‐gague spinal needles

Outcomes

The primary outcome was: incidence of headache and frequency of hearing loss

Notes

Knudsen 1998

Methods

Prospective, randomized study

Participants

A total of 106 patients, aged below 40 years, scheduled for surgery in the lower part of the body were chosen for this study

Interventions

Patients were allocated randomly to have spinal analgesia with either a Sprotte 24 G or an Atraucan 26 G spinal needle

Outcomes

The primary outcome was: incidence of PDPH. Secondary outcomes were: ease of needle insertion and number of puncture attempts

Notes

Lim 1992

Methods

Prospective, randomized study

Participants

A total of 56 patients were recruited in this study

Interventions

Patients underwent spinal anaesthesia for extra‐corporeal shockwave lithotripsy using either a Sprotte 24 G (n = 28) or Vygon 29 G or Quincke type needle (n = 28)

Outcomes

Frequency of PDPH

Notes

Maclean 1994

Methods

Prospective, randomized, double‐blind study

Participants

A total of 60 nulliparous women

Interventions

Participants were randomized to receive an epidural infusion of either 0.125% plain bupivacaine or 0.0625% bupivacaine with 2.5µg/ml fentanyl

Outcomes

The primary outcome was pain and motor block. Secondary outcomes were maternal side effects and cardio‐tocograph abnormalities

Notes

Mignonsin 1991

Methods

Prospective, controlled study

Participants

30 ASA I or II patients

Interventions

Lumbar puncture was carried out with 26 G in group I and 18 G in group II

Outcomes

Complications during spinal anaesthesia included: vomiting, nausea, allergia and low blood pressure. Postspinal headache.

Notes

Palmieri 1993

Methods

Prospective, randomized study

Participants

A total of 92 pregnant patients undergoing elective caesarean section

Interventions

Patients undergoing lumbar puncture were randomized to 2 groups (Group I: 22 G Quincke disposable needle and group II: 22 G Quincke reusable needle)

Outcomes

The primary outcome was the assessment of PDPH. There were no secondary outcomes.

Notes

Puolakka 1997

Methods

Prospective follow‐up study

Participants

A total of 400 patients were included in this study

Interventions

Patients were randomly selected to have a spinal anaesthesia using either a 27 G Quincke‐type needle or a 27 G pencil point needle

Outcomes

The primary outcome was the severity of needle damage according to the type and number of attempts

Notes

Vandana 2004

Methods

Prospective study

Participants

200 patients between 18 and 45 years of age belonging to ASA grade I and II of either sex

Interventions

Spinal anaesthesia with 25 G or 29 G Quincke type spinal needle

Outcomes

Incidence, type, severity, duration, day of onset and site of post‐dural puncture headache were recorded for the first 5 postoperative days

Notes

ASA: American Society of Anesthesiologists; G: gauge; PDPH: post‐dural puncture headache

Characteristics of ongoing studies [ordered by study ID]

Ahmed 2012

Trial name or title

'Incidence and severity of post dural puncture headache after spinal anaesthesia for caesarean section; a comparison between 25G Quincke cutting and 25G Pencan pencil point spinal needles'

Methods

Study design: double‐blind randomized controlled trial

Participants

Patients and methods: 200 adult female patients aged 20 to 40 years, ASA I and II, presenting for elective or emergency caesarean deliveries under spinal anaesthesia were randomly divided into 2 groups of 100 patients each

Interventions

In group P, spinal anaesthesia was performed by Pencan needle while in group Q spinal anaesthesia was performed by Quincke cutting needle using a standardized technique

Outcomes

Level of block (sympathetic, sensory, motor) was assessed intraoperatively. Patients were followed for 3 consecutive days postoperatively for headache, its onset, severity and associated symptoms

Starting date

August 2009 to August 2010

Contact information

Ahmed J

Notes

Akdemir 2011

Trial name or title

'The association between needle types and headache'

Methods

Not known

Participants

664 ASA I‐II group elective caesarean patients who had no contraindications for spinal anaesthesia were included to this study. The thickness of the needle and the shape of tip of the spinal needle was recorded after anaesthesia. The education period of the anaesthesia performer, number of attempts, the space used for anaesthesia (L3‐4, LL4‐5) and movement of patient during anaesthesia were recorded

Interventions

Patients were randomly divided into 2 groups: group I (Atraucan 26G n = 323) and group II (Quincke 26G n = 342)

Outcomes

Patients were questioned about headache for 72 hours. Chi2 and comparison of proportions were used for statistical evaluations

Starting date

Not known

Contact information

AkdemirMS

Notes

Bertolotto 2014

Trial name or title

'Post‐dural puncture headache is markedly reduced when 25 Sprotte needles are used'

Methods

To evaluate the frequency of post‐dural puncture headache (PDPH) using 4 types of needles with a prospective, rater‐blind study

Participants

365 lumbar punctures were performed using 4 different types of needles as follows: 39 with 20 G Quincke traumatic needle, 62 with 22G Sprotte needle, 133 with 25G Whitacre needle, 131 with 25G Sprotte needle

Interventions

25 G Whitacre needle, 25 G Sprotte needle

Outcomes

The patient was blinded to the needle used; a neurologist, blinded to the type of the needle, interviewed the patient for PDPH. Safety and time consumption were evaluated.

Starting date

Not known

Contact information

Bertolotto A

Notes

Bertolotto 2014a

Trial name or title

'25G Sprotte needle strongly reduces the risk of post‐lumbar puncture headache in clinical practice'

Methods

To evaluate the frequency of post‐lumbar puncture headache (PLPH) using 5 types of needles

Participants

363 lumbar punctures were performed using 5 different types of needles as follows: 39 with 20 G Quincke traumatic needle, 11 with 22 G Quincke needle, 53 with 22 G Whitacre needle, 134 with 25 G Whitacre needle, 126 with 25 G Sprotte needle

Interventions

25 G Whitacre needle, 25 G Sprotte needle

Outcomes

The patient was blinded to the needle used; a neurologist, blinded to the type of the needle, interviewed the patient for PLPH. Safety and time consumption were evaluated.

Starting date

Unclear

Contact information

Bertolotto A

Notes

Bham 2010

Trial name or title

'Comparison of 22/27g Microtip vs 25g Pencan spinal needle; insertion characteristic and complications'

Methods

Single‐blind, randomized study

Participants

A total of 101 parturients admitted for elective lower segment caesarian sections under spinal anaesthesia were admitted in the study

Interventions

Patients were randomly assigned to have Pencan (n = 50) or Microtip (n = 51) needle

Outcomes

The outcomes of this study were: ease of needle insertion, first attempt success rate and CSF flow rate as well as incidence of paraesthesia, post‐dural puncture headache (PDPH) and backache (PDPB), transient neurological symptoms (TNS)

Starting date

Not known

Contact information

Not known

Notes

IRCT201009292080N4

Trial name or title

'Comparison of Sprotte and Quincke needles with respect to post dural puncture headache'

Methods

Randomization: randomized
Blinding: double‐blind
Placebo: not used
Assignment: parallel
Purpose: others.

Participants

Inclusion criteria: age 16 to 65, patients with major surgery of the lower limb or lower abdominal segment under spinal anaesthesia
Exclusion criteria: patients with chronic headache and drug‐induced headache

Age minimum: 16

Age maximum: 65

Gender: both male and female

Interventions

Intervention 1: Sprotte spinal needle. Intervention 2: Quincke spinal needle

Outcomes

Headache

Hypotension

Nausea & vomiting

Nuchal rigidity

Time point (all outcomes): every 4 hours until 24 hours after surgery. Method of measurement (all outcomes): checklist and physical exam.

Starting date

21 April 2010

Contact information

Afsane Norouzi

Notes

Lorthe 2014

Trial name or title

'CSE for caesarean section: Gertie Marx versus Pencan spinal needles'

Methods

Compared Gertie Marx spinal needle with PENCAN needle to determine which one is preferred by obstetric patients

Participants

Following IRB approval and informed consent, 124 ASA I‐II parturients, who requested neuraxial block for C/S, were included. The epidural space was located with ESPOCAN 18 gauge epidural 'Braun' needle (B. Braun Medical Inc.) at L3‐4 or L4‐5 interspace with loss of resistance to air technique using a midline approach in the lateral or sitting flexed position

Interventions

Patients were then randomized to 1 of 2 groups. Group I: 59 patients had a 25 G PENCAN spinal needle placed in the subarachnoid space. Group II: 65 had a 26 G Gertie Marx spinal needle (IMD Inc. USA) placed in the subarachnoid space.

Outcomes

An investigator recorded patients' height, weight, parity, position, the distance of the epidural space from the skin, technical problems, paraesthesia and pain upon insertion of the spinal needle, time to incision, difficulty with catheter insertion, post‐dural puncture headache, transient radicular irritability, duration of procedure and overall satisfaction with the technique use

Starting date

Not known

Contact information

Lorthe J

Notes

NCT00370604

Trial name or title

'Effect of small versus large epidural needles on postdural puncture headache study'

Methods

Allocation: randomized
Endpoint classification: safety/efficacy study
Intervention model: parallel assignment
Masking: single‐blind (outcomes assessor)
Primary purpose: prevention

Participants

Inclusion criteria:
‐ American Society of Anesthesiologists status 1 to 2
‐ Must have provided written informed consent = or < 6 cm cervical dilation
‐ Fetus 37 to 42 weeks gestation
‐ Must be able to read and write English well enough to provide written informed consent
Exclusion criteria:
‐ BMI = or > 40
‐ Multiple gestation pregnancy
‐ Known contraindications to use of epidural analgesia
‐ Pregnancy‐induced hypertension
‐ Investigator concern for maternal or neonatal welfare
‐ Receipt of spinal or epidural anaesthesia within 14 days of labour epidural request
‐ Women with chronic headaches (defined as headaches that occur 15 or more days per month for more than 3 months)
‐ Already participated in study
‐ History of narcotic abuse

Age minimum: 18 years

Age maximum: N/A

Gender: female

Interventions

Device: => 18 G Tuohy‐type needle

Device: 19 G Tuohy‐type epidural needle, 23 G catheter

Outcomes

Incidence of post‐dural puncture headache (time frame: within the first 14 days of epidural placement)

Anaesthesiologist satisfaction with the 19 G Tuohy epidural needle and 23 G catheter compared with traditional Tuohy‐type epidural needles and traditional catheters (time frame: during labour and delivery)

Degree of dysfunction and disability related to PDPH symptoms (time frame: within first 14 days post‐epidural placement and, if necessary, up to 1 year post‐epidural placement)

Starting date

June 2007

Contact information

Pamela J Angle

Notes

NCT01821807

Trial name or title

'Comparison of two spinal needles regarding postdural puncture headache'

Methods

Time perspective: prospective

Participants

Inclusion Criteria:
‐ Pregnant female patients between 18‐40 years old undergoing caesarean section
‐ Patient accepting spinal anaesthesia
Exclusion Criteria:
‐ Infection at the spinal needle insertion cite
‐ Coagulability disorder
‐ Patient not accepting the procedure

Age minimum: 18 Years
Age maximum: 40 Years
Gender: Female

Interventions

Two kind of spinal anaesthesia needles will be used:

  1. 26 Gauge Quincke (cutting‐tip needle)

  2. 26 Gauge Atraucan (atraumatic needle)

Outcomes

Post‐dural puncture headache in patients receiving spinal anaesthesia for caesarean section (time frame: 1 week)

Backache in patients receiving spinal anaesthesia for caesarean section (time frame: 1 week)

Starting date

June 2013

Contact information

Ruslan Abdullayev

Notes

NCT02384031

Trial name or title

'Post‐dural puncture headache ‐ needles and biomarkers in CSF'

Methods

Allocation: randomized
Intervention model: parallel assignment
Masking: double‐blind (subject, investigator)
Primary purpose: prevention

Participants

Inclusion criteria:
1. Patients at Department of Neurology, Nordland Hospital Trust in Bodø, scheduled for diagnostic LP
Exclusion criteria:
1. Dementia
2. Non‐compliance or coma
3. Local skin infections over proposed puncture site
4. Suspicion of raised intracranial pressure due to neurological or radiological findings
5. Bleeding diathesis (thrombocytopenia < 50 x 109/L) or ongoing anticoagulant therapy
6. Major spinal column deformities
7. Procedural complications whereby needle type or size change is a requisite
8. Recent LP (< 7 days)

Age minimum: 18 years

Age maximum: 60 years

Gender: both

Interventions

Device: atraumatic needle

Device: traumatic needle

Outcomes

Post‐dural puncture headache (PDPH) (time frame: at day 7 post LP)

Levels of inflammatory mediators in CSF (time frame: during lumbar puncture)

Levels of metabolites in CSF (time frame: during lumbar puncture)

Levels of neuropeptides in CSF (time frame: during lumbar puncture)

Starting date

February 2012

Contact information

Francis Odeh, MD, PhD

Notes

Shah 2011

Trial name or title

'Combined spinal epidural (CSE) for cesarean section: Gertie Marx versus Pencan spinal needles'

Methods

Prospective, randomized study

Participants

A total of 124 ASA I‐II parturients who requested neuraxial block for caesarean section were included in this study

Interventions

Patients were randomized into 2 groups (Group I: n = 59 has a 25 G PENCAN spinal needle placed in the subarachnoid space and Group II: n = 65 had a 26 G Gertie Marx spinal needle in the subarachnoid space

Outcomes

Need to rotate or reinsert the epidural needle, the efficacy of the block, side effects from the block, difficulty with catheter insertion and the sensory level overall satisfaction

Starting date

Not known

Contact information

Not known

Notes

Shaikh 2013

Trial name or title

'Post dural puncture headache after spinal anaesthesia for caesarean section: a comparison of 25G Quincke, 27G Quincke and 27G Whitacre spinal needles'

Methods

Comparative, randomized, double‐blind, interventional study

Participants

A total of 480 ASA I‐II full‐term pregnant women, 18 to 45 years of age, scheduled for elective caesarean section, under spinal anaesthesia

Interventions

Participants were randomized into 3 groups: Group I (25 G Quincke spinal needle: n = 168), Group II (27 G Quincke spinal needle: n = 160) and Group III (27 G Whitacre spinal needle: n = 152)

Outcomes

The primary outcome was the frequency of PDPH. Secondary outcomes were the severity and onset of PDPH.

Starting date

From October 2005 to December 2006

Contact information

Not known

Notes

Acronyms and abbreviations used in this table

ASA: American Society of Anesthesiologists; ASN: Atraucan spinal needle; BMI: body mass index; CI: confidence interval; c‐section: caesarean section; CSF: cerebrospinal fluid; G: gauge; IQR: interquartile range; L2‐3 to L3‐4: lumbar vertebrae 2‐3 to 3‐4; LP: lumbar puncture; NRS: numerical rating scale; NYHA: New York Heart Association; PDPH: post‐dural puncture headache; RCT: randomized controlled trial; SD: standard deviation; SEM: standard error of the mean; VAS: visual analogue scale; WSN: Whitacre spinal needle

Data and analyses

Open in table viewer
Comparison 1. Traumatic needle versus atraumatic needle

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 PDPH by indication Show forest plot

36

9378

Risk Ratio (M‐H, Random, 95% CI)

2.14 [1.72, 2.67]

Analysis 1.1

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 1 PDPH by indication.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 1 PDPH by indication.

1.1 Anaesthesia only

30

8401

Risk Ratio (M‐H, Random, 95% CI)

2.21 [1.60, 3.04]

1.2 Myelography only

3

548

Risk Ratio (M‐H, Random, 95% CI)

2.01 [1.34, 3.00]

1.3 Diagnostic lumbar puncture only

3

429

Risk Ratio (M‐H, Random, 95% CI)

2.22 [1.38, 3.58]

2 PDPH by gauge Show forest plot

20

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 1.2

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 2 PDPH by gauge.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 2 PDPH by gauge.

2.1 22 gauge

5

877

Risk Ratio (M‐H, Random, 95% CI)

2.15 [1.56, 2.97]

2.2 25 gauge

5

1260

Risk Ratio (M‐H, Random, 95% CI)

2.48 [1.56, 3.95]

2.3 27 gauge

11

4076

Risk Ratio (M‐H, Random, 95% CI)

2.87 [1.81, 4.53]

3 PDPH by gender Show forest plot

9

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 1.3

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 3 PDPH by gender.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 3 PDPH by gender.

3.1 Only women

9

1424

Risk Ratio (M‐H, Random, 95% CI)

2.60 [1.62, 4.17]

4 PDPH/anaesthesia: type of surgery Show forest plot

30

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 1.4

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 4 PDPH/anaesthesia: type of surgery.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 4 PDPH/anaesthesia: type of surgery.

4.1 Caesarean section

8

1324

Risk Ratio (M‐H, Random, 95% CI)

3.12 [1.60, 6.10]

4.2 Orthopaedic procedures

3

994

Risk Ratio (M‐H, Random, 95% CI)

1.35 [0.58, 3.19]

4.3 Other surgeries

19

6083

Risk Ratio (M‐H, Random, 95% CI)

2.30 [1.50, 3.51]

5 PDPH by position Show forest plot

20

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 1.5

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 5 PDPH by position.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 5 PDPH by position.

5.1 Lateral position

9

3242

Risk Ratio (M‐H, Random, 95% CI)

4.70 [2.39, 9.24]

5.2 Sitting position

11

2193

Risk Ratio (M‐H, Random, 95% CI)

2.11 [1.52, 2.94]

6 PDPH by age Show forest plot

36

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 1.6

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 6 PDPH by age.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 6 PDPH by age.

6.1 No distinctions by age

34

9063

Risk Ratio (M‐H, Random, 95% CI)

2.17 [1.73, 2.73]

6.2 Only < 18 years

2

315

Risk Ratio (M‐H, Random, 95% CI)

1.69 [0.56, 5.12]

7 AE: paraesthesia Show forest plot

3

573

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.47, 1.96]

Analysis 1.7

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 7 AE: paraesthesia.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 7 AE: paraesthesia.

8 AE: backache Show forest plot

12

3027

Risk Ratio (M‐H, Random, 95% CI)

0.94 [0.78, 1.13]

Analysis 1.8

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 8 AE: backache.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 8 AE: backache.

9 Severe PDPH by indication Show forest plot

24

6420

Risk Ratio (M‐H, Random, 95% CI)

1.88 [1.20, 2.94]

Analysis 1.9

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 9 Severe PDPH by indication.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 9 Severe PDPH by indication.

9.1 Anesthesia

19

5542

Risk Ratio (M‐H, Random, 95% CI)

1.77 [0.88, 3.53]

9.2 Myelography

4

778

Risk Ratio (M‐H, Random, 95% CI)

1.70 [0.68, 4.28]

9.3 Diagnostic lumbar puncture

1

100

Risk Ratio (M‐H, Random, 95% CI)

3.0 [1.18, 7.63]

10 Any headache by indication Show forest plot

18

4104

Risk Ratio (M‐H, Random, 95% CI)

1.35 [1.17, 1.57]

Analysis 1.10

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 10 Any headache by indication.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 10 Any headache by indication.

10.1 Anaesthesia

16

3656

Risk Ratio (M‐H, Random, 95% CI)

1.38 [1.17, 1.63]

10.2 Myelography

2

448

Risk Ratio (M‐H, Random, 95% CI)

1.34 [0.81, 2.21]

11 PDPH sensitivity analysis Show forest plot

3

802

Risk Ratio (M‐H, Random, 95% CI)

2.78 [1.26, 6.15]

Analysis 1.11

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 11 PDPH sensitivity analysis.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 11 PDPH sensitivity analysis.

Open in table viewer
Comparison 2. Larger gauge traumatic needles versus smaller gauge traumatic needles

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 PDPH larger gauge vs smaller gauge Show forest plot

10

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 2.1

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 1 PDPH larger gauge vs smaller gauge.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 1 PDPH larger gauge vs smaller gauge.

1.1 23 G vs 25 G

1

53

Risk Ratio (M‐H, Random, 95% CI)

2.08 [0.20, 21.55]

1.2 25 G vs 27 G

4

1041

Risk Ratio (M‐H, Random, 95% CI)

1.82 [0.98, 3.39]

1.3 25 G vs 29 G

3

376

Risk Ratio (M‐H, Random, 95% CI)

2.13 [0.46, 9.78]

1.4 26 G vs 27 G

1

658

Risk Ratio (M‐H, Random, 95% CI)

6.47 [2.55, 16.43]

1.5 21 G vs 25 G

1

160

Risk Ratio (M‐H, Random, 95% CI)

0.86 [0.30, 2.44]

2 PDPH by type of surgery Show forest plot

10

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 2.2

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 2 PDPH by type of surgery.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 2 PDPH by type of surgery.

2.1 Caesarean section

2

455

Risk Ratio (M‐H, Random, 95% CI)

1.28 [0.64, 2.57]

2.2 Orthopaedic surgeries

2

213

Risk Ratio (M‐H, Random, 95% CI)

0.99 [0.38, 2.58]

2.3 Other surgeries

6

1620

Risk Ratio (M‐H, Random, 95% CI)

2.94 [1.23, 7.03]

3 PDPH by age Show forest plot

10

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 2.3

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 3 PDPH by age.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 3 PDPH by age.

3.1 No distinctions about age

8

2175

Risk Ratio (M‐H, Random, 95% CI)

2.09 [1.11, 3.95]

3.2 Only children

1

60

Risk Ratio (M‐H, Random, 95% CI)

3.0 [0.13, 70.83]

3.3 Only > 60 years

1

53

Risk Ratio (M‐H, Random, 95% CI)

2.08 [0.20, 21.55]

4 PDPH by position Show forest plot

7

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 2.4

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 4 PDPH by position.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 4 PDPH by position.

4.1 Lateral position

5

859

Risk Ratio (M‐H, Random, 95% CI)

1.76 [0.98, 3.16]

4.2 Sitting position

2

584

Risk Ratio (M‐H, Random, 95% CI)

1.00 [0.64, 1.56]

5 AE: backache Show forest plot

3

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 2.5

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 5 AE: backache.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 5 AE: backache.

6 Severe PDPH by gauge Show forest plot

6

Risk Difference (M‐H, Random, 95% CI)

Subtotals only

Analysis 2.6

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 6 Severe PDPH by gauge.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 6 Severe PDPH by gauge.

6.1 23 G vs 25 G

1

53

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.07, 0.07]

6.2 25 G vs 27 G

3

815

Risk Difference (M‐H, Random, 95% CI)

0.00 [‐0.01, 0.01]

6.3 25 G vs 29 G

1

100

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.04, 0.04]

6.4 21 G vs 25 G

1

160

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.02, 0.02]

7 Any headache Show forest plot

3

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 2.7

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 7 Any headache.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 7 Any headache.

Open in table viewer
Comparison 3. Larger gauge atraumatic needles versus smaller gauge atraumatic needles

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 PDPH larger gauge vs smaller gauge Show forest plot

13

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 3.1

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 1 PDPH larger gauge vs smaller gauge.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 1 PDPH larger gauge vs smaller gauge.

1.1 22 G vs 24 G

1

375

Risk Ratio (M‐H, Random, 95% CI)

0.98 [0.20, 4.81]

1.2 22 G vs 25 G

2

334

Risk Ratio (M‐H, Random, 95% CI)

3.00 [0.32, 28.50]

1.3 24 G vs 25 G

2

647

Risk Ratio (M‐H, Random, 95% CI)

5.62 [1.00, 31.67]

1.4 25 G vs 26 G

3

519

Risk Ratio (M‐H, Random, 95% CI)

0.76 [0.30, 1.90]

1.5 25 G vs 27 G

2

612

Risk Ratio (M‐H, Random, 95% CI)

3.72 [0.59, 23.64]

1.6 26 G vs 27 G

2

258

Risk Ratio (M‐H, Random, 95% CI)

1.79 [0.30, 10.73]

1.7 27 G vs 29 G

1

389

Risk Ratio (M‐H, Random, 95% CI)

1.59 [0.58, 4.37]

2 PDPH by type of surgery Show forest plot

13

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 3.2

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 2 PDPH by type of surgery.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 2 PDPH by type of surgery.

2.1 Caesarean section

6

1263

Risk Ratio (M‐H, Random, 95% CI)

1.92 [0.64, 5.79]

2.2 Orthopaedic procedures

2

392

Risk Ratio (M‐H, Random, 95% CI)

1.24 [0.30, 5.07]

2.3 Other surgeries

5

1479

Risk Ratio (M‐H, Random, 95% CI)

1.44 [0.73, 2.83]

3 PDPH by gender Show forest plot

8

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 3.3

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 3 PDPH by gender.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 3 PDPH by gender.

3.1 Only women

8

1853

Risk Ratio (M‐H, Random, 95% CI)

1.06 [0.51, 2.20]

4 PDPH by position Show forest plot

10

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 3.4

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 4 PDPH by position.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 4 PDPH by position.

4.1 Sitting position

5

1106

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.45, 2.06]

4.2 Lateral position

5

992

Risk Ratio (M‐H, Random, 95% CI)

1.88 [0.65, 5.41]

5 AE: paraesthesia Show forest plot

2

439

Risk Ratio (M‐H, Random, 95% CI)

2.19 [0.31, 15.30]

Analysis 3.5

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 5 AE: paraesthesia.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 5 AE: paraesthesia.

6 AE: backache Show forest plot

4

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 3.6

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 6 AE: backache.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 6 AE: backache.

7 Severe PDPH by gauge Show forest plot

8

Risk Difference (M‐H, Random, 95% CI)

Subtotals only

Analysis 3.7

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 7 Severe PDPH by gauge.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 7 Severe PDPH by gauge.

7.1 22 G vs 24 G

1

375

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.01, 0.01]

7.2 22 G vs 25 G

1

234

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.02, 0.02]

7.3 24 G vs 25 G

1

304

Risk Difference (M‐H, Random, 95% CI)

0.01 [‐0.02, 0.03]

7.4 25 G vs 26 G

2

311

Risk Difference (M‐H, Random, 95% CI)

0.01 [‐0.01, 0.03]

7.5 25 G vs 27 G

1

212

Risk Difference (M‐H, Random, 95% CI)

0.01 [‐0.02, 0.04]

7.6 26 G vs 27 G

1

158

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.02, 0.02]

7.7 27 G vs 29 G

1

389

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.01, 0.01]

8 Any headache by gauge Show forest plot

7

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 3.8

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 8 Any headache by gauge.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 8 Any headache by gauge.

8.1 22 G vs 25 G

1

234

Risk Ratio (M‐H, Random, 95% CI)

2.17 [0.85, 5.51]

8.2 24 G vs 25 G

2

645

Risk Ratio (M‐H, Random, 95% CI)

1.17 [0.49, 2.77]

8.3 25 G vs 26 G

2

311

Risk Ratio (M‐H, Random, 95% CI)

1.13 [0.65, 1.99]

8.4 25 G vs 27 G

1

212

Risk Ratio (M‐H, Random, 95% CI)

1.87 [0.65, 5.39]

8.5 27 G vs 29 G

1

389

Risk Ratio (M‐H, Random, 95% CI)

1.80 [0.85, 3.83]

Study flow diagram
Figures and Tables -
Figure 1

Study flow diagram

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figures and Tables -
Figure 2

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
Figures and Tables -
Figure 3

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Forest plot of comparison: 1 Traumatic needle versus atraumatic needle, outcome: 1.1 PDPH by indication.
Figures and Tables -
Figure 4

Forest plot of comparison: 1 Traumatic needle versus atraumatic needle, outcome: 1.1 PDPH by indication.

Funnel plot of comparison: 1 Traumatic needle versus atraumatic needle, outcome: 1.1 PDPH by indication.
Figures and Tables -
Figure 5

Funnel plot of comparison: 1 Traumatic needle versus atraumatic needle, outcome: 1.1 PDPH by indication.

Funnel plot of comparison: 3 Atraumatic needles: different gauges, outcome: 3.1 PDPH major gauge versus minor gauge by number.
Figures and Tables -
Figure 6

Funnel plot of comparison: 3 Atraumatic needles: different gauges, outcome: 3.1 PDPH major gauge versus minor gauge by number.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 1 PDPH by indication.
Figures and Tables -
Analysis 1.1

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 1 PDPH by indication.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 2 PDPH by gauge.
Figures and Tables -
Analysis 1.2

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 2 PDPH by gauge.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 3 PDPH by gender.
Figures and Tables -
Analysis 1.3

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 3 PDPH by gender.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 4 PDPH/anaesthesia: type of surgery.
Figures and Tables -
Analysis 1.4

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 4 PDPH/anaesthesia: type of surgery.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 5 PDPH by position.
Figures and Tables -
Analysis 1.5

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 5 PDPH by position.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 6 PDPH by age.
Figures and Tables -
Analysis 1.6

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 6 PDPH by age.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 7 AE: paraesthesia.
Figures and Tables -
Analysis 1.7

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 7 AE: paraesthesia.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 8 AE: backache.
Figures and Tables -
Analysis 1.8

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 8 AE: backache.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 9 Severe PDPH by indication.
Figures and Tables -
Analysis 1.9

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 9 Severe PDPH by indication.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 10 Any headache by indication.
Figures and Tables -
Analysis 1.10

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 10 Any headache by indication.

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 11 PDPH sensitivity analysis.
Figures and Tables -
Analysis 1.11

Comparison 1 Traumatic needle versus atraumatic needle, Outcome 11 PDPH sensitivity analysis.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 1 PDPH larger gauge vs smaller gauge.
Figures and Tables -
Analysis 2.1

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 1 PDPH larger gauge vs smaller gauge.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 2 PDPH by type of surgery.
Figures and Tables -
Analysis 2.2

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 2 PDPH by type of surgery.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 3 PDPH by age.
Figures and Tables -
Analysis 2.3

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 3 PDPH by age.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 4 PDPH by position.
Figures and Tables -
Analysis 2.4

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 4 PDPH by position.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 5 AE: backache.
Figures and Tables -
Analysis 2.5

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 5 AE: backache.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 6 Severe PDPH by gauge.
Figures and Tables -
Analysis 2.6

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 6 Severe PDPH by gauge.

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 7 Any headache.
Figures and Tables -
Analysis 2.7

Comparison 2 Larger gauge traumatic needles versus smaller gauge traumatic needles, Outcome 7 Any headache.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 1 PDPH larger gauge vs smaller gauge.
Figures and Tables -
Analysis 3.1

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 1 PDPH larger gauge vs smaller gauge.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 2 PDPH by type of surgery.
Figures and Tables -
Analysis 3.2

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 2 PDPH by type of surgery.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 3 PDPH by gender.
Figures and Tables -
Analysis 3.3

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 3 PDPH by gender.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 4 PDPH by position.
Figures and Tables -
Analysis 3.4

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 4 PDPH by position.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 5 AE: paraesthesia.
Figures and Tables -
Analysis 3.5

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 5 AE: paraesthesia.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 6 AE: backache.
Figures and Tables -
Analysis 3.6

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 6 AE: backache.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 7 Severe PDPH by gauge.
Figures and Tables -
Analysis 3.7

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 7 Severe PDPH by gauge.

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 8 Any headache by gauge.
Figures and Tables -
Analysis 3.8

Comparison 3 Larger gauge atraumatic needles versus smaller gauge atraumatic needles, Outcome 8 Any headache by gauge.

Summary of findings for the main comparison. Traumatic needles compared to atraumatic needles for prevention of post‐dural puncture headache (PDPH)

Traumatic needles compared to atraumatic needles for prevention of PDPH

Patient or population: patients undergoing lumbar punctures
Settings: all settings (countries: Argentina, Austria, Brazil, Canada, Denmark, Finland, France, Germany, India, Israel, Italy, Korea, Mexico, Nepal, Netherlands, Nigeria, Norway, Pakistan, Spain, Thailand, UK and USA)
Intervention: traumatic needles (Quincke, Greene, Hingson Ferguson, Lutz, Brace, Rovenstine, Lemmon)
Comparison: atraumatic needles (Whitacre, Atraucan, Sprotte, Cappe‐Deutsh, Pajunk, Gertie Marx, Durasafe, Cappe, Deutsch and Eldor)

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Atraumatic needles

Traumatic needles

Onset of PDPH

30 per 1000

64 per 1000
(52 to 80)

RR 2.14
(1.72 to 2.67)

9378
(36 studies)

⊕⊕⊕⊝
moderate1

Adverse events: paraesthesia

52 per 1000

50 per 1000
(25 to 102)

RR 0.96
(0.47 to 1.96)

573
(3 studies)

⊕⊕⊕⊝
moderate1

Adverse events: backache

155 per 1000

147 per 1000
(118 to 183)

RR 0.94
(0.78 to 1.13)

3027
(12 studies)

⊕⊕⊕⊝
moderate1

Severe PDPH

0 per 1000

10 per 1000

RD 0
(0.00 to 0.01)

6420
(24 studies)

⊕⊕⊝⊝
low1,2

Any headache

221 per 1000

290 per 1000
(228 to 367)

RR 1.35
(1.17 to 1.57)

4104
(18 studies)

⊕⊕⊕⊝
moderate1

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; PDPH: post‐dural puncture headache; RD: risk difference; RR: risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Risk of bias downgraded by one level due to unclear reporting (especially related to allocation concealment and random sequence generation issues).
2Inconsistency downgraded by one level due to presence of considerable heterogeneity (I2 = 42%), caused by one study focused on diagnostic lumbar punctures (Muller 1994).

Figures and Tables -
Summary of findings for the main comparison. Traumatic needles compared to atraumatic needles for prevention of post‐dural puncture headache (PDPH)
Summary of findings 2. Larger traumatic needles compared to smaller traumatic needles for prevention of post‐dural puncture headache (PDPH)

Traumatic needle(major gauge) compared to traumatic needle (minor gauge) for prevention of PDPH

Patient or population: patients undergoing lumbar punctures with traumatic needles (Quincke, Greene, Hingson Ferguson, Lutz, Brace, Rovenstine, Lemmon)
Settings: all settings (countries: Finland, Germany, India, Italy, Korea, Pakistan and USA)
Intervention: traumatic needle ‐ larger gauge (Quincke, Greene, Hingson Ferguson, Lutz, Brace, Rovenstine, Lemmon)
Comparison: traumatic needle ‐ smaller gauge (Quincke, Greene, Hingson Ferguson, Lutz, Brace, Rovenstine, Lemmon)

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Traumatic needle ‐ smaller gauge

Traumatic needle ‐ larger gauge

Onset of PDPH

RR ranged

from 0.86 to 6.47

2288
(10 studies)

⊕⊕⊝⊝
low1,3

We decided against overall pooling of results because the gauge of a needle could be considered small in one comparison but large in another.

Adverse events: paraesthesia ‐ not reported

See comment

See comment

Not estimable

See comment

We did not identify any studies reporting this outcome.

Adverse event: backache

RR ranged
from 0.81 to 2.00

948
(3 studies)

⊕⊕⊕⊝
moderate1

We decided against overall pooling of results because the gauge of a needle could be considered small in one comparison but large in another.

Severe PDPH

RD ranged
from 0.00 to 0.00

1128
(6 studies)

⊕⊕⊝⊝
low1,2

We decided against overall pooling of results because the gauge of a needle could be considered small in one comparison but large in another.

Any headache

RR ranged
from 0.75 to 1.56

771
(3 studies)

⊕⊕⊕⊝
moderate1

We decided against overall pooling of results because the gauge of a needle could be considered small in one comparison but large in another.

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; PDPH: post‐dural puncture headache; RD: risk difference; RR: risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Risk of bias downgraded by one level due to unclear reporting (especially related to allocation concealment and random sequence generation issues).

2Imprecision downgraded by one level due to few events reported in each arm.

3Imprecision downgraded by one level due unclear clinical decisions indicated by each confidence interval limit.

Figures and Tables -
Summary of findings 2. Larger traumatic needles compared to smaller traumatic needles for prevention of post‐dural puncture headache (PDPH)
Summary of findings 3. Larger atraumatic needles compared to smaller atraumatic needles for prevention of post‐dural puncture headache (PDPH)

Atraumatic needle (major gauge) compared to atraumatic needle (minor gauge) for prevention of PDPH

Patient or population: patients undergoing lumbar punctures with atraumatic needles (Whitacre, Atraucan, Sprotte, Cappe‐Deutsh, Pajunk, Gertie Marx, Durasafe, Cappe, Deutsch and Eldor)
Settings: all settings (countries: Canada, France, India, Italy, Spain, UK and USA)
Intervention: atraumatic needle ‐ larger gauge (Whitacre, Atraucan, Sprotte, Cappe‐Deutsh, Pajunk, Gertie Marx, Durasafe, Cappe, Deutsch and Eldor)
Comparison: atraumatic needle ‐ smaller gauge (Whitacre, Atraucan, Sprotte, Cappe‐Deutsh, Pajunk, Gertie Marx, Durasafe, Cappe, Deutsch and Eldor)

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Atraumatic needle ‐ smaller gauge

Atraumatic needle ‐ larger gauge

Onset of PDPH

RR ranged from 0.38 to 9.3

3134
(13 studies)

⊕⊕⊝⊝
low1,2

We decided against overall pooling of results because the gauge of a needle could be considered small in one comparison but large in other.

Adverse events: paraesthesia

RR ranged from 1.03 to 7.61

439
(2 studies)

⊕⊕⊕⊝
moderate1

We decided against overall pooling of results because the gauge of a needle could be considered small in one comparison but large in other.

Adverse events: backache

RR ranged
from 0.95 to 5.00

526
(4 studies)

⊕⊕⊕⊝
moderate1

We decided against overall pooling of results because the gauge of a needle could be considered small in one comparison but large in other.

Severe PDPH

RD ranged
from 0 to 0.01

1983
(8 studies)

⊕⊕⊝⊝
low1,2

We decided against overall pooling of results because the gauge of a needle could be considered small in one comparison but large in other.

Any headache

RR ranged
from 1.13 to 2.17

1791
(7 studies)

⊕⊕⊕⊝
moderate1

We decided against overall pooling of results because the gauge of a needle could be considered small in one comparison but large in other.

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; PDPH: post‐dural puncture headache; RD: risk difference; RR: risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Risk of bias downgraded by one level due to unclear reporting (especially related to allocation concealment and random sequence generation issues).
2Imprecision downgraded by one level due unclear clinical decisions indicated by each confidence interval limit.

Figures and Tables -
Summary of findings 3. Larger atraumatic needles compared to smaller atraumatic needles for prevention of post‐dural puncture headache (PDPH)
Comparison 1. Traumatic needle versus atraumatic needle

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 PDPH by indication Show forest plot

36

9378

Risk Ratio (M‐H, Random, 95% CI)

2.14 [1.72, 2.67]

1.1 Anaesthesia only

30

8401

Risk Ratio (M‐H, Random, 95% CI)

2.21 [1.60, 3.04]

1.2 Myelography only

3

548

Risk Ratio (M‐H, Random, 95% CI)

2.01 [1.34, 3.00]

1.3 Diagnostic lumbar puncture only

3

429

Risk Ratio (M‐H, Random, 95% CI)

2.22 [1.38, 3.58]

2 PDPH by gauge Show forest plot

20

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

2.1 22 gauge

5

877

Risk Ratio (M‐H, Random, 95% CI)

2.15 [1.56, 2.97]

2.2 25 gauge

5

1260

Risk Ratio (M‐H, Random, 95% CI)

2.48 [1.56, 3.95]

2.3 27 gauge

11

4076

Risk Ratio (M‐H, Random, 95% CI)

2.87 [1.81, 4.53]

3 PDPH by gender Show forest plot

9

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

3.1 Only women

9

1424

Risk Ratio (M‐H, Random, 95% CI)

2.60 [1.62, 4.17]

4 PDPH/anaesthesia: type of surgery Show forest plot

30

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

4.1 Caesarean section

8

1324

Risk Ratio (M‐H, Random, 95% CI)

3.12 [1.60, 6.10]

4.2 Orthopaedic procedures

3

994

Risk Ratio (M‐H, Random, 95% CI)

1.35 [0.58, 3.19]

4.3 Other surgeries

19

6083

Risk Ratio (M‐H, Random, 95% CI)

2.30 [1.50, 3.51]

5 PDPH by position Show forest plot

20

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

5.1 Lateral position

9

3242

Risk Ratio (M‐H, Random, 95% CI)

4.70 [2.39, 9.24]

5.2 Sitting position

11

2193

Risk Ratio (M‐H, Random, 95% CI)

2.11 [1.52, 2.94]

6 PDPH by age Show forest plot

36

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

6.1 No distinctions by age

34

9063

Risk Ratio (M‐H, Random, 95% CI)

2.17 [1.73, 2.73]

6.2 Only < 18 years

2

315

Risk Ratio (M‐H, Random, 95% CI)

1.69 [0.56, 5.12]

7 AE: paraesthesia Show forest plot

3

573

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.47, 1.96]

8 AE: backache Show forest plot

12

3027

Risk Ratio (M‐H, Random, 95% CI)

0.94 [0.78, 1.13]

9 Severe PDPH by indication Show forest plot

24

6420

Risk Ratio (M‐H, Random, 95% CI)

1.88 [1.20, 2.94]

9.1 Anesthesia

19

5542

Risk Ratio (M‐H, Random, 95% CI)

1.77 [0.88, 3.53]

9.2 Myelography

4

778

Risk Ratio (M‐H, Random, 95% CI)

1.70 [0.68, 4.28]

9.3 Diagnostic lumbar puncture

1

100

Risk Ratio (M‐H, Random, 95% CI)

3.0 [1.18, 7.63]

10 Any headache by indication Show forest plot

18

4104

Risk Ratio (M‐H, Random, 95% CI)

1.35 [1.17, 1.57]

10.1 Anaesthesia

16

3656

Risk Ratio (M‐H, Random, 95% CI)

1.38 [1.17, 1.63]

10.2 Myelography

2

448

Risk Ratio (M‐H, Random, 95% CI)

1.34 [0.81, 2.21]

11 PDPH sensitivity analysis Show forest plot

3

802

Risk Ratio (M‐H, Random, 95% CI)

2.78 [1.26, 6.15]

Figures and Tables -
Comparison 1. Traumatic needle versus atraumatic needle
Comparison 2. Larger gauge traumatic needles versus smaller gauge traumatic needles

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 PDPH larger gauge vs smaller gauge Show forest plot

10

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

1.1 23 G vs 25 G

1

53

Risk Ratio (M‐H, Random, 95% CI)

2.08 [0.20, 21.55]

1.2 25 G vs 27 G

4

1041

Risk Ratio (M‐H, Random, 95% CI)

1.82 [0.98, 3.39]

1.3 25 G vs 29 G

3

376

Risk Ratio (M‐H, Random, 95% CI)

2.13 [0.46, 9.78]

1.4 26 G vs 27 G

1

658

Risk Ratio (M‐H, Random, 95% CI)

6.47 [2.55, 16.43]

1.5 21 G vs 25 G

1

160

Risk Ratio (M‐H, Random, 95% CI)

0.86 [0.30, 2.44]

2 PDPH by type of surgery Show forest plot

10

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

2.1 Caesarean section

2

455

Risk Ratio (M‐H, Random, 95% CI)

1.28 [0.64, 2.57]

2.2 Orthopaedic surgeries

2

213

Risk Ratio (M‐H, Random, 95% CI)

0.99 [0.38, 2.58]

2.3 Other surgeries

6

1620

Risk Ratio (M‐H, Random, 95% CI)

2.94 [1.23, 7.03]

3 PDPH by age Show forest plot

10

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

3.1 No distinctions about age

8

2175

Risk Ratio (M‐H, Random, 95% CI)

2.09 [1.11, 3.95]

3.2 Only children

1

60

Risk Ratio (M‐H, Random, 95% CI)

3.0 [0.13, 70.83]

3.3 Only > 60 years

1

53

Risk Ratio (M‐H, Random, 95% CI)

2.08 [0.20, 21.55]

4 PDPH by position Show forest plot

7

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

4.1 Lateral position

5

859

Risk Ratio (M‐H, Random, 95% CI)

1.76 [0.98, 3.16]

4.2 Sitting position

2

584

Risk Ratio (M‐H, Random, 95% CI)

1.00 [0.64, 1.56]

5 AE: backache Show forest plot

3

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

6 Severe PDPH by gauge Show forest plot

6

Risk Difference (M‐H, Random, 95% CI)

Subtotals only

6.1 23 G vs 25 G

1

53

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.07, 0.07]

6.2 25 G vs 27 G

3

815

Risk Difference (M‐H, Random, 95% CI)

0.00 [‐0.01, 0.01]

6.3 25 G vs 29 G

1

100

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.04, 0.04]

6.4 21 G vs 25 G

1

160

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.02, 0.02]

7 Any headache Show forest plot

3

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Figures and Tables -
Comparison 2. Larger gauge traumatic needles versus smaller gauge traumatic needles
Comparison 3. Larger gauge atraumatic needles versus smaller gauge atraumatic needles

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 PDPH larger gauge vs smaller gauge Show forest plot

13

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

1.1 22 G vs 24 G

1

375

Risk Ratio (M‐H, Random, 95% CI)

0.98 [0.20, 4.81]

1.2 22 G vs 25 G

2

334

Risk Ratio (M‐H, Random, 95% CI)

3.00 [0.32, 28.50]

1.3 24 G vs 25 G

2

647

Risk Ratio (M‐H, Random, 95% CI)

5.62 [1.00, 31.67]

1.4 25 G vs 26 G

3

519

Risk Ratio (M‐H, Random, 95% CI)

0.76 [0.30, 1.90]

1.5 25 G vs 27 G

2

612

Risk Ratio (M‐H, Random, 95% CI)

3.72 [0.59, 23.64]

1.6 26 G vs 27 G

2

258

Risk Ratio (M‐H, Random, 95% CI)

1.79 [0.30, 10.73]

1.7 27 G vs 29 G

1

389

Risk Ratio (M‐H, Random, 95% CI)

1.59 [0.58, 4.37]

2 PDPH by type of surgery Show forest plot

13

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

2.1 Caesarean section

6

1263

Risk Ratio (M‐H, Random, 95% CI)

1.92 [0.64, 5.79]

2.2 Orthopaedic procedures

2

392

Risk Ratio (M‐H, Random, 95% CI)

1.24 [0.30, 5.07]

2.3 Other surgeries

5

1479

Risk Ratio (M‐H, Random, 95% CI)

1.44 [0.73, 2.83]

3 PDPH by gender Show forest plot

8

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

3.1 Only women

8

1853

Risk Ratio (M‐H, Random, 95% CI)

1.06 [0.51, 2.20]

4 PDPH by position Show forest plot

10

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

4.1 Sitting position

5

1106

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.45, 2.06]

4.2 Lateral position

5

992

Risk Ratio (M‐H, Random, 95% CI)

1.88 [0.65, 5.41]

5 AE: paraesthesia Show forest plot

2

439

Risk Ratio (M‐H, Random, 95% CI)

2.19 [0.31, 15.30]

6 AE: backache Show forest plot

4

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

7 Severe PDPH by gauge Show forest plot

8

Risk Difference (M‐H, Random, 95% CI)

Subtotals only

7.1 22 G vs 24 G

1

375

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.01, 0.01]

7.2 22 G vs 25 G

1

234

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.02, 0.02]

7.3 24 G vs 25 G

1

304

Risk Difference (M‐H, Random, 95% CI)

0.01 [‐0.02, 0.03]

7.4 25 G vs 26 G

2

311

Risk Difference (M‐H, Random, 95% CI)

0.01 [‐0.01, 0.03]

7.5 25 G vs 27 G

1

212

Risk Difference (M‐H, Random, 95% CI)

0.01 [‐0.02, 0.04]

7.6 26 G vs 27 G

1

158

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.02, 0.02]

7.7 27 G vs 29 G

1

389

Risk Difference (M‐H, Random, 95% CI)

0.0 [‐0.01, 0.01]

8 Any headache by gauge Show forest plot

7

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

8.1 22 G vs 25 G

1

234

Risk Ratio (M‐H, Random, 95% CI)

2.17 [0.85, 5.51]

8.2 24 G vs 25 G

2

645

Risk Ratio (M‐H, Random, 95% CI)

1.17 [0.49, 2.77]

8.3 25 G vs 26 G

2

311

Risk Ratio (M‐H, Random, 95% CI)

1.13 [0.65, 1.99]

8.4 25 G vs 27 G

1

212

Risk Ratio (M‐H, Random, 95% CI)

1.87 [0.65, 5.39]

8.5 27 G vs 29 G

1

389

Risk Ratio (M‐H, Random, 95% CI)

1.80 [0.85, 3.83]

Figures and Tables -
Comparison 3. Larger gauge atraumatic needles versus smaller gauge atraumatic needles